activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
Not Determined	6364740	CHEMBL1832995	Displacement of H4Ac4 peptide from first bromodomain of human BRD2 by peptide displacement assay	B	Cc1noc(C)c1-c1ccc2c(c1)CN(C)C(=O)N2		CHEMBL1828978		IC50			CHEMBL1293289	Homo sapiens	IC50		
Not Determined	6364740	CHEMBL1832995	Displacement of H4Ac4 peptide from first bromodomain of human BRD2 by peptide displacement assay	B	Cc1noc(C)c1-c1ccc2c(c1)CN(C)C(=O)N2		CHEMBL1828978		IC50			CHEMBL1293289	Homo sapiens	IC50		
	6364741	CHEMBL1832995	Displacement of H4Ac4 peptide from first bromodomain of human BRD2 by peptide displacement assay	B	Cc1noc(C)c1-c1ccccc1		CHEMBL1828979	=	IC50	nM	34300.0	CHEMBL1293289	Homo sapiens	IC50	uM	34.3
	6364742	CHEMBL1832995	Displacement of H4Ac4 peptide from first bromodomain of human BRD2 by peptide displacement assay	B	CC(=O)c1cccc(-c2c(C)noc2C)c1		CHEMBL1828980	=	IC50	nM	6000.0	CHEMBL1293289	Homo sapiens	IC50	uM	6.0
	6364743	CHEMBL1832995	Displacement of H4Ac4 peptide from first bromodomain of human BRD2 by peptide displacement assay	B	CCOc1cccc(-c2c(C)noc2C)c1		CHEMBL1828981	=	IC50	nM	7400.0	CHEMBL1293289	Homo sapiens	IC50	uM	7.4
	6364744	CHEMBL1832995	Displacement of H4Ac4 peptide from first bromodomain of human BRD2 by peptide displacement assay	B	Cc1noc(C)c1-c1cccc(C(C)O)c1		CHEMBL1828982	=	IC50	nM	4200.0	CHEMBL1293289	Homo sapiens	IC50	uM	4.2
	6364745	CHEMBL1832995	Displacement of H4Ac4 peptide from first bromodomain of human BRD2 by peptide displacement assay	B	CCOC(=O)c1cc(OCC)cc(-c2c(C)noc2C)c1		CHEMBL1828983	=	IC50	nM	3300.0	CHEMBL1293289	Homo sapiens	IC50	uM	3.3
	6364746	CHEMBL1832995	Displacement of H4Ac4 peptide from first bromodomain of human BRD2 by peptide displacement assay	B	CCOc1cc(C(=O)O)cc(-c2c(C)noc2C)c1		CHEMBL1828984	=	IC50	nM	28200.0	CHEMBL1293289	Homo sapiens	IC50	uM	28.2
	6364747	CHEMBL1832995	Displacement of H4Ac4 peptide from first bromodomain of human BRD2 by peptide displacement assay	B	CCOc1cc(C(C)=O)cc(-c2c(C)noc2C)c1		CHEMBL1828985	=	IC50	nM	2300.0	CHEMBL1293289	Homo sapiens	IC50	uM	2.3
	6364748	CHEMBL1832995	Displacement of H4Ac4 peptide from first bromodomain of human BRD2 by peptide displacement assay	B	CCOc1cc(-c2c(C)noc2C)cc(C(C)O)c1		CHEMBL1828986	=	IC50	nM	1600.0	CHEMBL1293289	Homo sapiens	IC50	uM	1.6
	6364767	CHEMBL1832992	Binding affinity to first bromodomain of BRD2 assessed as change in melting temperature at 100 uM by differential scanning fluorimetry	B	Cc1noc(C)c1-c1ccc2c(c1)CN(C)C(=O)N2		CHEMBL1828978	=	Delta Tm	degrees C	5.4	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	5.4
	6364768	CHEMBL1832992	Binding affinity to first bromodomain of BRD2 assessed as change in melting temperature at 100 uM by differential scanning fluorimetry	B	Cc1noc(C)c1-c1ccccc1		CHEMBL1828979	=	Delta Tm	degrees C	0.9	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	0.9
	6364769	CHEMBL1832992	Binding affinity to first bromodomain of BRD2 assessed as change in melting temperature at 100 uM by differential scanning fluorimetry	B	CC(=O)c1cccc(-c2c(C)noc2C)c1		CHEMBL1828980	=	Delta Tm	degrees C	1.3	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	1.3
	6364770	CHEMBL1832992	Binding affinity to first bromodomain of BRD2 assessed as change in melting temperature at 100 uM by differential scanning fluorimetry	B	CCOc1cccc(-c2c(C)noc2C)c1		CHEMBL1828981	=	Delta Tm	degrees C	1.3	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	1.3
	6364771	CHEMBL1832992	Binding affinity to first bromodomain of BRD2 assessed as change in melting temperature at 100 uM by differential scanning fluorimetry	B	Cc1noc(C)c1-c1cccc(C(C)O)c1		CHEMBL1828982	=	Delta Tm	degrees C	3.3	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	3.3
	6364772	CHEMBL1832992	Binding affinity to first bromodomain of BRD2 assessed as change in melting temperature at 100 uM by differential scanning fluorimetry	B	CCOC(=O)c1cc(OCC)cc(-c2c(C)noc2C)c1		CHEMBL1828983	=	Delta Tm	degrees C	2.3	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	2.3
	6364773	CHEMBL1832992	Binding affinity to first bromodomain of BRD2 assessed as change in melting temperature at 100 uM by differential scanning fluorimetry	B	CCOc1cc(C(=O)O)cc(-c2c(C)noc2C)c1		CHEMBL1828984	=	Delta Tm	degrees C	1.1	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	1.1
	6364774	CHEMBL1832992	Binding affinity to first bromodomain of BRD2 assessed as change in melting temperature at 100 uM by differential scanning fluorimetry	B	CCOc1cc(C(C)=O)cc(-c2c(C)noc2C)c1		CHEMBL1828985	=	Delta Tm	degrees C	3.2	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	3.2
	6364775	CHEMBL1832992	Binding affinity to first bromodomain of BRD2 assessed as change in melting temperature at 100 uM by differential scanning fluorimetry	B	CCOc1cc(-c2c(C)noc2C)cc(C(C)O)c1		CHEMBL1828986	=	Delta Tm	degrees C	6.1	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	6.1
	6364776	CHEMBL1832991	Binding affinity to second bromodomain of BRD2 assessed as change in melting temperature at 100 uM by differential scanning fluorimetry	B	Cc1noc(C)c1-c1ccc2c(c1)CN(C)C(=O)N2		CHEMBL1828978	=	Delta Tm	degrees C	6.2	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	6.2
	6364777	CHEMBL1832991	Binding affinity to second bromodomain of BRD2 assessed as change in melting temperature at 100 uM by differential scanning fluorimetry	B	Cc1noc(C)c1-c1ccccc1		CHEMBL1828979	=	Delta Tm	degrees C	2.1	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	2.1
	6364778	CHEMBL1832991	Binding affinity to second bromodomain of BRD2 assessed as change in melting temperature at 100 uM by differential scanning fluorimetry	B	CC(=O)c1cccc(-c2c(C)noc2C)c1		CHEMBL1828980	=	Delta Tm	degrees C	2.6	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	2.6
	6364779	CHEMBL1832991	Binding affinity to second bromodomain of BRD2 assessed as change in melting temperature at 100 uM by differential scanning fluorimetry	B	CCOc1cccc(-c2c(C)noc2C)c1		CHEMBL1828981	=	Delta Tm	degrees C	3.7	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	3.7
	6364780	CHEMBL1832991	Binding affinity to second bromodomain of BRD2 assessed as change in melting temperature at 100 uM by differential scanning fluorimetry	B	Cc1noc(C)c1-c1cccc(C(C)O)c1		CHEMBL1828982	=	Delta Tm	degrees C	5.6	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	5.6
	6364781	CHEMBL1832991	Binding affinity to second bromodomain of BRD2 assessed as change in melting temperature at 100 uM by differential scanning fluorimetry	B	CCOC(=O)c1cc(OCC)cc(-c2c(C)noc2C)c1		CHEMBL1828983	=	Delta Tm	degrees C	3.3	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	3.3
	6364782	CHEMBL1832991	Binding affinity to second bromodomain of BRD2 assessed as change in melting temperature at 100 uM by differential scanning fluorimetry	B	CCOc1cc(C(=O)O)cc(-c2c(C)noc2C)c1		CHEMBL1828984	=	Delta Tm	degrees C	2.5	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	2.5
	6364783	CHEMBL1832991	Binding affinity to second bromodomain of BRD2 assessed as change in melting temperature at 100 uM by differential scanning fluorimetry	B	CCOc1cc(C(C)=O)cc(-c2c(C)noc2C)c1		CHEMBL1828985	=	Delta Tm	degrees C	5.3	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	5.3
	6364784	CHEMBL1832991	Binding affinity to second bromodomain of BRD2 assessed as change in melting temperature at 100 uM by differential scanning fluorimetry	B	CCOc1cc(-c2c(C)noc2C)cc(C(C)O)c1		CHEMBL1828986	=	Delta Tm	degrees C	8.3	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	8.3
	6365474	CHEMBL1833000	Inhibition of first bromodomain of BRD2	B	Cc1noc(C)c1-c1ccc2c(c1)CN(C)C(=O)N2		CHEMBL1828978	=	IC50	nM	3000.0	CHEMBL1293289	Homo sapiens	IC50	uM	3.0
	8034555	CHEMBL1953100	Binding affinity to His-6 tagged BRD2 expressed in Escherichia coli at 100 uM after 60 mins by fluorescence anisotropic analysis	B	CC(=O)N1c2ccccc2CCC1C		CHEMBL1950955	=	Activity	%	44.0	CHEMBL1293289	Homo sapiens	Activity	%	44.0
	8034558	CHEMBL1953103	Inhibition of His-6 tagged BRD2-RD12 precoupled with biotinylated tetra-acetylated histone H4 expressed in Escherichia coli assessed as protein-protein interaction at 50 uM after 1 hr by TR-FRET assay	B	CC(=O)N1c2ccccc2CCC1C		CHEMBL1950955	=	Inhibition	%	44.0	CHEMBL1293289	Homo sapiens	INH	%	44.0
	8034561	CHEMBL1953106	Inhibition of His-6 tagged BRD2 expressed in Escherichia coli after 60 mins by fluorescence anisotropic analysis	B	CC(=O)c1cc(-c2ccccn2)c2ccccn12		CHEMBL1950956	=	IC50	nM	12600.0	CHEMBL1293289	Homo sapiens	IC50	uM	12.6
	8034564	CHEMBL1953109	Inhibition of His-6 tagged BRD2-RD12 interaction precoupled with biotinylated tetra-acetylated histone H4 expressed in Escherichia coli after 1 hr by TR-FRET assay	B	CC(=O)c1cc(-c2ccccn2)c2ccccn12		CHEMBL1950956	=	IC50	nM	2000.0	CHEMBL1293289	Homo sapiens	IC50	uM	2.0
	8034569	CHEMBL1953100	Binding affinity to His-6 tagged BRD2 expressed in Escherichia coli at 100 uM after 60 mins by fluorescence anisotropic analysis	B	CN1Cc2ccccc2NC1=O		CHEMBL1230189	=	Activity	%	12.0	CHEMBL1293289	Homo sapiens	Activity	%	12.0
	8034572	CHEMBL1953103	Inhibition of His-6 tagged BRD2-RD12 precoupled with biotinylated tetra-acetylated histone H4 expressed in Escherichia coli assessed as protein-protein interaction at 50 uM after 1 hr by TR-FRET assay	B	CN1Cc2ccccc2NC1=O		CHEMBL1230189	=	Inhibition	%	23.0	CHEMBL1293289	Homo sapiens	INH	%	23.0
	8034575	CHEMBL1953106	Inhibition of His-6 tagged BRD2 expressed in Escherichia coli after 60 mins by fluorescence anisotropic analysis	B	CN1Cc2cc(S(=O)(=O)N3CCOCC3)ccc2N(C)C1=O		CHEMBL1950957	=	IC50	nM	30000.0	CHEMBL1293289	Homo sapiens	IC50	uM	30.0
	8034578	CHEMBL1953100	Binding affinity to His-6 tagged BRD2 expressed in Escherichia coli at 100 uM after 60 mins by fluorescence anisotropic analysis	B	CC(=O)Nc1ccc(O)cc1		CHEMBL112	=	Activity	%	11.0	CHEMBL1293289	Homo sapiens	Activity	%	11.0
	8034581	CHEMBL1953103	Inhibition of His-6 tagged BRD2-RD12 precoupled with biotinylated tetra-acetylated histone H4 expressed in Escherichia coli assessed as protein-protein interaction at 50 uM after 1 hr by TR-FRET assay	B	CC(=O)Nc1ccc(O)cc1		CHEMBL112	=	Inhibition	%	6.0	CHEMBL1293289	Homo sapiens	INH	%	6.0
Active	8034584	CHEMBL1953113	Binding affinity to His-6 tagged BRD2 expressed in Escherichia coli at 10 mM after 60 mins by fluorescence anisotropic analysis	B	CC(=O)Nc1ccc(O)cc1		CHEMBL112		Activity			CHEMBL1293289	Homo sapiens	Activity		
	8034586	CHEMBL1953100	Binding affinity to His-6 tagged BRD2 expressed in Escherichia coli at 100 uM after 60 mins by fluorescence anisotropic analysis	B	CN1CCCC1=O		CHEMBL12543	<	Activity	%	5.0	CHEMBL1293289	Homo sapiens	Activity	%	5.0
	8034589	CHEMBL1953103	Inhibition of His-6 tagged BRD2-RD12 precoupled with biotinylated tetra-acetylated histone H4 expressed in Escherichia coli assessed as protein-protein interaction at 50 uM after 1 hr by TR-FRET assay	B	CN1CCCC1=O		CHEMBL12543	<	Inhibition	%	5.0	CHEMBL1293289	Homo sapiens	INH	%	5.0
	8046385	CHEMBL1960807	Binding affinity to BRD2-BD1 by isothermal titration calorimetry	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	Kd	nM	128.4	CHEMBL1293289	Homo sapiens	Kd	nM	128.4
	8046394	CHEMBL1958567	Binding affinity to BRD2-BD1 by SPR spectroscopy	B	Cn1c(=S)n(CCSc2nc3ccccc3[nH]2)c2ccccc21		CHEMBL1738777	=	Kd	nM	28000.0	CHEMBL1293289	Homo sapiens	Kd	nM	28000.0
	8046395	CHEMBL1958571	Displacement of acetylated histone peptide from BRD2-BD1,2 by FRET assay	B	Cc1nnc2n1-c1ccccc1C(c1ccccc1)=N[C@H]2NC(=O)OCc1ccccc1		CHEMBL1738926	=	IC50	nM	29.9	CHEMBL1293289	Homo sapiens	IC50	nM	29.9
	8046398	CHEMBL1958564	Binding affinity to BRD2-BD1,2 by isothermal titration calorimetry	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461	=	Kd	nM	61.3	CHEMBL1293289	Homo sapiens	Kd	nM	61.3
	8046401	CHEMBL1958571	Displacement of acetylated histone peptide from BRD2-BD1,2 by FRET assay	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461	=	IC50	nM	32.5	CHEMBL1293289	Homo sapiens	IC50	nM	32.5
	8046404	CHEMBL1958564	Binding affinity to BRD2-BD1,2 by isothermal titration calorimetry	B	Cc1nnc2n1-c1ccccc1C(c1ccccc1)=N[C@H]2NC(=O)OCc1ccccc1		CHEMBL1738926	=	Kd	nM	52.0	CHEMBL1293289	Homo sapiens	Kd	nM	52.0
	8055833	CHEMBL1958928	Binding affinity to BRD2-BD1 assessed as change in melting temperature at 100 uM by protein stability shift assay	B	CCC1=NCC(=O)Nc2ccc(Cl)cc21		CHEMBL1958341	<=	Delta Tm	degrees C	2.0	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	2.0
	8055834	CHEMBL1958928	Binding affinity to BRD2-BD1 assessed as change in melting temperature at 100 uM by protein stability shift assay	B	CCC1=NCC(=S)Nc2ccc(Cl)cc21		CHEMBL1958342	<=	Delta Tm	degrees C	2.0	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	2.0
	8055835	CHEMBL1958928	Binding affinity to BRD2-BD1 assessed as change in melting temperature at 100 uM by protein stability shift assay	B	CCC1=NCc2nnc(CC)n2-c2ccc(Cl)cc21		CHEMBL1958340	<=	Delta Tm	degrees C	2.0	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	2.0
	8055836	CHEMBL1958928	Binding affinity to BRD2-BD1 assessed as change in melting temperature at 100 uM by protein stability shift assay	B	CCC1=NCc2nnc(-c3ccccc3)n2-c2ccc(Cl)cc21		CHEMBL1958346	<=	Delta Tm	degrees C	2.0	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	2.0
	8055837	CHEMBL1958928	Binding affinity to BRD2-BD1 assessed as change in melting temperature at 100 uM by protein stability shift assay	B	CCC1=NCc2nnc(-c3ccncc3)n2-c2ccc(Cl)cc21		CHEMBL1958343	<=	Delta Tm	degrees C	2.0	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	2.0
	8055838	CHEMBL1958928	Binding affinity to BRD2-BD1 assessed as change in melting temperature at 100 uM by protein stability shift assay	B	CCC1=NCc2nnc(-c3cccc(OC)c3)n2-c2ccc(Cl)cc21		CHEMBL1958345	<=	Delta Tm	degrees C	2.0	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	2.0
	8055839	CHEMBL1958928	Binding affinity to BRD2-BD1 assessed as change in melting temperature at 100 uM by protein stability shift assay	B	CCC1=NCc2nnc(C)n2-c2ccc(Cl)cc21		CHEMBL1958344	<=	Delta Tm	degrees C	2.0	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	2.0
	8055840	CHEMBL1958928	Binding affinity to BRD2-BD1 assessed as change in melting temperature at 100 uM by protein stability shift assay	B	CN1N=C(c2ccccc2)c2cc(Cl)ccc2NC1=S		CHEMBL1958335	<=	Delta Tm	degrees C	2.0	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	2.0
	8055841	CHEMBL1958928	Binding affinity to BRD2-BD1 assessed as change in melting temperature at 100 uM by protein stability shift assay	B	CC(=O)NNC1=Nc2ccc(Cl)cc2C(c2ccccc2)=NN1C		CHEMBL1958336	<=	Delta Tm	degrees C	2.0	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	2.0
	8055842	CHEMBL1958928	Binding affinity to BRD2-BD1 assessed as change in melting temperature at 100 uM by protein stability shift assay	B	Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NN2C		CHEMBL1958337	<=	Delta Tm	degrees C	2.0	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	2.0
	8055843	CHEMBL1958928	Binding affinity to BRD2-BD1 assessed as change in melting temperature at 100 uM by protein stability shift assay	B	CN1N=C(c2ccccc2)c2cc(Cl)ccc2-n2c(N)nnc21		CHEMBL1958338	<=	Delta Tm	degrees C	2.0	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	2.0
	8055844	CHEMBL1958928	Binding affinity to BRD2-BD1 assessed as change in melting temperature at 100 uM by protein stability shift assay	B	CN1N=C(c2ccccc2)c2cc(Cl)ccc2-n2c1n[nH]c2=O		CHEMBL1958339	<=	Delta Tm	degrees C	2.0	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	2.0
Active	8055941	CHEMBL1958937	Binding affinity to BRD2-BD1 assessed as change in melting temperature at 10 uM by protein stability shift assay	B	Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2		CHEMBL661		Activity			CHEMBL1293289	Homo sapiens	Activity		
Active	8055942	CHEMBL1958937	Binding affinity to BRD2-BD1 assessed as change in melting temperature at 10 uM by protein stability shift assay	B	Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NN2C		CHEMBL1958337		Activity			CHEMBL1293289	Homo sapiens	Activity		
Not Active	8055943	CHEMBL1958937	Binding affinity to BRD2-BD1 assessed as change in melting temperature at 10 uM by protein stability shift assay	B	Clc1ccc2c(c1)C(c1ccccc1)=NCc1nncn1-2		CHEMBL285674		Activity			CHEMBL1293289	Homo sapiens	Activity		
Active	8055944	CHEMBL1958937	Binding affinity to BRD2-BD1 assessed as change in melting temperature at 10 uM by protein stability shift assay	B	CCOC(=O)c1ncn2c1[C@@H]1CCCN1C(=O)c1cc(OC)ccc1-2		CHEMBL52030		Activity			CHEMBL1293289	Homo sapiens	Activity		
Active	8055945	CHEMBL1958937	Binding affinity to BRD2-BD1 assessed as change in melting temperature at 10 uM by protein stability shift assay	B	Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2		CHEMBL655		Activity			CHEMBL1293289	Homo sapiens	Activity		
Active	8055946	CHEMBL1958937	Binding affinity to BRD2-BD1 assessed as change in melting temperature at 10 uM by protein stability shift assay	B	Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1Cl)=NC2		CHEMBL646		Activity			CHEMBL1293289	Homo sapiens	Activity		
	8056001	CHEMBL1959066	Binding affinity to BRD2-BD2 assessed as change in melting temperature at 100 uM by protein stability shift assay	B	CCC1=NCC(=O)Nc2ccc(Cl)cc21		CHEMBL1958341	<=	Delta Tm	degrees C	2.0	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	2.0
	8056002	CHEMBL1959066	Binding affinity to BRD2-BD2 assessed as change in melting temperature at 100 uM by protein stability shift assay	B	CCC1=NCC(=S)Nc2ccc(Cl)cc21		CHEMBL1958342	<=	Delta Tm	degrees C	2.0	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	2.0
	8056003	CHEMBL1959066	Binding affinity to BRD2-BD2 assessed as change in melting temperature at 100 uM by protein stability shift assay	B	CCC1=NCc2nnc(CC)n2-c2ccc(Cl)cc21		CHEMBL1958340	<=	Delta Tm	degrees C	2.0	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	2.0
	8056004	CHEMBL1959066	Binding affinity to BRD2-BD2 assessed as change in melting temperature at 100 uM by protein stability shift assay	B	CCC1=NCc2nnc(-c3ccccc3)n2-c2ccc(Cl)cc21		CHEMBL1958346	<=	Delta Tm	degrees C	2.0	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	2.0
	8056005	CHEMBL1959066	Binding affinity to BRD2-BD2 assessed as change in melting temperature at 100 uM by protein stability shift assay	B	CCC1=NCc2nnc(-c3ccncc3)n2-c2ccc(Cl)cc21		CHEMBL1958343	<=	Delta Tm	degrees C	2.0	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	2.0
	8056006	CHEMBL1959066	Binding affinity to BRD2-BD2 assessed as change in melting temperature at 100 uM by protein stability shift assay	B	CCC1=NCc2nnc(-c3cccc(OC)c3)n2-c2ccc(Cl)cc21		CHEMBL1958345	<=	Delta Tm	degrees C	2.0	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	2.0
	8056007	CHEMBL1959066	Binding affinity to BRD2-BD2 assessed as change in melting temperature at 100 uM by protein stability shift assay	B	CCC1=NCc2nnc(C)n2-c2ccc(Cl)cc21		CHEMBL1958344	<=	Delta Tm	degrees C	2.0	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	2.0
	8056008	CHEMBL1959066	Binding affinity to BRD2-BD2 assessed as change in melting temperature at 100 uM by protein stability shift assay	B	CN1N=C(c2ccccc2)c2cc(Cl)ccc2NC1=S		CHEMBL1958335	<=	Delta Tm	degrees C	2.0	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	2.0
	8056009	CHEMBL1959066	Binding affinity to BRD2-BD2 assessed as change in melting temperature at 100 uM by protein stability shift assay	B	CC(=O)NNC1=Nc2ccc(Cl)cc2C(c2ccccc2)=NN1C		CHEMBL1958336	<=	Delta Tm	degrees C	2.0	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	2.0
	8056010	CHEMBL1959066	Binding affinity to BRD2-BD2 assessed as change in melting temperature at 100 uM by protein stability shift assay	B	Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NN2C		CHEMBL1958337	<=	Delta Tm	degrees C	2.0	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	2.0
	8056011	CHEMBL1959066	Binding affinity to BRD2-BD2 assessed as change in melting temperature at 100 uM by protein stability shift assay	B	CN1N=C(c2ccccc2)c2cc(Cl)ccc2-n2c(N)nnc21		CHEMBL1958338	<=	Delta Tm	degrees C	2.0	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	2.0
	8056012	CHEMBL1959066	Binding affinity to BRD2-BD2 assessed as change in melting temperature at 100 uM by protein stability shift assay	B	CN1N=C(c2ccccc2)c2cc(Cl)ccc2-n2c1n[nH]c2=O		CHEMBL1958339	<=	Delta Tm	degrees C	2.0	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	2.0
Active	8056037	CHEMBL1959069	Binding affinity to BRD2-BD2 assessed as change in melting temperature at 10 uM by protein stability shift assay	B	Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2		CHEMBL661		Activity			CHEMBL1293289	Homo sapiens	Activity		
Active	8056038	CHEMBL1959069	Binding affinity to BRD2-BD2 assessed as change in melting temperature at 10 uM by protein stability shift assay	B	Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NN2C		CHEMBL1958337		Activity			CHEMBL1293289	Homo sapiens	Activity		
Not Active	8056039	CHEMBL1959069	Binding affinity to BRD2-BD2 assessed as change in melting temperature at 10 uM by protein stability shift assay	B	Clc1ccc2c(c1)C(c1ccccc1)=NCc1nncn1-2		CHEMBL285674		Activity			CHEMBL1293289	Homo sapiens	Activity		
Not Active	8056040	CHEMBL1959069	Binding affinity to BRD2-BD2 assessed as change in melting temperature at 10 uM by protein stability shift assay	B	CCOC(=O)c1ncn2c1[C@@H]1CCCN1C(=O)c1cc(OC)ccc1-2		CHEMBL52030		Activity			CHEMBL1293289	Homo sapiens	Activity		
Active	8056041	CHEMBL1959069	Binding affinity to BRD2-BD2 assessed as change in melting temperature at 10 uM by protein stability shift assay	B	Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2		CHEMBL655		Activity			CHEMBL1293289	Homo sapiens	Activity		
Active	8056042	CHEMBL1959069	Binding affinity to BRD2-BD2 assessed as change in melting temperature at 10 uM by protein stability shift assay	B	Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1Cl)=NC2		CHEMBL646		Activity			CHEMBL1293289	Homo sapiens	Activity		
	12062959	CHEMBL2156110	Binding affinity to N-terminal portion of human Brd2 containing bromodomain BD12 expressed in Escherichia coli by isothermal titration calorimetric analysis	B	Cc1nnc2n1-c1ccccc1C(c1ccccc1)=NC2NC(=O)OCc1ccccc1		CHEMBL2153434	=	Kd	nM	19.0	CHEMBL1293289	Homo sapiens	Kd	nM	19.0
	12062962	CHEMBL2156126	Binding affinity to N-terminal portion of human Brd2 containing bromodomain BD1 expressed in Escherichia coli at 16 degC by isothermal titration calorimetric analysis	B	Cc1nnc2n1-c1ccccc1C(c1ccccc1)=NC2NC(=O)OCc1ccccc1		CHEMBL2153434	=	Kd	nM	46.0	CHEMBL1293289	Homo sapiens	Kd	nM	46.0
	12062963	CHEMBL2156115	Binding affinity to N-terminal portion of human Brd2 containing bromodomain BD2 expressed in Escherichia coli at 26 degC by isothermal titration calorimetric analysis	B	Cc1nnc2n1-c1ccccc1C(c1ccccc1)=NC2NC(=O)OCc1ccccc1		CHEMBL2153434	=	Kd	nM	52.5	CHEMBL1293289	Homo sapiens	Kd	nM	52.5
	12062965	CHEMBL2156116	Ratio of Kd for human Brd2 containing bromodomain BD1 at 25 degC by SPR assay to Kd for human Brd2 containing bromodomain BD1 at 16 degC by ITC	B	Cc1nnc2n1-c1ccccc1C(c1ccccc1)=NC2NC(=O)OCc1ccccc1		CHEMBL2153434	=	Ratio		5.0	CHEMBL1293289	Homo sapiens	Ratio		5.0
	12062966	CHEMBL2156125	Binding affinity to N-terminal portion of human Brd2 containing bromodomain BD12 expressed in Escherichia coli at 26 degC by isothermal titration calorimetric analysis	B	Cc1nnc2n1-c1ccccc1C(c1ccccc1)=NC2NC(=O)OCc1ccccc1		CHEMBL2153434	=	Kd	nM	52.0	CHEMBL1293289	Homo sapiens	Kd	nM	52.0
	12062967	CHEMBL2156117	Displacement of tetra-acetylated H4 peptide from human Brd2 bromodomain BD12 after 1 hr by FRET analysis	B	Cc1nnc2n1-c1ccccc1C(c1ccccc1)=NC2NC(=O)OCc1ccccc1		CHEMBL2153434	=	IC50	nM	29.9	CHEMBL1293289	Homo sapiens	IC50	nM	29.9
	12062970	CHEMBL2156117	Displacement of tetra-acetylated H4 peptide from human Brd2 bromodomain BD12 after 1 hr by FRET analysis	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461	=	IC50	nM	32.5	CHEMBL1293289	Homo sapiens	IC50	nM	32.5
	12062973	CHEMBL2156113	Binding affinity to human Brd2 containing bromodomain BD1 expressed in Escherichia coli assessed as dissociation constant at 25 degC by surface plasma resonance	B	Cc1nnc2n1-c1ccccc1C(c1ccccc1)=NC2NC(=O)OCc1ccccc1		CHEMBL2153434	=	Kd	nM	220.0	CHEMBL1293289	Homo sapiens	Kd	nM	220.0
	12062974	CHEMBL2156114	Binding affinity to human Brd2 containing bromodomain BD2 expressed in Escherichia coli assessed as dissociation constant at 25 degC by surface plasma resonance	B	Cc1nnc2n1-c1ccccc1C(c1ccccc1)=NC2NC(=O)OCc1ccccc1		CHEMBL2153434	=	Kd	nM	54.0	CHEMBL1293289	Homo sapiens	Kd	nM	54.0
Dose-dependent effect	12062975	CHEMBL2156117	Displacement of tetra-acetylated H4 peptide from human Brd2 bromodomain BD12 after 1 hr by FRET analysis	B	Cc1nnc2n1-c1ccccc1C(c1ccccc1)=NC2NC(=O)OCc1ccccc1		CHEMBL2153434		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Dose-dependent effect	12062978	CHEMBL2156117	Displacement of tetra-acetylated H4 peptide from human Brd2 bromodomain BD12 after 1 hr by FRET analysis	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
	12134079	CHEMBL2183677	Binding affinity to BRD2 isoform 2 assessed as change in melting temperature at 10 uM by thermal shift assay	B	COc1ccccc1S(=O)(=O)Nc1ccc2c(c1)CN(C)C(=O)N2		CHEMBL2179387	=	Delta Tm	degrees C	5.32	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	5.32
	12134080	CHEMBL2183678	Binding affinity to BRD2 isoform 1 assessed as change in melting temperature at 10 uM by thermal shift assay	B	COc1ccccc1S(=O)(=O)Nc1ccc2c(c1)CN(C)C(=O)N2		CHEMBL2179387	=	Delta Tm	degrees C	4.61	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	4.61
	12135021	CHEMBL2187905	Binding affinity to human BRD2 assessed as inhibition of Alexa Fluor 488 binding after 60 mins by fluorescence anisotropic analysis	B	COc1cc2c(cc1-c1c(C)noc1C)ncc1[nH]c(=O)n([C@@H](C)c3ccccn3)c12		CHEMBL2181820	=	IC50	nM	1584.89	CHEMBL1293289	Homo sapiens	pIC50		5.8
	12135022	CHEMBL2187905	Binding affinity to human BRD2 assessed as inhibition of Alexa Fluor 488 binding after 60 mins by fluorescence anisotropic analysis	B	COc1cc2c(cc1-c1c(C)noc1C)ncc1[nH]c(=O)n([C@H](C)c3ccccn3)c12		CHEMBL2017291	=	IC50	nM	501.19	CHEMBL1293289	Homo sapiens	pIC50		6.3
	12135023	CHEMBL2187905	Binding affinity to human BRD2 assessed as inhibition of Alexa Fluor 488 binding after 60 mins by fluorescence anisotropic analysis	B	COc1cc2c(cc1-c1c(C)noc1C)ncc1[nH]c(=O)n([C@@H](C)c3ccccc3)c12		CHEMBL2017289	=	IC50	nM	1995.26	CHEMBL1293289	Homo sapiens	pIC50		5.7
	12135024	CHEMBL2187905	Binding affinity to human BRD2 assessed as inhibition of Alexa Fluor 488 binding after 60 mins by fluorescence anisotropic analysis	B	COc1cc2c(cc1-c1c(C)noc1C)ncc1[nH]c(=O)n([C@H](C)c3ccccc3)c12		CHEMBL2017288	=	IC50	nM	398.11	CHEMBL1293289	Homo sapiens	pIC50		6.4
	12135025	CHEMBL2187905	Binding affinity to human BRD2 assessed as inhibition of Alexa Fluor 488 binding after 60 mins by fluorescence anisotropic analysis	B	COc1cc2c(cc1-c1c(C)noc1C)ncc1[nH]c(=O)n(Cc3ccccn3)c12		CHEMBL2017286	=	IC50	nM	1584.89	CHEMBL1293289	Homo sapiens	pIC50		5.8
	12135026	CHEMBL2187905	Binding affinity to human BRD2 assessed as inhibition of Alexa Fluor 488 binding after 60 mins by fluorescence anisotropic analysis	B	COc1cc2c(cc1-c1c(C)noc1C)ncc1[nH]c(=O)n(Cc3ccccc3)c12		CHEMBL2017285	=	IC50	nM	501.19	CHEMBL1293289	Homo sapiens	pIC50		6.3
	12135027	CHEMBL2187905	Binding affinity to human BRD2 assessed as inhibition of Alexa Fluor 488 binding after 60 mins by fluorescence anisotropic analysis	B	COc1cc2c(cc1-c1c(C)noc1C)ncc1[nH]c(=O)n(-c3ccccc3F)c12		CHEMBL2017282	=	IC50	nM	2511.89	CHEMBL1293289	Homo sapiens	pIC50		5.6
	12135028	CHEMBL2187905	Binding affinity to human BRD2 assessed as inhibition of Alexa Fluor 488 binding after 60 mins by fluorescence anisotropic analysis	B	COc1cc2c(cc1-c1c(C)noc1C)ncc1[nH]c(=O)n(-c3ccccc3C(C)(C)C)c12		CHEMBL2017283	=	IC50	nM	501.19	CHEMBL1293289	Homo sapiens	pIC50		6.3
	12135029	CHEMBL2187905	Binding affinity to human BRD2 assessed as inhibition of Alexa Fluor 488 binding after 60 mins by fluorescence anisotropic analysis	B	COc1cc2c(NC3CCCCC3)c(C(N)=O)cnc2cc1-c1c(C)noc1C		CHEMBL2017277	=	IC50	nM	1995.26	CHEMBL1293289	Homo sapiens	pIC50		5.7
	12135030	CHEMBL2187905	Binding affinity to human BRD2 assessed as inhibition of Alexa Fluor 488 binding after 60 mins by fluorescence anisotropic analysis	B	COc1cc2c(Nc3cccc4cccnc34)c(C(N)=O)cnc2cc1-c1c(C)noc1C		CHEMBL2017281	=	IC50	nM	1000.0	CHEMBL1293289	Homo sapiens	pIC50		6.0
	12135031	CHEMBL2187905	Binding affinity to human BRD2 assessed as inhibition of Alexa Fluor 488 binding after 60 mins by fluorescence anisotropic analysis	B	Cc1noc(C)c1-c1ccc2c(Nc3ccccc3C(C)(C)C)c(C(=O)O)cnc2c1		CHEMBL2017269	=	IC50	nM	794.33	CHEMBL1293289	Homo sapiens	pIC50		6.1
	12135032	CHEMBL2187905	Binding affinity to human BRD2 assessed as inhibition of Alexa Fluor 488 binding after 60 mins by fluorescence anisotropic analysis	B	Cc1noc(C)c1-c1ccc2c(Nc3ccccc3F)c(C(=O)O)cnc2c1		CHEMBL2181818	=	IC50	nM	1584.89	CHEMBL1293289	Homo sapiens	pIC50		5.8
	12135033	CHEMBL2187905	Binding affinity to human BRD2 assessed as inhibition of Alexa Fluor 488 binding after 60 mins by fluorescence anisotropic analysis	B	Cc1noc(C)c1-c1ccc2c(Nc3ccccc3F)c(C(N)=O)cnc2c1		CHEMBL2017264	=	IC50	nM	12589.25	CHEMBL1293289	Homo sapiens	pIC50		4.9
	12135034	CHEMBL2187905	Binding affinity to human BRD2 assessed as inhibition of Alexa Fluor 488 binding after 60 mins by fluorescence anisotropic analysis	B	COc1cc2c(Nc3ccccc3F)c(C(N)=O)cnc2cc1-c1c(C)noc1C		CHEMBL2017273	=	IC50	nM	501.19	CHEMBL1293289	Homo sapiens	pIC50		6.3
	12135035	CHEMBL2187905	Binding affinity to human BRD2 assessed as inhibition of Alexa Fluor 488 binding after 60 mins by fluorescence anisotropic analysis	B	COc1cc2c(Nc3ccccc3F)ccnc2cc1-c1c(C)noc1C		CHEMBL2181819	=	IC50	nM	3162.28	CHEMBL1293289	Homo sapiens	pIC50		5.5
	12139756	CHEMBL2184783	Binding affinity to BRD2 isoform 1 by SPR	B	Cn1c(=S)n(CCSc2nc3ccccc3[nH]2)c2ccccc21		CHEMBL1738777	=	Kd	nM	28000.0	CHEMBL1293289	Homo sapiens	Kd	uM	28.0
	12161571	CHEMBL2182554	Binding affinity to His6-tagged BRD2 expressed in Escherichia coli by surface plasmon resonance assay	B	Cc1noc(C)c1-c1ccc(OCCCN2CCOCC2)c(S(=O)(=O)NC2CCCC2)c1		CHEMBL2181718	=	Kd	nM	3140.0	CHEMBL1293289	Homo sapiens	Kd	uM	3.14
	12161611	CHEMBL2187424	Inhibition of His6FLAG-tagged BRD2-BD1 expressed in Escherichia coli assessed as change in melting temperature at 100 uM by thermal shift assay	B	Cc1noc(C)c1-c1ccc(OCCCN2CCOCC2)c(S(=O)(=O)NC2CCCC2)c1		CHEMBL2181718	=	Delta Tm	degrees C	1.0	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	1.0
	12161612	CHEMBL2187424	Inhibition of His6FLAG-tagged BRD2-BD1 expressed in Escherichia coli assessed as change in melting temperature at 100 uM by thermal shift assay	B	Cc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)NC1CCCC1		CHEMBL2181721	=	Delta Tm	degrees C	1.0	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	1.0
	12161617	CHEMBL2187427	Inhibition of His6FLAG-tagged BRD2-BD12 expressed in Escherichia coli assessed as change in melting temperature at 100 uM by thermal shift assay	B	Cc1noc(C)c1-c1ccc(OCCCN2CCOCC2)c(S(=O)(=O)NC2CCCC2)c1		CHEMBL2181718	=	Delta Tm	degrees C	2.0	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	2.0
	12161618	CHEMBL2187427	Inhibition of His6FLAG-tagged BRD2-BD12 expressed in Escherichia coli assessed as change in melting temperature at 100 uM by thermal shift assay	B	Cc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)NC1CCCC1		CHEMBL2181721	=	Delta Tm	degrees C	2.0	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	2.0
	12161624	CHEMBL2182554	Binding affinity to His6-tagged BRD2 expressed in Escherichia coli by surface plasmon resonance assay	B	Cc1noc(C)c1-c1ccc(OCCCN2CCOCC2)c(S(=O)(=O)NC2CCCC2)c1		CHEMBL2181718	=	RUmax	%	34.0	CHEMBL1293289	Homo sapiens	RUmax	%	34.0
	12161629	CHEMBL2182557	Binding affinity to His6-tagged BRD2 expressed in Escherichia coli by isothermal colorimetric analysis	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461	=	Kd	nM	101.0	CHEMBL1293289	Homo sapiens	Kd	nM	101.0
	12161630	CHEMBL2182557	Binding affinity to His6-tagged BRD2 expressed in Escherichia coli by isothermal colorimetric analysis	B	Cc1nnc2n1-c1ccccc1C(c1ccccc1)=N[C@H]2NC(=O)OCc1ccccc1		CHEMBL1738926	=	Kd	nM	52.0	CHEMBL1293289	Homo sapiens	Kd	nM	52.0
	12161717	CHEMBL2182560	Inhibition of His6-tagged BRD2 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	Cc1noc(C)c1-c1ccc(OCCCN2CCOCC2)c(S(=O)(=O)NC2CCCC2)c1		CHEMBL2181718	=	IC50	nM	1500.0	CHEMBL1293289	Homo sapiens	IC50	uM	1.5
	12161718	CHEMBL2182560	Inhibition of His6-tagged BRD2 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	Cc1noc(C)c1-c1ccc(OCCN2CCNCC2)c(S(=O)(=O)NC2CCCC2)c1		CHEMBL2181717	=	IC50	nM	3600.0	CHEMBL1293289	Homo sapiens	IC50	uM	3.6
	12161719	CHEMBL2182560	Inhibition of His6-tagged BRD2 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	Cc1noc(C)c1-c1ccc(O)c(S(=O)(=O)NC2CCCC2)c1		CHEMBL2181716	=	IC50	nM	1500.0	CHEMBL1293289	Homo sapiens	IC50	uM	1.5
	12161720	CHEMBL2182560	Inhibition of His6-tagged BRD2 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	Cc1noc(C)c1-c1cccc(S(=O)(=O)NC2CC2)c1		CHEMBL2181715	=	IC50	nM	3600.0	CHEMBL1293289	Homo sapiens	IC50	uM	3.6
	12161721	CHEMBL2182560	Inhibition of His6-tagged BRD2 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	COc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)NC1CCCNC1		CHEMBL2181714	=	IC50	nM	9000.0	CHEMBL1293289	Homo sapiens	IC50	uM	9.0
	12161722	CHEMBL2182560	Inhibition of His6-tagged BRD2 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	Cc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)NC1CCCNC1		CHEMBL2181713	=	IC50	nM	11000.0	CHEMBL1293289	Homo sapiens	IC50	uM	11.0
	12161723	CHEMBL2182560	Inhibition of His6-tagged BRD2 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	COc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)NC1CCNCC1		CHEMBL2181712	=	IC50	nM	31000.0	CHEMBL1293289	Homo sapiens	IC50	uM	31.0
	12161724	CHEMBL2182560	Inhibition of His6-tagged BRD2 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	Cc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)NC1CCNCC1		CHEMBL2181711	=	IC50	nM	19000.0	CHEMBL1293289	Homo sapiens	IC50	uM	19.0
	12161725	CHEMBL2182560	Inhibition of His6-tagged BRD2 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	COc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)N1CCOCC1		CHEMBL2181710	=	IC50	nM	11000.0	CHEMBL1293289	Homo sapiens	IC50	uM	11.0
	12161726	CHEMBL2182560	Inhibition of His6-tagged BRD2 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	Cc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)N1CCOCC1		CHEMBL2181709	=	IC50	nM	4200.0	CHEMBL1293289	Homo sapiens	IC50	uM	4.2
	12161727	CHEMBL2182560	Inhibition of His6-tagged BRD2 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	COc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)N1CCNCC1		CHEMBL2181708	=	IC50	nM	16000.0	CHEMBL1293289	Homo sapiens	IC50	uM	16.0
	12161728	CHEMBL2182560	Inhibition of His6-tagged BRD2 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	Cc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)N1CCNCC1		CHEMBL2181707	=	IC50	nM	14000.0	CHEMBL1293289	Homo sapiens	IC50	uM	14.0
	12161729	CHEMBL2182560	Inhibition of His6-tagged BRD2 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	Cc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)N1CCCCC1		CHEMBL2181706	=	IC50	nM	1100.0	CHEMBL1293289	Homo sapiens	IC50	uM	1.1
	12161730	CHEMBL2182560	Inhibition of His6-tagged BRD2 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	Cc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)N1CCCC1		CHEMBL2181705	=	IC50	nM	1700.0	CHEMBL1293289	Homo sapiens	IC50	uM	1.7
	12161731	CHEMBL2182560	Inhibition of His6-tagged BRD2 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	CCN(C1CCCC1)S(=O)(=O)c1cc(-c2c(C)noc2C)ccc1OC		CHEMBL2181704	=	IC50	nM	800.0	CHEMBL1293289	Homo sapiens	IC50	uM	0.8
	12161732	CHEMBL2182560	Inhibition of His6-tagged BRD2 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	COc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)N(C)C1CCCC1		CHEMBL2181703	=	IC50	nM	800.0	CHEMBL1293289	Homo sapiens	IC50	uM	0.8
	12161733	CHEMBL2182560	Inhibition of His6-tagged BRD2 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	CCNS(=O)(=O)c1cc(-c2c(C)noc2C)ccc1C		CHEMBL2181702	=	IC50	nM	2200.0	CHEMBL1293289	Homo sapiens	IC50	uM	2.2
	12161734	CHEMBL2182560	Inhibition of His6-tagged BRD2 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	Cc1ccc(-c2c(C)noc2C)cc1S(N)(=O)=O		CHEMBL2181701	=	IC50	nM	8100.0	CHEMBL1293289	Homo sapiens	IC50	uM	8.1
	12161735	CHEMBL2182560	Inhibition of His6-tagged BRD2 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	Cc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)NC(C)(C)C		CHEMBL2181742	=	IC50	nM	2500.0	CHEMBL1293289	Homo sapiens	IC50	uM	2.5
	12161736	CHEMBL2182560	Inhibition of His6-tagged BRD2 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	Cc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)NCCCO		CHEMBL2181741	=	IC50	nM	5600.0	CHEMBL1293289	Homo sapiens	IC50	uM	5.6
	12161737	CHEMBL2182560	Inhibition of His6-tagged BRD2 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	COCCNS(=O)(=O)c1cc(-c2c(C)noc2C)ccc1C		CHEMBL2181740	=	IC50	nM	12000.0	CHEMBL1293289	Homo sapiens	IC50	uM	12.0
	12161738	CHEMBL2182560	Inhibition of His6-tagged BRD2 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	Cc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)NCCCc1ccccc1		CHEMBL2181739	=	IC50	nM	3900.0	CHEMBL1293289	Homo sapiens	IC50	uM	3.9
	12161739	CHEMBL2182560	Inhibition of His6-tagged BRD2 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	Cc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)NCCc1ccccc1		CHEMBL2181738	=	IC50	nM	4400.0	CHEMBL1293289	Homo sapiens	IC50	uM	4.4
	12161740	CHEMBL2182560	Inhibition of His6-tagged BRD2 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	COc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)NCc1ccccc1		CHEMBL2181737	=	IC50	nM	13000.0	CHEMBL1293289	Homo sapiens	IC50	uM	13.0
	12161741	CHEMBL2182560	Inhibition of His6-tagged BRD2 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	Cc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)NCc1ccccc1		CHEMBL2181736	=	IC50	nM	4700.0	CHEMBL1293289	Homo sapiens	IC50	uM	4.7
	12161742	CHEMBL2182560	Inhibition of His6-tagged BRD2 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	COc1ccc(NS(=O)(=O)c2cc(-c3c(C)noc3C)ccc2OC)cc1		CHEMBL2181735	=	IC50	nM	14000.0	CHEMBL1293289	Homo sapiens	IC50	uM	14.0
	12161743	CHEMBL2182560	Inhibition of His6-tagged BRD2 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	COc1ccc(NS(=O)(=O)c2cc(-c3c(C)noc3C)ccc2C)cc1		CHEMBL2181734	=	IC50	nM	6000.0	CHEMBL1293289	Homo sapiens	IC50	uM	6.0
	12161744	CHEMBL2182560	Inhibition of His6-tagged BRD2 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	COc1cccc(NS(=O)(=O)c2cc(-c3c(C)noc3C)ccc2OC)c1		CHEMBL2181733	=	IC50	nM	5200.0	CHEMBL1293289	Homo sapiens	IC50	uM	5.2
	12161745	CHEMBL2182560	Inhibition of His6-tagged BRD2 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	COc1cccc(NS(=O)(=O)c2cc(-c3c(C)noc3C)ccc2C)c1		CHEMBL2181732	=	IC50	nM	2000.0	CHEMBL1293289	Homo sapiens	IC50	uM	2.0
	12161746	CHEMBL2182560	Inhibition of His6-tagged BRD2 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	COc1ccccc1NS(=O)(=O)c1cc(-c2c(C)noc2C)ccc1OC		CHEMBL2181731	=	IC50	nM	4900.0	CHEMBL1293289	Homo sapiens	IC50	uM	4.9
	12161747	CHEMBL2182560	Inhibition of His6-tagged BRD2 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	COc1ccccc1NS(=O)(=O)c1cc(-c2c(C)noc2C)ccc1C		CHEMBL2181730	=	IC50	nM	1500.0	CHEMBL1293289	Homo sapiens	IC50	uM	1.5
	12161748	CHEMBL2182560	Inhibition of His6-tagged BRD2 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	Cc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)Nc1ccc(Cl)cc1		CHEMBL2181729	=	IC50	nM	3600.0	CHEMBL1293289	Homo sapiens	IC50	uM	3.6
	12161749	CHEMBL2182560	Inhibition of His6-tagged BRD2 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	Cc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)Nc1cccc(Cl)c1		CHEMBL2181728	=	IC50	nM	2500.0	CHEMBL1293289	Homo sapiens	IC50	uM	2.5
	12161750	CHEMBL2182560	Inhibition of His6-tagged BRD2 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	COc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)Nc1ccccc1Cl		CHEMBL2181727	=	IC50	nM	4300.0	CHEMBL1293289	Homo sapiens	IC50	uM	4.3
	12161751	CHEMBL2182560	Inhibition of His6-tagged BRD2 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	Cc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)Nc1ccccc1Cl		CHEMBL2181726	=	IC50	nM	1800.0	CHEMBL1293289	Homo sapiens	IC50	uM	1.8
	12161752	CHEMBL2182560	Inhibition of His6-tagged BRD2 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	COc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)Nc1ccccc1		CHEMBL2181725	=	IC50	nM	2400.0	CHEMBL1293289	Homo sapiens	IC50	uM	2.4
	12161753	CHEMBL2182560	Inhibition of His6-tagged BRD2 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	Cc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)Nc1ccccc1		CHEMBL2181724	=	IC50	nM	1100.0	CHEMBL1293289	Homo sapiens	IC50	uM	1.1
	12161754	CHEMBL2182560	Inhibition of His6-tagged BRD2 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	Cc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)NC1CCCCC1		CHEMBL2181723	=	IC50	nM	900.0	CHEMBL1293289	Homo sapiens	IC50	uM	0.9
	12161755	CHEMBL2182560	Inhibition of His6-tagged BRD2 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	COc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)NC1CCCC1		CHEMBL2181722	=	IC50	nM	1400.0	CHEMBL1293289	Homo sapiens	IC50	uM	1.4
	12161756	CHEMBL2182560	Inhibition of His6-tagged BRD2 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	Cc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)NC1CCCC1		CHEMBL2181721	=	IC50	nM	500.0	CHEMBL1293289	Homo sapiens	IC50	uM	0.5
	12161757	CHEMBL2182560	Inhibition of His6-tagged BRD2 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	COc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)NC1CC1		CHEMBL2181720	=	IC50	nM	1900.0	CHEMBL1293289	Homo sapiens	IC50	uM	1.9
	12161758	CHEMBL2182560	Inhibition of His6-tagged BRD2 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461	=	IC50	nM	150.0	CHEMBL1293289	Homo sapiens	IC50	nM	150.0
	12161759	CHEMBL2182560	Inhibition of His6-tagged BRD2 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	Cc1nnc2n1-c1ccccc1C(c1ccccc1)=N[C@H]2NC(=O)OCc1ccccc1		CHEMBL1738926	=	IC50	nM	160.0	CHEMBL1293289	Homo sapiens	IC50	nM	160.0
	12161768	CHEMBL2182567	Inhibition of His6-tagged BRD2 expressed in Escherichia coli after 60 mins by fluorescence anisotropy assay	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461	=	IC50	nM	810.0	CHEMBL1293289	Homo sapiens	IC50	nM	810.0
	12161769	CHEMBL2182567	Inhibition of His6-tagged BRD2 expressed in Escherichia coli after 60 mins by fluorescence anisotropy assay	B	Cc1nnc2n1-c1ccccc1C(c1ccccc1)=N[C@H]2NC(=O)OCc1ccccc1		CHEMBL1738926	=	IC50	nM	820.0	CHEMBL1293289	Homo sapiens	IC50	nM	820.0
	12161772	CHEMBL2182560	Inhibition of His6-tagged BRD2 expressed in Escherichia coli assessed as inhibition of binding to SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHGSGSK-biotin after 1 hr by TR-FRET assay	B	Cc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)NC1CC1		CHEMBL2181719	=	IC50	nM	1500.0	CHEMBL1293289	Homo sapiens	IC50	uM	1.5
	12185153	CHEMBL2216378	Inhibition of BRD2	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL1293289	Homo sapiens	pIC50		5.0
	13455997	CHEMBL2433593	Binding affinity to His6-tagged BRD2 (unknown origin) after 60 mins by fluorescence anisotropy binding Assay	B	CCOC(=O)NC1N=C(c2ccc(Cl)cc2)c2ccccc2-n2c(C)nnc21		CHEMBL2430874	=	IC50	nM	2511.89	CHEMBL1293289	Homo sapiens	pIC50		5.6
	13455998	CHEMBL2433593	Binding affinity to His6-tagged BRD2 (unknown origin) after 60 mins by fluorescence anisotropy binding Assay	B	CCOC(=O)N[C@@H]1N=C(c2ccccc2)c2ccccc2-n2c(C)nnc21		CHEMBL2430873	=	IC50	nM	1258.93	CHEMBL1293289	Homo sapiens	pIC50		5.9
	13455999	CHEMBL2433593	Binding affinity to His6-tagged BRD2 (unknown origin) after 60 mins by fluorescence anisotropy binding Assay	B	CCOC(=O)N[C@H]1N=C(c2ccccc2)c2ccccc2-n2c(C)nnc21		CHEMBL2430872	=	IC50	nM	100000.0	CHEMBL1293289	Homo sapiens	pIC50		4.0
	13456000	CHEMBL2433593	Binding affinity to His6-tagged BRD2 (unknown origin) after 60 mins by fluorescence anisotropy binding Assay	B	CCOC(=O)NC1N=C(c2ccccc2)c2ccccc2-n2c(C)nnc21		CHEMBL2430871	=	IC50	nM	2511.89	CHEMBL1293289	Homo sapiens	pIC50		5.6
	13456001	CHEMBL2433593	Binding affinity to His6-tagged BRD2 (unknown origin) after 60 mins by fluorescence anisotropy binding Assay	B	Cc1nnc2n1-c1ccccc1C(c1ccccc1)=NC2NC(=O)Oc1cccc(F)c1		CHEMBL2430870	=	IC50	nM	3162.28	CHEMBL1293289	Homo sapiens	pIC50		5.5
	13456002	CHEMBL2433593	Binding affinity to His6-tagged BRD2 (unknown origin) after 60 mins by fluorescence anisotropy binding Assay	B	Cc1nnc2n1-c1ccccc1C(c1ccccc1)=NC2NC(=O)OCc1ccc(F)cc1		CHEMBL2430869	=	IC50	nM	1995.26	CHEMBL1293289	Homo sapiens	pIC50		5.7
	13456003	CHEMBL2433593	Binding affinity to His6-tagged BRD2 (unknown origin) after 60 mins by fluorescence anisotropy binding Assay	B	Cc1ccc(C2=NC(NC(=O)OCc3ccccc3)c3nnc(C)n3-c3ccccc32)cc1		CHEMBL2430896	=	IC50	nM	1584.89	CHEMBL1293289	Homo sapiens	pIC50		5.8
	13456004	CHEMBL2433593	Binding affinity to His6-tagged BRD2 (unknown origin) after 60 mins by fluorescence anisotropy binding Assay	B	COc1ccc(C2=NC(NC(=O)OCc3ccccc3)c3nnc(C)n3-c3ccccc32)cc1		CHEMBL2430895	=	IC50	nM	1995.26	CHEMBL1293289	Homo sapiens	pIC50		5.7
	13456005	CHEMBL2433593	Binding affinity to His6-tagged BRD2 (unknown origin) after 60 mins by fluorescence anisotropy binding Assay	B	COc1cccc(C2=NC(NC(=O)OCc3ccccc3)c3nnc(C)n3-c3ccccc32)c1		CHEMBL2430894	=	IC50	nM	3162.28	CHEMBL1293289	Homo sapiens	pIC50		5.5
	13456006	CHEMBL2433593	Binding affinity to His6-tagged BRD2 (unknown origin) after 60 mins by fluorescence anisotropy binding Assay	B	COc1ccccc1C1=NC(NC(=O)OCc2ccccc2)c2nnc(C)n2-c2ccccc21		CHEMBL2430893	=	IC50	nM	10000.0	CHEMBL1293289	Homo sapiens	pIC50		5.0
	13456007	CHEMBL2433593	Binding affinity to His6-tagged BRD2 (unknown origin) after 60 mins by fluorescence anisotropy binding Assay	B	COc1ccc2c(c1)C(c1ccccc1)=NC(NC(=O)OCc1ccccc1)c1nnc(C)n1-2		CHEMBL2430892	=	IC50	nM	794.33	CHEMBL1293289	Homo sapiens	pIC50		6.1
	13456008	CHEMBL2433593	Binding affinity to His6-tagged BRD2 (unknown origin) after 60 mins by fluorescence anisotropy binding Assay	B	Cc1ccc2c(c1)-n1c(C)nnc1C(NC(=O)OCc1ccccc1)N=C2c1ccccc1		CHEMBL2430891	=	IC50	nM	2511.89	CHEMBL1293289	Homo sapiens	pIC50		5.6
	13456009	CHEMBL2433593	Binding affinity to His6-tagged BRD2 (unknown origin) after 60 mins by fluorescence anisotropy binding Assay	B	Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2NC(=O)OCc1ccccc1		CHEMBL2430890	=	IC50	nM	3162.28	CHEMBL1293289	Homo sapiens	pIC50		5.5
	13456010	CHEMBL2433593	Binding affinity to His6-tagged BRD2 (unknown origin) after 60 mins by fluorescence anisotropy binding Assay	B	Cc1nnc2n1-c1ccc([N+](=O)[O-])cc1C(c1ccccc1)=NC2NC(=O)OCc1ccccc1		CHEMBL2430889	=	IC50	nM	12589.25	CHEMBL1293289	Homo sapiens	pIC50		4.9
	13456011	CHEMBL2433593	Binding affinity to His6-tagged BRD2 (unknown origin) after 60 mins by fluorescence anisotropy binding Assay	B	Cc1nnc2n1-c1ccccc1C(c1ccccc1)=NC2CC(=O)NCc1ccccc1		CHEMBL2430888	=	IC50	nM	2511.89	CHEMBL1293289	Homo sapiens	pIC50		5.6
	13456012	CHEMBL2433593	Binding affinity to His6-tagged BRD2 (unknown origin) after 60 mins by fluorescence anisotropy binding Assay	B	Cc1nnc2n1-c1ccccc1C(c1ccccc1)=NC2NS(=O)(=O)Cc1ccccc1		CHEMBL2430887	=	IC50	nM	31622.78	CHEMBL1293289	Homo sapiens	pIC50		4.5
	13456013	CHEMBL2433593	Binding affinity to His6-tagged BRD2 (unknown origin) after 60 mins by fluorescence anisotropy binding Assay	B	Cc1nnc2n1-c1ccccc1C(c1ccccc1)=NC2NC(=O)NCc1ccccc1		CHEMBL2430886	=	IC50	nM	1995.26	CHEMBL1293289	Homo sapiens	pIC50		5.7
	13456014	CHEMBL2433593	Binding affinity to His6-tagged BRD2 (unknown origin) after 60 mins by fluorescence anisotropy binding Assay	B	Cc1nnc2n1-c1ccccc1C(c1ccccc1)=NC2NC(=O)CCc1ccccc1		CHEMBL2430885	=	IC50	nM	15848.93	CHEMBL1293289	Homo sapiens	pIC50		4.8
	13456015	CHEMBL2433593	Binding affinity to His6-tagged BRD2 (unknown origin) after 60 mins by fluorescence anisotropy binding Assay	B	Cc1nnc2n1-c1ccccc1C(c1ccccc1)=NC2N		CHEMBL2430884	=	IC50	nM	25118.86	CHEMBL1293289	Homo sapiens	pIC50		4.6
	13456016	CHEMBL2433593	Binding affinity to His6-tagged BRD2 (unknown origin) after 60 mins by fluorescence anisotropy binding Assay	B	Cc1nnc2n1-c1ccccc1C(c1ccccc1)=NC2NC(=O)OCc1ccccc1		CHEMBL2153434	=	IC50	nM	1258.93	CHEMBL1293289	Homo sapiens	pIC50		5.9
	13477949	CHEMBL2439862	Inhibition of first bromodomain of BRD2 (unknown origin)	B	Cn1c(=S)n(CCSc2nc3ccccc3[nH]2)c2ccccc21		CHEMBL1738777	=	IC50	nM	28000.0	CHEMBL1293289	Homo sapiens	IC50	uM	28.0
	13890195	CHEMBL3111102	Binding affinity to BRD2 bromodomain-2 (unknown origin) assessed as change in melting temperature at 100 uM by differential scanning fluorimetric analysis	B	CNC(=O)N1CCc2[nH]c3ccc(Cl)cc3c2C1		CHEMBL3110241	=	Delta Tm	degrees C	-0.2	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	-0.2
	13890196	CHEMBL3111102	Binding affinity to BRD2 bromodomain-2 (unknown origin) assessed as change in melting temperature at 100 uM by differential scanning fluorimetric analysis	B	CC(=O)N1CCc2[nH]c3ccc(Br)cc3c2C1		CHEMBL3110228	=	Delta Tm	degrees C	3.5	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	3.5
	13890197	CHEMBL3111103	Binding affinity to BRD2 bromodomain-1 (unknown origin) assessed as change in melting temperature at 100 uM by differential scanning fluorimetric analysis	B	CNC(=O)N1CCc2[nH]c3ccc(Cl)cc3c2C1		CHEMBL3110241	=	Delta Tm	degrees C	-0.6	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	-0.6
	13890198	CHEMBL3111103	Binding affinity to BRD2 bromodomain-1 (unknown origin) assessed as change in melting temperature at 100 uM by differential scanning fluorimetric analysis	B	CC(=O)N1CCc2[nH]c3ccc(Br)cc3c2C1		CHEMBL3110228	=	Delta Tm	degrees C	7.3	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	7.3
Active	14529940	CHEMBL3224047	Binding affinity to BRD2 in human HL60 cell nuclear extracts assessed as inhibition of protein binding to N-I-BET functionalised sepharose beads at 10 uM after 1 hr by coomassie staining-based chemoproteomic profiling	B	CC(=O)N1c2ccc(-c3ccc(NC(=O)CCCCCCC(=O)NO)cc3)cc2[C@H](NC(=O)OC(C)C)C[C@@H]1C		CHEMBL3220922		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Active	14529941	CHEMBL3224047	Binding affinity to BRD2 in human HL60 cell nuclear extracts assessed as inhibition of protein binding to N-I-BET functionalised sepharose beads at 10 uM after 1 hr by coomassie staining-based chemoproteomic profiling	B	CC(=O)N1c2ccc(-c3ccccc3)cc2[C@H](NC(=O)CCCCCCC(=O)NO)C[C@@H]1C		CHEMBL3220924		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Active	14529942	CHEMBL3224047	Binding affinity to BRD2 in human HL60 cell nuclear extracts assessed as inhibition of protein binding to N-I-BET functionalised sepharose beads at 10 uM after 1 hr by coomassie staining-based chemoproteomic profiling	B	CNCc1ccc(-c2ccc3c(c2)[C@H](NC(=O)OC(C)C)C[C@H](C)N3C(C)=O)cc1		CHEMBL3220926		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Active	14529943	CHEMBL3224047	Binding affinity to BRD2 in human HL60 cell nuclear extracts assessed as inhibition of protein binding to N-I-BET functionalised sepharose beads at 10 uM after 1 hr by coomassie staining-based chemoproteomic profiling	B	CC(=O)N1c2ccc(NC(=O)CCCCCCC(=O)O)cc2[C@H](NC(=O)OC(C)C)C[C@@H]1C		CHEMBL3220927		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
	14529952	CHEMBL3224050	Binding affinity to BRD2 in human HL60 cell nuclear extracts assessed as inhibition of protein binding to N-I-BET functionalised sepharose beads after 1 hr by coomassie staining-based chemoproteomic competition binding assay	B	CC(=O)N1c2ccc(-c3ccc(NC(=O)CCCCCCC(=O)NO)cc3)cc2[C@H](NC(=O)OC(C)C)C[C@@H]1C		CHEMBL3220922	=	Kd	nM	32.0	CHEMBL1293289	Homo sapiens	Kd(app)	nM	32.0
	15086815	CHEMBL3382827	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD2 (1 to 473 aa) (unknown origin) after 1 hr by TR-FRET assay	B	COC(=O)c1ccc(-c2ccc3c(c2)[C@H](Nc2ccccc2)C[C@H](C)N3C(C)=O)cc1		CHEMBL3353986	=	IC50	nM	1258.93	CHEMBL1293289	Homo sapiens	pIC50		5.9
	15086816	CHEMBL3382827	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD2 (1 to 473 aa) (unknown origin) after 1 hr by TR-FRET assay	B	CC(=O)N1c2ccc(-c3ccc(C#N)cc3)cc2[C@H](Nc2ccccc2)C[C@@H]1C		CHEMBL3353985	=	IC50	nM	1000.0	CHEMBL1293289	Homo sapiens	pIC50		6.0
	15086817	CHEMBL3382827	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD2 (1 to 473 aa) (unknown origin) after 1 hr by TR-FRET assay	B	CC(=O)N1c2ccc(-c3ccccc3)cc2[C@H](Nc2ccccc2)C[C@@H]1C		CHEMBL3353984	=	IC50	nM	794.33	CHEMBL1293289	Homo sapiens	pIC50		6.1
	15086827	CHEMBL3382827	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD2 (1 to 473 aa) (unknown origin) after 1 hr by TR-FRET assay	B	CC(=O)N1c2ccc(-c3ccc(C(=O)O)cc3)cc2[C@H](Nc2ccccc2)C[C@@H]1C		CHEMBL3352833	=	IC50	nM	630.96	CHEMBL1293289	Homo sapiens	pIC50		6.2
	15086828	CHEMBL3382827	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD2 (1 to 473 aa) (unknown origin) after 1 hr by TR-FRET assay	B	CC(=O)N1c2ccc(-c3ccc(C(F)(F)F)cc3)cc2[C@H](Nc2ccccc2)C[C@@H]1C		CHEMBL3353987	=	IC50	nM	1995.26	CHEMBL1293289	Homo sapiens	pIC50		5.7
	15086829	CHEMBL3382827	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD2 (1 to 473 aa) (unknown origin) after 1 hr by TR-FRET assay	B	COc1ccc(-c2ccc3c(c2)[C@H](Nc2ccccc2)C[C@H](C)N3C(C)=O)cc1		CHEMBL3353988	=	IC50	nM	1258.93	CHEMBL1293289	Homo sapiens	pIC50		5.9
	15086830	CHEMBL3382827	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD2 (1 to 473 aa) (unknown origin) after 1 hr by TR-FRET assay	B	CC(=O)N1c2ccc(-c3ccc(CO)cc3)cc2[C@H](Nc2ccccc2)C[C@@H]1C		CHEMBL3353989	=	IC50	nM	794.33	CHEMBL1293289	Homo sapiens	pIC50		6.1
	15086831	CHEMBL3382827	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD2 (1 to 473 aa) (unknown origin) after 1 hr by TR-FRET assay	B	CC(=O)N1c2ccc(-c3ccc(CN4CCOCC4)cc3)cc2[C@H](Nc2ccccc2)C[C@@H]1C		CHEMBL3353990	=	IC50	nM	794.33	CHEMBL1293289	Homo sapiens	pIC50		6.1
	15086832	CHEMBL3382827	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD2 (1 to 473 aa) (unknown origin) after 1 hr by TR-FRET assay	B	CC(=O)N1c2ccc(-c3cccc(CN4CCCCC4)c3)cc2[C@H](Nc2ccccc2)C[C@@H]1C		CHEMBL3353991	=	IC50	nM	1258.93	CHEMBL1293289	Homo sapiens	pIC50		5.9
	15086833	CHEMBL3382827	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD2 (1 to 473 aa) (unknown origin) after 1 hr by TR-FRET assay	B	CC(=O)N1c2ccc(-c3ccc(CN4CCCCC4)cc3)cc2[C@H](NC=O)C[C@@H]1C		CHEMBL3353993	=	IC50	nM	15848.93	CHEMBL1293289	Homo sapiens	pIC50		4.8
	15086834	CHEMBL3382827	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD2 (1 to 473 aa) (unknown origin) after 1 hr by TR-FRET assay	B	CC(=O)N1c2ccc(-c3ccc(CN4CCCCC4)cc3)cc2[C@H](N)C[C@@H]1C		CHEMBL3353994	=	IC50	nM	50118.72	CHEMBL1293289	Homo sapiens	pIC50		4.3
	15086835	CHEMBL3382827	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD2 (1 to 473 aa) (unknown origin) after 1 hr by TR-FRET assay	B	CC(=O)N1c2ccc(-c3ccc(CN4CCCCC4)cc3)cc2[C@H](Nc2ccccc2)C[C@@H]1C		CHEMBL3353992	=	IC50	nM	501.19	CHEMBL1293289	Homo sapiens	pIC50		6.3
	15086836	CHEMBL3382827	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD2 (1 to 473 aa) (unknown origin) after 1 hr by TR-FRET assay	B	CC(=O)N1c2ccc(-c3ccc(CN4CCCCC4)cc3)cc2[C@@H](Nc2ccccc2)C[C@H]1C		CHEMBL3353995	=	IC50	nM	25118.86	CHEMBL1293289	Homo sapiens	pIC50		4.6
	15086837	CHEMBL3382827	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD2 (1 to 473 aa) (unknown origin) after 1 hr by TR-FRET assay	B	COC(=O)c1ccc(-c2ccc3c(c2)[C@H](Nc2ccc(C(C)(C)C)cc2)C[C@H](C)N3C(C)=O)cc1		CHEMBL3353996	=	IC50	nM	501.19	CHEMBL1293289	Homo sapiens	pIC50		6.3
	15086838	CHEMBL3382827	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD2 (1 to 473 aa) (unknown origin) after 1 hr by TR-FRET assay	B	CC(=O)N1c2ccc(-c3ccc(C(=O)O)cc3)cc2[C@H](Nc2ccc(S(C)(=O)=O)cc2)C[C@@H]1C		CHEMBL3353997	=	IC50	nM	1000.0	CHEMBL1293289	Homo sapiens	pIC50		6.0
	15086839	CHEMBL3382827	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD2 (1 to 473 aa) (unknown origin) after 1 hr by TR-FRET assay	B	COC(=O)c1ccc(-c2ccc3c(c2)[C@H](Nc2ccc(S(C)(=O)=O)cc2)C[C@H](C)N3C(C)=O)cc1		CHEMBL3353998	=	IC50	nM	1258.93	CHEMBL1293289	Homo sapiens	pIC50		5.9
	15086840	CHEMBL3382827	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD2 (1 to 473 aa) (unknown origin) after 1 hr by TR-FRET assay	B	CC(=O)N1c2ccc(-c3ccc(C(=O)O)cc3)cc2[C@H](Nc2ccc(C)cc2)C[C@@H]1C		CHEMBL3353999	=	IC50	nM	501.19	CHEMBL1293289	Homo sapiens	pIC50		6.3
	15086841	CHEMBL3382827	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD2 (1 to 473 aa) (unknown origin) after 1 hr by TR-FRET assay	B	CC(=O)N1c2ccc(-c3ccc(C(=O)O)cc3)cc2[C@H](Nc2ccc(Cl)cc2)C[C@@H]1C		CHEMBL2177300	=	IC50	nM	398.11	CHEMBL1293289	Homo sapiens	pIC50		6.4
	15086842	CHEMBL3382827	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD2 (1 to 473 aa) (unknown origin) after 1 hr by TR-FRET assay	B	COC(=O)c1ccc(-c2ccc3c(c2)[C@H](Nc2ccc(F)cc2)C[C@H](C)N3C(C)=O)cc1		CHEMBL3354000	=	IC50	nM	1584.89	CHEMBL1293289	Homo sapiens	pIC50		5.8
	15086843	CHEMBL3382827	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD2 (1 to 473 aa) (unknown origin) after 1 hr by TR-FRET assay	B	CC(=O)N1c2ccc(-c3ccc(C#N)cc3)cc2[C@H](Nc2cccc(F)c2)C[C@@H]1C		CHEMBL3354001	=	IC50	nM	1258.93	CHEMBL1293289	Homo sapiens	pIC50		5.9
	15086844	CHEMBL3382827	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD2 (1 to 473 aa) (unknown origin) after 1 hr by TR-FRET assay	B	COc1cccc(N[C@@H]2C[C@H](C)N(C(C)=O)c3ccc(-c4ccc(C#N)cc4)cc32)c1		CHEMBL3354002	=	IC50	nM	1584.89	CHEMBL1293289	Homo sapiens	pIC50		5.8
	15086845	CHEMBL3382827	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD2 (1 to 473 aa) (unknown origin) after 1 hr by TR-FRET assay	B	COc1cccc(N[C@@H]2C[C@H](C)N(C(C)=O)c3ccc(-c4ccc(C(=O)O)cc4)cc32)c1		CHEMBL3354003	=	IC50	nM	630.96	CHEMBL1293289	Homo sapiens	pIC50		6.2
	15086846	CHEMBL3382827	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD2 (1 to 473 aa) (unknown origin) after 1 hr by TR-FRET assay	B	COc1ccccc1N[C@@H]1C[C@H](C)N(C(C)=O)c2ccc(-c3ccc(C(=O)O)cc3)cc21		CHEMBL3354004	=	IC50	nM	630.96	CHEMBL1293289	Homo sapiens	pIC50		6.2
	15086847	CHEMBL3382827	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD2 (1 to 473 aa) (unknown origin) after 1 hr by TR-FRET assay	B	CC(=O)N1c2ccc(-c3ccc(CN4CCCCC4)cc3)cc2[C@H](Nc2ccc(Cl)cc2)C[C@@H]1C		CHEMBL3354005	=	IC50	nM	1000.0	CHEMBL1293289	Homo sapiens	pIC50		6.0
	15086848	CHEMBL3382827	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD2 (1 to 473 aa) (unknown origin) after 1 hr by TR-FRET assay	B	CC(=O)N1c2ccc(-c3cccc(C(=O)O)c3)cc2[C@H](Nc2ccc(Cl)cc2)C[C@@H]1C		CHEMBL3354006	=	IC50	nM	794.33	CHEMBL1293289	Homo sapiens	pIC50		6.1
	15086849	CHEMBL3382827	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD2 (1 to 473 aa) (unknown origin) after 1 hr by TR-FRET assay	B	COC(=O)c1cccc(-c2ccc3c(c2)[C@H](Nc2ccc(Cl)cc2)C[C@H](C)N3C(C)=O)c1		CHEMBL3354007	=	IC50	nM	1995.26	CHEMBL1293289	Homo sapiens	pIC50		5.7
	15086850	CHEMBL3382827	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD2 (1 to 473 aa) (unknown origin) after 1 hr by TR-FRET assay	B	CC(=O)N1c2ccc(-c3ccc(C(N)=O)cc3)cc2[C@H](Nc2ccc(Cl)cc2)C[C@@H]1C		CHEMBL3354008	=	IC50	nM	794.33	CHEMBL1293289	Homo sapiens	pIC50		6.1
	15086851	CHEMBL3382827	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD2 (1 to 473 aa) (unknown origin) after 1 hr by TR-FRET assay	B	CC(=O)N1c2ccc(-c3ccccc3C)cc2[C@H](Nc2ccc(Cl)cc2)C[C@@H]1C		CHEMBL3354009	=	IC50	nM	3981.07	CHEMBL1293289	Homo sapiens	pIC50		5.4
	15086852	CHEMBL3382827	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD2 (1 to 473 aa) (unknown origin) after 1 hr by TR-FRET assay	B	COc1ccc(-c2ccc3c(c2)[C@H](Nc2ccccc2)CCN3C(C)=O)cc1		CHEMBL3354010	=	IC50	nM	6309.57	CHEMBL1293289	Homo sapiens	pIC50		5.2
	15086853	CHEMBL3382827	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD2 (1 to 473 aa) (unknown origin) after 1 hr by TR-FRET assay	B	CC(=O)N1c2ccc(-c3ccc(C(=O)O)cc3)cc2[C@H](Nc2ccc(C)cc2)C[C@@H]1C		CHEMBL3353999	=	IC50	nM	199.53	CHEMBL1293289	Homo sapiens	pIC50		6.7
	15086854	CHEMBL3382827	Displacement of biotinylated tetra-acetylated histone H4 from His6-tagged BRD2 (1 to 473 aa) (unknown origin) after 1 hr by TR-FRET assay	B	CC(=O)N1c2ccc(-c3ccc(C(=O)O)cc3)cc2[C@H](Nc2ccc(Cl)cc2)C[C@@H]1C		CHEMBL2177300	=	IC50	nM	158.49	CHEMBL1293289	Homo sapiens	pIC50		6.8
	15091456	CHEMBL3382844	Binding affinity to His6-tagged BRD2 (1 to 473 aa) (unknown origin) by SPR method	B	CC(=O)N1c2ccc(-c3ccc(C(=O)O)cc3)cc2[C@H](Nc2ccc(Cl)cc2)C[C@@H]1C		CHEMBL2177300	=	Kd	nM	25.0	CHEMBL1293289	Homo sapiens	Kd	nM	25.0
	15091466	CHEMBL3383408	Inhibition of human BRD2 bromodomain 1 by BROMOscan assay	B	CC(=O)N1c2ccc(-c3ccc(C(=O)O)cc3)cc2[C@H](Nc2ccc(Cl)cc2)C[C@@H]1C		CHEMBL2177300	<	IC50	nM	31622.78	CHEMBL1293289	Homo sapiens	pIC50		4.5
	15091467	CHEMBL3383409	Inhibition of human BRD2 bromodomain 2 by BROMOscan assay	B	CC(=O)N1c2ccc(-c3ccc(C(=O)O)cc3)cc2[C@H](Nc2ccc(Cl)cc2)C[C@@H]1C		CHEMBL2177300	=	IC50	nM	3.162	CHEMBL1293289	Homo sapiens	pIC50		8.5
	15192232	CHEMBL3414204	Inhibition of BRD2 (unknown origin) by fluorescence anisotrophy	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461	=	IC50	nM	790.0	CHEMBL1293289	Homo sapiens	IC50	uM	0.79
	15192233	CHEMBL3414204	Inhibition of BRD2 (unknown origin) by fluorescence anisotrophy	B	COc1cc2c(cc1-c1c(C)noc1C)ncc1[nH]c(=O)n([C@H](C)c3ccccn3)c12		CHEMBL2017291	=	IC50	nM	500.0	CHEMBL1293289	Homo sapiens	IC50	uM	0.5
	15192309	CHEMBL3414212	Binding affinity to BRD2(1) (unknown origin) assessed as increase in protein melting temperature at 50 umol by real-time PCR system based thermal shift assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	Delta Tm	degrees C	5.47	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	5.47
	15192310	CHEMBL3414212	Binding affinity to BRD2(1) (unknown origin) assessed as increase in protein melting temperature at 50 umol by real-time PCR system based thermal shift assay	B	Cc1ccc(-c2csc(=O)[nH]2)cc1S(=O)(=O)NC1CCCC1		CHEMBL3409992	=	Delta Tm	degrees C	3.47	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	3.47
	15192311	CHEMBL3414212	Binding affinity to BRD2(1) (unknown origin) assessed as increase in protein melting temperature at 50 umol by real-time PCR system based thermal shift assay	B	COc1ccc(-c2csc(=O)[nH]2)cc1S(=O)(=O)NC1CCCC1		CHEMBL3409993	=	Delta Tm	degrees C	2.82	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	2.82
	15192312	CHEMBL3414212	Binding affinity to BRD2(1) (unknown origin) assessed as increase in protein melting temperature at 50 umol by real-time PCR system based thermal shift assay	B	Nc1ccc(-c2csc(=O)[nH]2)cc1S(=O)(=O)NC1CCCC1		CHEMBL3409996	=	Delta Tm	degrees C	4.06	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	4.06
	15192313	CHEMBL3414212	Binding affinity to BRD2(1) (unknown origin) assessed as increase in protein melting temperature at 50 umol by real-time PCR system based thermal shift assay	B	Cc1c(Br)cc(-c2csc(=O)[nH]2)cc1S(=O)(=O)NC1CCCC1		CHEMBL3410000	=	Delta Tm	degrees C	5.92	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	5.92
	15192314	CHEMBL3414212	Binding affinity to BRD2(1) (unknown origin) assessed as increase in protein melting temperature at 50 umol by real-time PCR system based thermal shift assay	B	Cc1c(N)cc(-c2csc(=O)[nH]2)cc1S(=O)(=O)NC1CCCC1		CHEMBL3410002	=	Delta Tm	degrees C	5.04	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	5.04
	15192315	CHEMBL3414212	Binding affinity to BRD2(1) (unknown origin) assessed as increase in protein melting temperature at 50 umol by real-time PCR system based thermal shift assay	B	O=C(Nc1cc(-c2csc(=O)[nH]2)cc(S(=O)(=O)NC2CCCC2)c1)C1CC1		CHEMBL3410003	=	Delta Tm	degrees C	5.63	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	5.63
	15613307	CHEMBL3584941	Displacement of FAM-labeled ZBA248 from BRD2 BD1 (72 to 205 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells after 30 mins by fluorescence polarization assay	B	CCc1n[nH]c(CC)c1-c1nccc2[nH]c3cc(-c4c(C)noc4C)c(OC)cc3c12		CHEMBL3581660	=	Ki	nM	21.0	CHEMBL1293289	Homo sapiens	Ki	nM	21.0
	15613308	CHEMBL3585074	Displacement of FAM-labeled ZBA248 from BRD2 BD2 (349 to 460 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells after 30 mins by fluorescence polarization assay	B	CCc1n[nH]c(CC)c1-c1nccc2[nH]c3cc(-c4c(C)noc4C)c(OC)cc3c12		CHEMBL3581660	=	Ki	nM	15.4	CHEMBL1293289	Homo sapiens	Ki	nM	15.4
	15613318	CHEMBL3584941	Displacement of FAM-labeled ZBA248 from BRD2 BD1 (72 to 205 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells after 30 mins by fluorescence polarization assay	B	COc1cc2c(cc1-c1c(C)noc1C)[nH]c1ccnc(-c3c(C4CC4)n[nH]c3C)c12		CHEMBL3581661	=	Ki	nM	11.1	CHEMBL1293289	Homo sapiens	Ki	nM	11.1
	15613319	CHEMBL3585074	Displacement of FAM-labeled ZBA248 from BRD2 BD2 (349 to 460 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells after 30 mins by fluorescence polarization assay	B	COc1cc2c(cc1-c1c(C)noc1C)[nH]c1ccnc(-c3c(C4CC4)n[nH]c3C)c12		CHEMBL3581661	=	Ki	nM	11.7	CHEMBL1293289	Homo sapiens	Ki	nM	11.7
	15613322	CHEMBL3583407	Binding affinity to biotinylated BRD2 BD1 (72 to 205 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells by bio-layer interferometry method	B	COc1cc2c(cc1-c1c(C)noc1C)[nH]c1ccnc(-c3c(C4CC4)n[nH]c3C)c12		CHEMBL3581661	=	Kd	nM	48.1	CHEMBL1293289	Homo sapiens	Kd	nM	48.1
	15613323	CHEMBL3583408	Binding affinity to biotinylated BRD2 BD2 (349 to 460 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells by bio-layer interferometry method	B	COc1cc2c(cc1-c1c(C)noc1C)[nH]c1ccnc(-c3c(C4CC4)n[nH]c3C)c12		CHEMBL3581661	=	Kd	nM	29.6	CHEMBL1293289	Homo sapiens	Kd	nM	29.6
	15613344	CHEMBL3584941	Displacement of FAM-labeled ZBA248 from BRD2 BD1 (72 to 205 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells after 30 mins by fluorescence polarization assay	B	CCc1[nH]nc(-c2ccccc2)c1-c1nccc2[nH]c3cc(-c4c(C)noc4C)c(OC)cc3c12		CHEMBL3581662	=	Ki	nM	12.2	CHEMBL1293289	Homo sapiens	Ki	nM	12.2
	15613345	CHEMBL3585074	Displacement of FAM-labeled ZBA248 from BRD2 BD2 (349 to 460 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells after 30 mins by fluorescence polarization assay	B	CCc1[nH]nc(-c2ccccc2)c1-c1nccc2[nH]c3cc(-c4c(C)noc4C)c(OC)cc3c12		CHEMBL3581662	=	Ki	nM	22.2	CHEMBL1293289	Homo sapiens	Ki	nM	22.2
	15613355	CHEMBL3584941	Displacement of FAM-labeled ZBA248 from BRD2 BD1 (72 to 205 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells after 30 mins by fluorescence polarization assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	Ki	nM	13.2	CHEMBL1293289	Homo sapiens	Ki	nM	13.2
	15613356	CHEMBL3585074	Displacement of FAM-labeled ZBA248 from BRD2 BD2 (349 to 460 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells after 30 mins by fluorescence polarization assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	Ki	nM	12.5	CHEMBL1293289	Homo sapiens	Ki	nM	12.5
	15613359	CHEMBL3583407	Binding affinity to biotinylated BRD2 BD1 (72 to 205 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells by bio-layer interferometry method	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	Kd	nM	14.7	CHEMBL1293289	Homo sapiens	Kd	nM	14.7
	15613360	CHEMBL3583408	Binding affinity to biotinylated BRD2 BD2 (349 to 460 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells by bio-layer interferometry method	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	Kd	nM	6.2	CHEMBL1293289	Homo sapiens	Kd	nM	6.2
	15613372	CHEMBL3584941	Displacement of FAM-labeled ZBA248 from BRD2 BD1 (72 to 205 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells after 30 mins by fluorescence polarization assay	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461	=	Ki	nM	56.8	CHEMBL1293289	Homo sapiens	Ki	nM	56.8
	15613373	CHEMBL3585074	Displacement of FAM-labeled ZBA248 from BRD2 BD2 (349 to 460 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells after 30 mins by fluorescence polarization assay	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461	=	Ki	nM	49.2	CHEMBL1293289	Homo sapiens	Ki	nM	49.2
	15613376	CHEMBL3583407	Binding affinity to biotinylated BRD2 BD1 (72 to 205 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells by bio-layer interferometry method	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461	=	Kd	nM	159.0	CHEMBL1293289	Homo sapiens	Kd	nM	159.0
	15613377	CHEMBL3583408	Binding affinity to biotinylated BRD2 BD2 (349 to 460 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells by bio-layer interferometry method	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461	=	Kd	nM	45.4	CHEMBL1293289	Homo sapiens	Kd	nM	45.4
	15613391	CHEMBL3584941	Displacement of FAM-labeled ZBA248 from BRD2 BD1 (72 to 205 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells after 30 mins by fluorescence polarization assay	B	COc1cc2c(cc1-c1c(C)noc1C)ncc1[nH]c(=O)n([C@H](C)c3ccccn3)c12		CHEMBL2017291	=	Ki	nM	9.0	CHEMBL1293289	Homo sapiens	Ki	nM	9.0
	15613392	CHEMBL3585074	Displacement of FAM-labeled ZBA248 from BRD2 BD2 (349 to 460 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells after 30 mins by fluorescence polarization assay	B	COc1cc2c(cc1-c1c(C)noc1C)ncc1[nH]c(=O)n([C@H](C)c3ccccn3)c12		CHEMBL2017291	=	Ki	nM	49.6	CHEMBL1293289	Homo sapiens	Ki	nM	49.6
	15613395	CHEMBL3583407	Binding affinity to biotinylated BRD2 BD1 (72 to 205 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells by bio-layer interferometry method	B	COc1cc2c(cc1-c1c(C)noc1C)ncc1[nH]c(=O)n([C@H](C)c3ccccn3)c12		CHEMBL2017291	=	Kd	nM	54.8	CHEMBL1293289	Homo sapiens	Kd	nM	54.8
	15613396	CHEMBL3583408	Binding affinity to biotinylated BRD2 BD2 (349 to 460 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells by bio-layer interferometry method	B	COc1cc2c(cc1-c1c(C)noc1C)ncc1[nH]c(=O)n([C@H](C)c3ccccn3)c12		CHEMBL2017291	=	Kd	nM	70.3	CHEMBL1293289	Homo sapiens	Kd	nM	70.3
	15613410	CHEMBL3584941	Displacement of FAM-labeled ZBA248 from BRD2 BD1 (72 to 205 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells after 30 mins by fluorescence polarization assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)Nc1ccc(O)cc1)c1nnc(C)n1-2		CHEMBL3581647	=	Ki	nM	16.6	CHEMBL1293289	Homo sapiens	Ki	nM	16.6
	15613411	CHEMBL3585074	Displacement of FAM-labeled ZBA248 from BRD2 BD2 (349 to 460 amino acid residues) (unknown origin) expressed in Rosetta2 DE3 cells after 30 mins by fluorescence polarization assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)Nc1ccc(O)cc1)c1nnc(C)n1-2		CHEMBL3581647	=	Ki	nM	5.4	CHEMBL1293289	Homo sapiens	Ki	nM	5.4
	15627971	CHEMBL3587526	Binding affinity to 6-His-Thr BRD2 (1 to 473) BD1 (unknown origin) harboring BD2 Y386A mutant	B	Cc1cncc(-c2cnc(NC3CCNCC3)c3[nH]c(=O)c(C)cc23)c1		CHEMBL3585452	=	IC50	nM	6309.57	CHEMBL1293289	Homo sapiens	pIC50		5.2
	15627972	CHEMBL3587526	Binding affinity to 6-His-Thr BRD2 (1 to 473) BD1 (unknown origin) harboring BD2 Y386A mutant	B	COc1cncc(-c2cnc(NC3CCNCC3)c3[nH]c(=O)c(C)cc23)c1		CHEMBL3585455	=	IC50	nM	3981.07	CHEMBL1293289	Homo sapiens	pIC50		5.4
	15627973	CHEMBL3587527	Binding affinity to 6-His-Thr BRD2 (1 to 473) BD2 (unknown origin) harboring BD1 Y113A mutant	B	Cc1cncc(-c2cnc(NC3CCNCC3)c3[nH]c(=O)c(C)cc23)c1		CHEMBL3585452	=	IC50	nM	19952.62	CHEMBL1293289	Homo sapiens	pIC50		4.7
	15627974	CHEMBL3587527	Binding affinity to 6-His-Thr BRD2 (1 to 473) BD2 (unknown origin) harboring BD1 Y113A mutant	B	COc1cncc(-c2cnc(NC3CCNCC3)c3[nH]c(=O)c(C)cc23)c1		CHEMBL3585455	=	IC50	nM	19952.62	CHEMBL1293289	Homo sapiens	pIC50		4.7
	15636884	CHEMBL3591389	Binding affinity to BRD2 in human HUT78 cells incubated for 45 mins by mass spectrometry based bromosphere chemoproteomic assay	B	Cc1cncc(-c2cnc(N[C@@H]3CCNC[C@H]3OCC3CCCCC3)c3[nH]c(=O)c(C)cc23)c1		CHEMBL3590389	=	Kd	nM	3162.28	CHEMBL1293289	Homo sapiens	pKd		5.5
	15636885	CHEMBL3591389	Binding affinity to BRD2 in human HUT78 cells incubated for 45 mins by mass spectrometry based bromosphere chemoproteomic assay	B	Cc1cncc(-c2ccc(N[C@@H]3CCNC[C@H]3OCC3CCS(=O)(=O)CC3)c3[nH]c(=O)c(C)cc23)c1		CHEMBL3590405	=	Kd	nM	630.96	CHEMBL1293289	Homo sapiens	pKd		6.2
	15636886	CHEMBL3591389	Binding affinity to BRD2 in human HUT78 cells incubated for 45 mins by mass spectrometry based bromosphere chemoproteomic assay	B	Cc1cncc(-c2cnc(N[C@@H]3CCN(C)C[C@H]3OCC3CCS(=O)(=O)CC3)c3[nH]c(=O)c(C)cc23)c1		CHEMBL3590408	=	Kd	nM	19952.62	CHEMBL1293289	Homo sapiens	pKd		4.7
	15636915	CHEMBL3591402	Binding affinity to BRD2 containing BD1 bromodomains (unknown origin) by TR-FRET assay	B	Cc1cncc(-c2cnc(N[C@@H]3CCNC[C@H]3OCC3CCS(=O)(=O)CC3)c3[nH]c(=O)c(C)cc23)c1		CHEMBL3590383	=	IC50	nM	31622.78	CHEMBL1293289	Homo sapiens	pIC50		4.5
	15636916	CHEMBL3591402	Binding affinity to BRD2 containing BD1 bromodomains (unknown origin) by TR-FRET assay	B	Cc1cncc(-c2cnc(N[C@@H]3CCN(C)C[C@H]3OCC3CCS(=O)(=O)CC3)c3[nH]c(=O)c(C)cc23)c1		CHEMBL3590408	<	IC50	nM	50118.72	CHEMBL1293289	Homo sapiens	pIC50		4.3
	15636925	CHEMBL3591407	Binding affinity to BRD2 containing BD2 bromodomains (unknown origin) by TR-FRET assay	B	Cc1cncc(-c2cnc(N[C@@H]3CCNC[C@H]3OCC3CCS(=O)(=O)CC3)c3[nH]c(=O)c(C)cc23)c1		CHEMBL3590383	<	IC50	nM	31622.78	CHEMBL1293289	Homo sapiens	pIC50		4.5
	15636926	CHEMBL3591407	Binding affinity to BRD2 containing BD2 bromodomains (unknown origin) by TR-FRET assay	B	Cc1cncc(-c2cnc(N[C@@H]3CCN(C)C[C@H]3OCC3CCS(=O)(=O)CC3)c3[nH]c(=O)c(C)cc23)c1		CHEMBL3590408	<	IC50	nM	50118.72	CHEMBL1293289	Homo sapiens	pIC50		4.3
	15644656	CHEMBL3591774	Inhibition of HTRF binding to N-terminal His-tagged BRD2(2) (unknown origin) at 50 uM using biotinylated tetra-acetylated histone H4 peptide and Cryptate-labeled streptavidin incubated for 2 hrs by TR-FRET assay	B	CSc1ccccc1C(=O)N1CC(=O)Nc2ccccc21		CHEMBL3589495	>	Inhibition	%	50.0	CHEMBL1293289	Homo sapiens	INH	%	50.0
	15644657	CHEMBL3591774	Inhibition of HTRF binding to N-terminal His-tagged BRD2(2) (unknown origin) at 50 uM using biotinylated tetra-acetylated histone H4 peptide and Cryptate-labeled streptavidin incubated for 2 hrs by TR-FRET assay	B	COc1cccc(OCC(=O)N2CC(=O)Nc3ccccc32)c1		CHEMBL3589496	=	Inhibition	%	25.0	CHEMBL1293289	Homo sapiens	INH	%	25.0
	15644658	CHEMBL3591774	Inhibition of HTRF binding to N-terminal His-tagged BRD2(2) (unknown origin) at 50 uM using biotinylated tetra-acetylated histone H4 peptide and Cryptate-labeled streptavidin incubated for 2 hrs by TR-FRET assay	B	COc1ccc(CC(=O)N2CC(=O)Nc3ccccc32)cc1OC		CHEMBL3589497	=	Inhibition	%	25.0	CHEMBL1293289	Homo sapiens	INH	%	25.0
	15644659	CHEMBL3591774	Inhibition of HTRF binding to N-terminal His-tagged BRD2(2) (unknown origin) at 50 uM using biotinylated tetra-acetylated histone H4 peptide and Cryptate-labeled streptavidin incubated for 2 hrs by TR-FRET assay	B	O=C1CN(C(=O)c2sc3ccccc3c2Cl)c2ccccc2N1		CHEMBL3589498	=	Inhibition	%	25.0	CHEMBL1293289	Homo sapiens	INH	%	25.0
	15644660	CHEMBL3591774	Inhibition of HTRF binding to N-terminal His-tagged BRD2(2) (unknown origin) at 50 uM using biotinylated tetra-acetylated histone H4 peptide and Cryptate-labeled streptavidin incubated for 2 hrs by TR-FRET assay	B	CC(C)Sc1ccccc1C(=O)N1CC(=O)Nc2ccccc21		CHEMBL3589499	=	Inhibition	%	25.0	CHEMBL1293289	Homo sapiens	INH	%	25.0
	15644661	CHEMBL3591774	Inhibition of HTRF binding to N-terminal His-tagged BRD2(2) (unknown origin) at 50 uM using biotinylated tetra-acetylated histone H4 peptide and Cryptate-labeled streptavidin incubated for 2 hrs by TR-FRET assay	B	O=C1CN(C(=O)Cc2ccc(Cl)cc2)c2ccccc2N1		CHEMBL3589500	=	Inhibition	%	25.0	CHEMBL1293289	Homo sapiens	INH	%	25.0
	15644662	CHEMBL3591774	Inhibition of HTRF binding to N-terminal His-tagged BRD2(2) (unknown origin) at 50 uM using biotinylated tetra-acetylated histone H4 peptide and Cryptate-labeled streptavidin incubated for 2 hrs by TR-FRET assay	B	O=C1CN(C(=O)c2cccc(F)c2)c2ccccc2N1		CHEMBL3589501	=	Inhibition	%	25.0	CHEMBL1293289	Homo sapiens	INH	%	25.0
	15644663	CHEMBL3591774	Inhibition of HTRF binding to N-terminal His-tagged BRD2(2) (unknown origin) at 50 uM using biotinylated tetra-acetylated histone H4 peptide and Cryptate-labeled streptavidin incubated for 2 hrs by TR-FRET assay	B	O=C1CN(C(=O)CCc2ccccc2Cl)c2ccccc2N1		CHEMBL3589502	=	Inhibition	%	25.0	CHEMBL1293289	Homo sapiens	INH	%	25.0
	15644664	CHEMBL3591774	Inhibition of HTRF binding to N-terminal His-tagged BRD2(2) (unknown origin) at 50 uM using biotinylated tetra-acetylated histone H4 peptide and Cryptate-labeled streptavidin incubated for 2 hrs by TR-FRET assay	B	Cc1cccc(OCCC(=O)N2CC(=O)Nc3ccccc32)c1		CHEMBL3589503	=	Inhibition	%	25.0	CHEMBL1293289	Homo sapiens	INH	%	25.0
	15644665	CHEMBL3591774	Inhibition of HTRF binding to N-terminal His-tagged BRD2(2) (unknown origin) at 50 uM using biotinylated tetra-acetylated histone H4 peptide and Cryptate-labeled streptavidin incubated for 2 hrs by TR-FRET assay	B	O=C1CN(C(=O)c2cc(-c3cccc(Cl)c3)[nH]n2)c2ccccc2N1		CHEMBL3589504	=	Inhibition	%	0.0	CHEMBL1293289	Homo sapiens	INH	%	0.0
	15644666	CHEMBL3591774	Inhibition of HTRF binding to N-terminal His-tagged BRD2(2) (unknown origin) at 50 uM using biotinylated tetra-acetylated histone H4 peptide and Cryptate-labeled streptavidin incubated for 2 hrs by TR-FRET assay	B	CS(=O)(=O)N(CC(=O)N1CC(=O)Nc2ccccc21)c1ccccc1F		CHEMBL3589505	=	Inhibition	%	0.0	CHEMBL1293289	Homo sapiens	INH	%	0.0
	15644667	CHEMBL3591774	Inhibition of HTRF binding to N-terminal His-tagged BRD2(2) (unknown origin) at 50 uM using biotinylated tetra-acetylated histone H4 peptide and Cryptate-labeled streptavidin incubated for 2 hrs by TR-FRET assay	B	CSc1ccc(Cl)c(C(=O)N2CC(=O)Nc3ccccc32)c1		CHEMBL3589506	=	Inhibition	%	0.0	CHEMBL1293289	Homo sapiens	INH	%	0.0
	15644668	CHEMBL3591774	Inhibition of HTRF binding to N-terminal His-tagged BRD2(2) (unknown origin) at 50 uM using biotinylated tetra-acetylated histone H4 peptide and Cryptate-labeled streptavidin incubated for 2 hrs by TR-FRET assay	B	Cc1ccc(-c2cc(C(=O)N3CC(=O)Nc4ccccc43)[nH]n2)cc1		CHEMBL3589218	=	Inhibition	%	0.0	CHEMBL1293289	Homo sapiens	INH	%	0.0
	15644669	CHEMBL3591774	Inhibition of HTRF binding to N-terminal His-tagged BRD2(2) (unknown origin) at 50 uM using biotinylated tetra-acetylated histone H4 peptide and Cryptate-labeled streptavidin incubated for 2 hrs by TR-FRET assay	B	CCc1ccc(CC(=O)N2CC(=O)Nc3ccccc32)cc1		CHEMBL3589219	=	Inhibition	%	0.0	CHEMBL1293289	Homo sapiens	INH	%	0.0
	15644670	CHEMBL3591774	Inhibition of HTRF binding to N-terminal His-tagged BRD2(2) (unknown origin) at 50 uM using biotinylated tetra-acetylated histone H4 peptide and Cryptate-labeled streptavidin incubated for 2 hrs by TR-FRET assay	B	CSc1ccc(CC(=O)N2CC(=O)Nc3ccccc32)cc1		CHEMBL3589220	=	Inhibition	%	0.0	CHEMBL1293289	Homo sapiens	INH	%	0.0
	15644671	CHEMBL3591774	Inhibition of HTRF binding to N-terminal His-tagged BRD2(2) (unknown origin) at 50 uM using biotinylated tetra-acetylated histone H4 peptide and Cryptate-labeled streptavidin incubated for 2 hrs by TR-FRET assay	B	O=C1CN(C(=O)Cc2cccs2)c2ccccc2N1		CHEMBL3589221	=	Inhibition	%	0.0	CHEMBL1293289	Homo sapiens	INH	%	0.0
	15644672	CHEMBL3591774	Inhibition of HTRF binding to N-terminal His-tagged BRD2(2) (unknown origin) at 50 uM using biotinylated tetra-acetylated histone H4 peptide and Cryptate-labeled streptavidin incubated for 2 hrs by TR-FRET assay	B	Cc1ccc(CC(=O)N2CC(=O)Nc3ccccc32)cc1		CHEMBL3589222	=	Inhibition	%	0.0	CHEMBL1293289	Homo sapiens	INH	%	0.0
	15644682	CHEMBL3591774	Inhibition of HTRF binding to N-terminal His-tagged BRD2(2) (unknown origin) at 50 uM using biotinylated tetra-acetylated histone H4 peptide and Cryptate-labeled streptavidin incubated for 2 hrs by TR-FRET assay	B	O=C1CN(C(=O)Cc2cccc3ccccc23)c2ccccc2N1		CHEMBL3589494	>	Inhibition	%	50.0	CHEMBL1293289	Homo sapiens	INH	%	50.0
	15644683	CHEMBL3591774	Inhibition of HTRF binding to N-terminal His-tagged BRD2(2) (unknown origin) at 50 uM using biotinylated tetra-acetylated histone H4 peptide and Cryptate-labeled streptavidin incubated for 2 hrs by TR-FRET assay	B	CCn1ccc(C(=O)N2CC(=O)Nc3ccccc32)n1		CHEMBL3589492	>	Inhibition	%	50.0	CHEMBL1293289	Homo sapiens	INH	%	50.0
	15644684	CHEMBL3591774	Inhibition of HTRF binding to N-terminal His-tagged BRD2(2) (unknown origin) at 50 uM using biotinylated tetra-acetylated histone H4 peptide and Cryptate-labeled streptavidin incubated for 2 hrs by TR-FRET assay	B	O=C1CN(C(=O)c2cccc(C(F)(F)F)c2)c2ccccc2N1		CHEMBL3589493	>	Inhibition	%	50.0	CHEMBL1293289	Homo sapiens	INH	%	50.0
	15644685	CHEMBL3591774	Inhibition of HTRF binding to N-terminal His-tagged BRD2(2) (unknown origin) at 50 uM using biotinylated tetra-acetylated histone H4 peptide and Cryptate-labeled streptavidin incubated for 2 hrs by TR-FRET assay	B	O=C1CN(C(=O)C(c2ccccc2)c2ccccc2)c2ccccc2N1		CHEMBL3589491	>	Inhibition	%	50.0	CHEMBL1293289	Homo sapiens	INH	%	50.0
	15644686	CHEMBL3591774	Inhibition of HTRF binding to N-terminal His-tagged BRD2(2) (unknown origin) at 50 uM using biotinylated tetra-acetylated histone H4 peptide and Cryptate-labeled streptavidin incubated for 2 hrs by TR-FRET assay	B	COc1ccc(/C=C(/C(=O)N2CC(=O)Nc3ccccc32)c2ccccc2)cc1		CHEMBL3589468	>	Inhibition	%	50.0	CHEMBL1293289	Homo sapiens	INH	%	50.0
	15644688	CHEMBL3591777	Inhibition of HTRF binding to N-terminal His-tagged BRD2(2) (unknown origin) using biotinylated tetra-acetylated histone H4 peptide and Cryptate-labeled streptavidin incubated for 2 hrs by TR-FRET assay	B	COc1ccc(/C=C(/C(=O)N2CC(=O)Nc3ccccc32)c2ccccc2)cc1		CHEMBL3589468	=	IC50	nM	22000.0	CHEMBL1293289	Homo sapiens	IC50	uM	22.0
	15644724	CHEMBL3591777	Inhibition of HTRF binding to N-terminal His-tagged BRD2(2) (unknown origin) using biotinylated tetra-acetylated histone H4 peptide and Cryptate-labeled streptavidin incubated for 2 hrs by TR-FRET assay	B	COc1ccc(/C=C(/C(=O)N2CC(=O)Nc3ccccc32)c2cccs2)cc1		CHEMBL3589469	=	IC50	nM	23000.0	CHEMBL1293289	Homo sapiens	IC50	uM	23.0
	15644725	CHEMBL3591777	Inhibition of HTRF binding to N-terminal His-tagged BRD2(2) (unknown origin) using biotinylated tetra-acetylated histone H4 peptide and Cryptate-labeled streptavidin incubated for 2 hrs by TR-FRET assay	B	COc1ccc(/C=C(/C(=O)N2CC(=O)Nc3ccccc32)c2ccc(NC(C)=O)cc2)cc1		CHEMBL3589470	=	IC50	nM	24000.0	CHEMBL1293289	Homo sapiens	IC50	uM	24.0
	15644726	CHEMBL3591777	Inhibition of HTRF binding to N-terminal His-tagged BRD2(2) (unknown origin) using biotinylated tetra-acetylated histone H4 peptide and Cryptate-labeled streptavidin incubated for 2 hrs by TR-FRET assay	B	COc1ccc(/C=C(/C(=O)N2CC(=O)Nc3cc(OC)ccc32)c2ccc(OC)cc2)cc1		CHEMBL3589471	=	IC50	nM	13000.0	CHEMBL1293289	Homo sapiens	IC50	uM	13.0
	15644727	CHEMBL3591777	Inhibition of HTRF binding to N-terminal His-tagged BRD2(2) (unknown origin) using biotinylated tetra-acetylated histone H4 peptide and Cryptate-labeled streptavidin incubated for 2 hrs by TR-FRET assay	B	COc1ccc(/C=C(/C(=O)N2CC(=O)Nc3ccccc32)c2ccc(C)c(C)c2)cc1		CHEMBL3589472	>	IC50	nM	50000.0	CHEMBL1293289	Homo sapiens	IC50	uM	50.0
	15644728	CHEMBL3591777	Inhibition of HTRF binding to N-terminal His-tagged BRD2(2) (unknown origin) using biotinylated tetra-acetylated histone H4 peptide and Cryptate-labeled streptavidin incubated for 2 hrs by TR-FRET assay	B	COc1ccc(/C=C(/C(=O)N2CC(=O)Nc3ccccc32)c2ccc(OC)cc2)cc1		CHEMBL3589473	=	IC50	nM	13000.0	CHEMBL1293289	Homo sapiens	IC50	uM	13.0
	15644729	CHEMBL3591777	Inhibition of HTRF binding to N-terminal His-tagged BRD2(2) (unknown origin) using biotinylated tetra-acetylated histone H4 peptide and Cryptate-labeled streptavidin incubated for 2 hrs by TR-FRET assay	B	COc1ccc(/C=C(/C(=O)N2CC(=O)Nc3ccccc32)c2ccc(OC)c(OC)c2)cc1		CHEMBL3589474	=	IC50	nM	26000.0	CHEMBL1293289	Homo sapiens	IC50	uM	26.0
	15644730	CHEMBL3591777	Inhibition of HTRF binding to N-terminal His-tagged BRD2(2) (unknown origin) using biotinylated tetra-acetylated histone H4 peptide and Cryptate-labeled streptavidin incubated for 2 hrs by TR-FRET assay	B	COc1ccc(/C(=C\c2ccncc2)C(=O)N2CC(=O)Nc3ccccc32)cc1		CHEMBL3589475	=	IC50	nM	5000.0	CHEMBL1293289	Homo sapiens	IC50	uM	5.0
	15644731	CHEMBL3591777	Inhibition of HTRF binding to N-terminal His-tagged BRD2(2) (unknown origin) using biotinylated tetra-acetylated histone H4 peptide and Cryptate-labeled streptavidin incubated for 2 hrs by TR-FRET assay	B	COC(=O)c1ccc(/C=C(/C(=O)N2CC(=O)Nc3ccccc32)c2ccccc2)cc1		CHEMBL3589476	=	IC50	nM	25000.0	CHEMBL1293289	Homo sapiens	IC50	uM	25.0
	15644732	CHEMBL3591777	Inhibition of HTRF binding to N-terminal His-tagged BRD2(2) (unknown origin) using biotinylated tetra-acetylated histone H4 peptide and Cryptate-labeled streptavidin incubated for 2 hrs by TR-FRET assay	B	COc1ccc(/C=C(/C(=O)N2CC(=O)Nc3cc(OC)ccc32)c2ccccc2)cc1		CHEMBL3589477	>	IC50	nM	50000.0	CHEMBL1293289	Homo sapiens	IC50	uM	50.0
	15644733	CHEMBL3591777	Inhibition of HTRF binding to N-terminal His-tagged BRD2(2) (unknown origin) using biotinylated tetra-acetylated histone H4 peptide and Cryptate-labeled streptavidin incubated for 2 hrs by TR-FRET assay	B	CC(=O)Nc1cccc(/C=C(/C(=O)N2CC(=O)Nc3ccccc32)c2ccccc2)c1		CHEMBL3589478	=	IC50	nM	10000.0	CHEMBL1293289	Homo sapiens	IC50	uM	10.0
	15644734	CHEMBL3591777	Inhibition of HTRF binding to N-terminal His-tagged BRD2(2) (unknown origin) using biotinylated tetra-acetylated histone H4 peptide and Cryptate-labeled streptavidin incubated for 2 hrs by TR-FRET assay	B	COc1ccc(/C=C(/C(=O)Nc2c(C)noc2C)c2ccc(OC)cc2)cc1		CHEMBL3589479	=	IC50	nM	12000.0	CHEMBL1293289	Homo sapiens	IC50	uM	12.0
	15644735	CHEMBL3591777	Inhibition of HTRF binding to N-terminal His-tagged BRD2(2) (unknown origin) using biotinylated tetra-acetylated histone H4 peptide and Cryptate-labeled streptavidin incubated for 2 hrs by TR-FRET assay	B	NC(=O)c1ccc(/C=C(/C(=O)N2CC(=O)Nc3ccccc32)c2ccccc2)cc1		CHEMBL3589480	=	IC50	nM	49000.0	CHEMBL1293289	Homo sapiens	IC50	uM	49.0
	15644736	CHEMBL3591777	Inhibition of HTRF binding to N-terminal His-tagged BRD2(2) (unknown origin) using biotinylated tetra-acetylated histone H4 peptide and Cryptate-labeled streptavidin incubated for 2 hrs by TR-FRET assay	B	COc1ccc(/C=C(/C(=O)N2CC(=O)Nc3ccccc32)c2ccc(OC)cc2OC)cc1		CHEMBL3589481	>	IC50	nM	50000.0	CHEMBL1293289	Homo sapiens	IC50	uM	50.0
Not Determined	15644737	CHEMBL3591777	Inhibition of HTRF binding to N-terminal His-tagged BRD2(2) (unknown origin) using biotinylated tetra-acetylated histone H4 peptide and Cryptate-labeled streptavidin incubated for 2 hrs by TR-FRET assay	B	O=C1CN(C(=O)c2cc(O)cc(-c3ccccc3)c2)c2ccccc2N1		CHEMBL3589482		IC50			CHEMBL1293289	Homo sapiens	IC50		
Not Determined	15644738	CHEMBL3591777	Inhibition of HTRF binding to N-terminal His-tagged BRD2(2) (unknown origin) using biotinylated tetra-acetylated histone H4 peptide and Cryptate-labeled streptavidin incubated for 2 hrs by TR-FRET assay	B	COc1cc(C(=O)N2CC(=O)Nc3ccccc32)cc(-c2ccccc2)c1		CHEMBL3589483		IC50			CHEMBL1293289	Homo sapiens	IC50		
Not Determined	15644739	CHEMBL3591777	Inhibition of HTRF binding to N-terminal His-tagged BRD2(2) (unknown origin) using biotinylated tetra-acetylated histone H4 peptide and Cryptate-labeled streptavidin incubated for 2 hrs by TR-FRET assay	B	COc1cccc(-c2cncc(C(=O)N3CC(=O)Nc4ccccc43)c2)c1		CHEMBL3589484		IC50			CHEMBL1293289	Homo sapiens	IC50		
	15644740	CHEMBL3591777	Inhibition of HTRF binding to N-terminal His-tagged BRD2(2) (unknown origin) using biotinylated tetra-acetylated histone H4 peptide and Cryptate-labeled streptavidin incubated for 2 hrs by TR-FRET assay	B	O=C1CN(C(=O)c2cncc(-c3ccccc3)c2)c2ccccc2N1		CHEMBL3589485	=	IC50	nM	20000.0	CHEMBL1293289	Homo sapiens	IC50	uM	20.0
Not Determined	15644741	CHEMBL3591777	Inhibition of HTRF binding to N-terminal His-tagged BRD2(2) (unknown origin) using biotinylated tetra-acetylated histone H4 peptide and Cryptate-labeled streptavidin incubated for 2 hrs by TR-FRET assay	B	O=C1CN(C(=O)c2cncc(-c3cccc(O)c3)c2)c2ccccc2N1		CHEMBL3589486		IC50			CHEMBL1293289	Homo sapiens	IC50		
	15644742	CHEMBL3591777	Inhibition of HTRF binding to N-terminal His-tagged BRD2(2) (unknown origin) using biotinylated tetra-acetylated histone H4 peptide and Cryptate-labeled streptavidin incubated for 2 hrs by TR-FRET assay	B	N#Cc1cccc(-c2cncc(C(=O)N3CC(=O)Nc4ccccc43)c2)c1		CHEMBL3589487	=	IC50	nM	12000.0	CHEMBL1293289	Homo sapiens	IC50	uM	12.0
Not Determined	15644743	CHEMBL3591777	Inhibition of HTRF binding to N-terminal His-tagged BRD2(2) (unknown origin) using biotinylated tetra-acetylated histone H4 peptide and Cryptate-labeled streptavidin incubated for 2 hrs by TR-FRET assay	B	O=C1CN(C(=O)c2cncc(-c3ccc(F)cc3)c2)c2ccccc2N1		CHEMBL3589488		IC50			CHEMBL1293289	Homo sapiens	IC50		
Not Determined	15644744	CHEMBL3591777	Inhibition of HTRF binding to N-terminal His-tagged BRD2(2) (unknown origin) using biotinylated tetra-acetylated histone H4 peptide and Cryptate-labeled streptavidin incubated for 2 hrs by TR-FRET assay	B	O=C1CN(C(=O)c2cncc(-c3ccc(Cl)cc3)c2)c2ccccc2N1		CHEMBL3589489		IC50			CHEMBL1293289	Homo sapiens	IC50		
Not Determined	15644745	CHEMBL3591777	Inhibition of HTRF binding to N-terminal His-tagged BRD2(2) (unknown origin) using biotinylated tetra-acetylated histone H4 peptide and Cryptate-labeled streptavidin incubated for 2 hrs by TR-FRET assay	B	COc1cc(NCc2ccccc2)cc(C(=O)N2CC(=O)Nc3ccccc32)c1		CHEMBL3589490		IC50			CHEMBL1293289	Homo sapiens	IC50		
Not Active	15728648	CHEMBL3626422	Inhibition of BRD2 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	Cc1ccc(-n2c(C)nnc2C)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621233		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Not Active	15728649	CHEMBL3626422	Inhibition of BRD2 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	Cc1ccc(-n2cnnc2C)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621268		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Not Active	15728650	CHEMBL3626422	Inhibition of BRD2 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	Cc1ccc(NS(C)(=O)=O)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621267		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Not Active	15728651	CHEMBL3626422	Inhibition of BRD2 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	CC(=O)Nc1ccc(C)c(S(=O)(=O)NC2CCCC2)c1		CHEMBL3621266		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Not Active	15728652	CHEMBL3626422	Inhibition of BRD2 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	CC(=O)NCc1ccc(C)c(S(=O)(=O)NC2CCCC2)c1		CHEMBL3621265		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Not Active	15728653	CHEMBL3626422	Inhibition of BRD2 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	Cc1ccc(-c2nnnn2C)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621264		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Not Active	15728654	CHEMBL3626422	Inhibition of BRD2 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	Cc1ccc(-c2nnn(C)n2)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621263		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Not Active	15728655	CHEMBL3626422	Inhibition of BRD2 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	Cc1nc(-c2ccc(C)c(S(=O)(=O)NC3CCCC3)c2)no1		CHEMBL3621262		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Not Active	15728656	CHEMBL3626422	Inhibition of BRD2 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	COc1ccc(-c2cc[n+]([O-])cc2)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621260		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Not Active	15728657	CHEMBL3626422	Inhibition of BRD2 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	COc1ccc(-c2cn(C)nn2)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621259		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Active	15728658	CHEMBL3626422	Inhibition of BRD2 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	COc1ccc(-c2ccc(N)nc2C)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621257		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Not Active	15728659	CHEMBL3626422	Inhibition of BRD2 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	COc1ccc(-c2ccccc2NS(C)(=O)=O)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621256		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Not Active	15728660	CHEMBL3626422	Inhibition of BRD2 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	COc1ccc(-c2cccc(N)c2C)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621255		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Not Active	15728661	CHEMBL3626422	Inhibition of BRD2 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	COc1ccc(-c2ccc(N)cc2C)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621254		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Not Active	15728662	CHEMBL3626422	Inhibition of BRD2 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	COc1ccc(-c2cc(N)ccc2C)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621253		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Not Active	15728663	CHEMBL3626422	Inhibition of BRD2 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	COc1ccc(-c2cccc(NC(C)=O)c2)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621252		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Not Active	15728664	CHEMBL3626422	Inhibition of BRD2 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	COc1ccc(-c2ccc(NC(C)=O)cc2)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621251		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Not Active	15728665	CHEMBL3626422	Inhibition of BRD2 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	COc1ccc(-c2cnc(N)nc2)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621250		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Not Active	15728666	CHEMBL3626422	Inhibition of BRD2 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	COc1ccc(-c2ccc(N)nc2)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621249		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Not Active	15728667	CHEMBL3626422	Inhibition of BRD2 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	COc1ccc(-c2ccncc2)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621279		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Not Active	15728668	CHEMBL3626422	Inhibition of BRD2 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	COc1ccc(-c2cccnc2)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621278		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Not Active	15728669	CHEMBL3626422	Inhibition of BRD2 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	COc1ccc(-c2ccsc2C)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621277		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Not Active	15728670	CHEMBL3626422	Inhibition of BRD2 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	COc1ccc(-c2ccsc2)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621276		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Active	15728671	CHEMBL3626422	Inhibition of BRD2 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	COc1ccc(-c2ccnn2C)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621275		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Not Active	15728672	CHEMBL3626422	Inhibition of BRD2 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	COc1ccc(-c2cn[nH]c2)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621274		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Not Active	15728673	CHEMBL3626422	Inhibition of BRD2 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	COc1ccc(-c2c(C)nn(C)c2C)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621273		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Active	15728674	CHEMBL3626422	Inhibition of BRD2 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	COc1ccc(-c2c(C)n[nH]c2C)cc1S(=O)(=O)NC1CCCC1		CHEMBL3621272		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Active	15728675	CHEMBL3626422	Inhibition of BRD2 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	Cc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)NC1CCCC1		CHEMBL2181721		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Active	15728676	CHEMBL3626422	Inhibition of BRD2 (D1) (unknown origin) at 5 uM incubated for 30 mins using histone H4 peptide (1-21) K5/8/12/16Ac-biotin by alpha screen assay	B	COc1ccc(-c2c(C)noc2C)cc1S(=O)(=O)NC1CCCC1		CHEMBL2181722		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
289113	16258204	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCn1nc2c(c1C)C(c1ccc(F)cc1F)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3654305	=	IC50	nM	120.0	CHEMBL1293289	Homo sapiens	IC50	nM	120.0
289047	16259889	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CC2)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c3nnn(C)c3n1)C2=O		CHEMBL3650955	=	IC50	nM	18.0	CHEMBL1293289	Homo sapiens	IC50	nM	18.0
289031	16260120	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3nn(C4CC4)c(C)c3C2c2ccc(Cl)cc2)cn2c(C)nnc12		CHEMBL3650939	=	IC50	nM	45.0	CHEMBL1293289	Homo sapiens	IC50	nM	45.0
288950	16260260	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1c2c(nn1C)C(=O)N(c1cc(Cl)c(=O)n(C)c1)[C@@H]2c1ccc(Cl)cc1		CHEMBL3650860	=	IC50	nM	100.0	CHEMBL1293289	Homo sapiens	IC50	nM	100.0
289023	16260770	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(-c2cncn2C)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3650931	=	IC50	nM	120.0	CHEMBL1293289	Homo sapiens	IC50	nM	120.0
289057	16260977	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(-c2ccnn2C)c2c1[C@@H](c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3650965	=	IC50	nM	78.0	CHEMBL1293289	Homo sapiens	IC50	nM	78.0
289074	16261524	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CN(C)C2)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3654271	=	IC50	nM	420.0	CHEMBL1293289	Homo sapiens	IC50	nM	420.0
289079	16262503	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CNC(=O)n1nc(C)c2c1C(=O)N(c1cc(C)c3nnc(C)n3c1)C2c1ccc(Cl)cc1		CHEMBL3654276	=	IC50	nM	180.0	CHEMBL1293289	Homo sapiens	IC50	nM	180.0
289088	16262520	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CC(=O)N1CC(n2nc(C)c3c2C(=O)N(c2cc(C)c4nnc(C)n4c2)C3c2ccc(Cl)cc2)C1		CHEMBL3654283	=	IC50	nM	120.0	CHEMBL1293289	Homo sapiens	IC50	nM	120.0
289098	16262836	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3c(c(CO)nn3C3CC3)[C@H]2c2ccc(Cl)cc2)cn2c(C)nnc12		CHEMBL3654324	=	IC50	nM	16.0	CHEMBL1293289	Homo sapiens	IC50	nM	16.0
289050	16263101	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CNc1cc(N2C(=O)c3c(c(C)nn3C3CC3)C2c2ccc(Cl)cc2)nn2c(C)nnc12		CHEMBL3650958	=	IC50	nM	86.0	CHEMBL1293289	Homo sapiens	IC50	nM	86.0
288968	16263767	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1[nH]nc2c1C(c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3650879	=	IC50	nM	210.0	CHEMBL1293289	Homo sapiens	IC50	nM	210.0
288979	16263812	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CC(C)n1ncc2c1C(=O)N(c1cc(Cl)c(=O)n(C)c1)C2c1ccc(Cl)cc1		CHEMBL3650890	=	IC50	nM	49.0	CHEMBL1293289	Homo sapiens	IC50	nM	49.0
289107	16264285	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3nn(C(C)C)c(C)c3C2c2ccc(F)cc2F)cn2c(C)nnc12		CHEMBL3654298	=	IC50	nM	72.0	CHEMBL1293289	Homo sapiens	IC50	nM	72.0
288953	16265771	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cn1cc2c(n1)C(=O)N(c1cc(Cl)c(=O)n(C)c1)C2c1ccc(Cl)cc1		CHEMBL3650863	=	IC50	nM	150.0	CHEMBL1293289	Homo sapiens	IC50	nM	150.0
288986	16265886	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3c(c(C(F)(F)F)nn3C3CC3)C2c2ccc(Cl)cc2)cn(C)c1=O		CHEMBL3650896	=	IC50	nM	60.0	CHEMBL1293289	Homo sapiens	IC50	nM	60.0
289024	16266178	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCc1nn(C2CC2)c2c1C(c1ccc(Cl)cc1)N(c1cc(OC)c3nnc(C)n3c1)C2=O		CHEMBL3650932	=	IC50	nM	37.0	CHEMBL1293289	Homo sapiens	IC50	nM	37.0
289072	16266550	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2COC2)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3654268	=	IC50	nM	92.0	CHEMBL1293289	Homo sapiens	IC50	nM	92.0
289068	16266599	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COCc1nn(C2CC2)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3654263	=	IC50	nM	81.0	CHEMBL1293289	Homo sapiens	IC50	nM	81.0
289108	16266798	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CC2)c2c1C(c1ccc(F)cc1F)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3654299	=	IC50	nM	120.0	CHEMBL1293289	Homo sapiens	IC50	nM	120.0
288981	16268840	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cn1cc(N2C(=O)c3nn(C4CC4)c(C(F)(F)F)c3C2c2ccc(Cl)cc2)cc(Cl)c1=O		CHEMBL3650891	=	IC50	nM	160.0	CHEMBL1293289	Homo sapiens	IC50	nM	160.0
289055	16269015	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CC2)c2c1[C@H](c1ccc(Cl)cc1)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3650963	>	IC50	nM	37000.0	CHEMBL1293289	Homo sapiens	IC50	nM	37000.0
289073	16269358	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3nn(C4CN(C)C4)c(C)c3C2c2ccc(Cl)cc2)cn(C)c1=O		CHEMBL3654270	=	IC50	nM	160.0	CHEMBL1293289	Homo sapiens	IC50	nM	160.0
289042	16269779	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCc1nn(C)c2c1C(c1ccc(Cl)cc1)N(c1cc(OC)c3nnc(C)n3c1)C2=O		CHEMBL3650950	=	IC50	nM	130.0	CHEMBL1293289	Homo sapiens	IC50	nM	130.0
288951	16269935	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1c2c(nn1C)C(=O)N(c1cc(Cl)c(=O)n(C)c1)[C@H]2c1ccc(Cl)cc1		CHEMBL3650861	=	IC50	nM	36000.0	CHEMBL1293289	Homo sapiens	IC50	nM	36000.0
288980	16270380	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cn1cc(N2C(=O)c3nn(C4CC4)cc3C2c2ccc(Cl)cc2)cc(Cl)c1=O		CHEMBL3650889	=	IC50	nM	78.0	CHEMBL1293289	Homo sapiens	IC50	nM	78.0
288998	16271027	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3650906	=	IC50	nM	270.0	CHEMBL1293289	Homo sapiens	IC50	nM	270.0
289017	16272294	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COc1c2c(nn1C)C(=O)N(c1cc(C)c(=O)n(C)c1)C2c1ccc(Cl)cc1		CHEMBL3650925	=	IC50	nM	120.0	CHEMBL1293289	Homo sapiens	IC50	nM	120.0
288991	16272663	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CC2)c2c1[C@H](c1ccc(Cl)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O		CHEMBL3650900	>	IC50	nM	6700.0	CHEMBL1293289	Homo sapiens	IC50	nM	6700.0
289040	16273535	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C(C)C)c2c1[C@H](c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3650948	=	IC50	nM	5300.0	CHEMBL1293289	Homo sapiens	IC50	nM	5300.0
289123	16273758	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COc1ncccc1-n1nc2c(c1C)C(c1ccc(Cl)cc1F)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3654317	=	IC50	nM	90.0	CHEMBL1293289	Homo sapiens	IC50	nM	90.0
288955	16274090	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cn1cc2c(n1)C(=O)N(c1cc(Cl)c(=O)n(C)c1)[C@H]2c1ccc(Cl)cc1		CHEMBL3650865	>	IC50	nM	37000.0	CHEMBL1293289	Homo sapiens	IC50	nM	37000.0
288949	16275313	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1c2c(nn1C)C(=O)N(c1cc(Cl)c(=O)n(C)c1)C2c1ccc(Cl)cc1		CHEMBL3650859	=	IC50	nM	350.0	CHEMBL1293289	Homo sapiens	IC50	nM	350.0
289035	16275594	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CC2)c2c1C(c1ccc(C(F)(F)F)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3650943	=	IC50	nM	88.0	CHEMBL1293289	Homo sapiens	IC50	nM	88.0
288967	16275826	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1c2c(nn1C)C(=O)N(c1ccc3nnc(C)n3c1)C2c1ccc(Cl)cc1		CHEMBL3650878	=	IC50	nM	270.0	CHEMBL1293289	Homo sapiens	IC50	nM	270.0
289083	16276277	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C(=O)N(C)C)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3654326	=	IC50	nM	36.0	CHEMBL1293289	Homo sapiens	IC50	nM	36.0
289012	16276783	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COc1ncccc1-n1nc(C)c2c1C(=O)N(c1cc(C)c(=O)n(C)c1)C2c1ccc(Cl)cc1		CHEMBL3650920	=	IC50	nM	41.0	CHEMBL1293289	Homo sapiens	IC50	nM	41.0
288966	16276874	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CC2)c2c1C(c1ccc(Cl)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O		CHEMBL3650877	=	IC50	nM	230.0	CHEMBL1293289	Homo sapiens	IC50	nM	230.0
289019	16277674	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCc1nn(CCO)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c3onc(C)c3c1)C2=O		CHEMBL3650927	=	IC50	nM	110.0	CHEMBL1293289	Homo sapiens	IC50	nM	110.0
288959	16279562	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1c2c(nn1C1CC1)C(=O)N(c1cc(Cl)c(=O)n(C)c1)C2c1ccc(Cl)cc1		CHEMBL3650870	=	IC50	nM	180.0	CHEMBL1293289	Homo sapiens	IC50	nM	180.0
289089	16280269	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCOC(=O)N1CC(n2nc(C)c3c2C(=O)N(c2cc(C)c(=O)n(C)c2)C3c2ccc(Cl)cc2)C1		CHEMBL3654284	=	IC50	nM	80.0	CHEMBL1293289	Homo sapiens	IC50	nM	80.0
289067	16281015	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3c(c(CO)nn3C3CC3)C2c2ccc(Cl)cc2)cn2c(C)nnc12		CHEMBL3650976	=	IC50	nM	46.0	CHEMBL1293289	Homo sapiens	IC50	nM	46.0
288954	16281097	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cn1cc2c(n1)C(=O)N(c1cc(Cl)c(=O)n(C)c1)[C@@H]2c1ccc(Cl)cc1		CHEMBL3650864	=	IC50	nM	140.0	CHEMBL1293289	Homo sapiens	IC50	nM	140.0
289112	16281256	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCn1nc(C)c2c1C(=O)N(c1cc(C)c3nnc(C)n3c1)C2c1ccc(F)cc1F		CHEMBL3654304	=	IC50	nM	62.0	CHEMBL1293289	Homo sapiens	IC50	nM	62.0
289009	16282314	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCc1c2c(nn1C1CC1)C(=O)N(c1cc(C)c(=O)n(C)c1)C2c1ccc(Cl)cc1		CHEMBL3650917	=	IC50	nM	37.0	CHEMBL1293289	Homo sapiens	IC50	nM	37.0
289093	16282331	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CNc1cc(N2C(=O)c3c(c(C)nn3C3CC3)[C@H]2c2ccc(Cl)cc2)nn2c(C)nnc12		CHEMBL3654320	=	IC50	nM	33.0	CHEMBL1293289	Homo sapiens	IC50	nM	33.0
289111	16282838	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C(C)C)c2c1C(c1ccc(Cl)cc1F)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3654303	=	IC50	nM	89.0	CHEMBL1293289	Homo sapiens	IC50	nM	89.0
289045	16283738	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCc1nn(CCOCC(F)(F)F)c2c1C(c1ccc(Cl)cc1)N(c1cc(OC)c3nnc(C)n3c1)C2=O		CHEMBL3650953	=	IC50	nM	210.0	CHEMBL1293289	Homo sapiens	IC50	nM	210.0
289008	16285278	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COc1ncc(-n2nc3c(c2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(C)c4nnc(C)n4c2)C3=O)c(OC)n1		CHEMBL3650916	=	IC50	nM	43.0	CHEMBL1293289	Homo sapiens	IC50	nM	43.0
289027	16286470	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCc1nn(CCOC)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3650935	=	IC50	nM	72.0	CHEMBL1293289	Homo sapiens	IC50	nM	72.0
289087	16288742	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CC(=O)N1CC(n2nc(C)c3c2C(=O)N(c2cc(C)c(=O)n(C)c2)C3c2ccc(Cl)cc2)C1		CHEMBL3654282	=	IC50	nM	160.0	CHEMBL1293289	Homo sapiens	IC50	nM	160.0
288948	16289356	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1[nH]nc2c1C(c1ccc(Cl)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O		CHEMBL3650858	=	IC50	nM	730.0	CHEMBL1293289	Homo sapiens	IC50	nM	730.0
289104	16289538	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1n[nH]c2c1C(c1ccc(F)cc1F)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3654295	=	IC50	nM	220.0	CHEMBL1293289	Homo sapiens	IC50	nM	220.0
289081	16289696	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCc1nn(C(=O)N(C)C)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3654278	=	IC50	nM	140.0	CHEMBL1293289	Homo sapiens	IC50	nM	140.0
289030	16290416	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CC2)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3650938	=	IC50	nM	29.0	CHEMBL1293289	Homo sapiens	IC50	nM	29.0
289051	16290763	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(-c2ccnn2C)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c3nnc(C)n3n1)C2=O		CHEMBL3650959	=	IC50	nM	35.0	CHEMBL1293289	Homo sapiens	IC50	nM	35.0
289090	16290862	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCOC(=O)N1CC(n2nc(C)c3c2C(=O)N(c2cc(C)c4nnc(C)n4c2)C3c2ccc(Cl)cc2)C1		CHEMBL3654285	=	IC50	nM	59.0	CHEMBL1293289	Homo sapiens	IC50	nM	59.0
288965	16291448	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1[nH][n+](C2CC2)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL4110697	=	IC50	nM	99.0	CHEMBL1293289	Homo sapiens	IC50	nM	99.0
289004	16292273	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C(C)C)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3650912	=	IC50	nM	130.0	CHEMBL1293289	Homo sapiens	IC50	nM	130.0
288987	16292727	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COc1ncc(-n2nc3c(c2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(C)c4onc(C)c4c2)C3=O)c(OC)n1		CHEMBL3639497	=	IC50	nM	130.0	CHEMBL1293289	Homo sapiens	IC50	nM	130.0
289085	16293474	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CNC2)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3654280	=	IC50	nM	150.0	CHEMBL1293289	Homo sapiens	IC50	nM	150.0
288956	16293505	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3nn(C)cc3C2c2ccc(Cl)cc2)cn(C)c1=O		CHEMBL3650866	=	IC50	nM	180.0	CHEMBL1293289	Homo sapiens	IC50	nM	180.0
289071	16295691	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3nn(C4COC4)c(C)c3C2c2ccc(Cl)cc2)cn2c(C)nnc12		CHEMBL3654267	=	IC50	nM	140.0	CHEMBL1293289	Homo sapiens	IC50	nM	140.0
289036	16296239	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COc1ncc(-n2nc(C)c3c2C(=O)N(c2cc(C)c(=O)n(C)c2)[C@H]3c2ccc(Cl)cc2)c(OC)n1		CHEMBL3650944	=	IC50	nM	6000.0	CHEMBL1293289	Homo sapiens	IC50	nM	6000.0
288963	16296923	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3nn(C4CC4)c(C)c3[C@H]2c2ccc(Cl)cc2)cn(C)c1=O		CHEMBL3650874	=	IC50	nM	48.0	CHEMBL1293289	Homo sapiens	IC50	nM	48.0
288970	16297613	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3nn(C)c(C)c3C2c2ccc(Cl)cc2)cn(C)c1=O		CHEMBL3650880	=	IC50	nM	320.0	CHEMBL1293289	Homo sapiens	IC50	nM	320.0
289094	16297682	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COCc1nn(C2CC2)c2c1[C@@H](c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3654290	=	IC50	nM	39.0	CHEMBL1293289	Homo sapiens	IC50	nM	39.0
289118	16299195	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C(C)C)c2c1[C@@H](c1ccc(Cl)cc1F)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3654312	=	IC50	nM	40.0	CHEMBL1293289	Homo sapiens	IC50	nM	40.0
288977	16299837	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3c(cnn3C(C)C)C2c2ccc(Cl)cc2)cn(C)c1=O		CHEMBL3650888	=	IC50	nM	57.0	CHEMBL1293289	Homo sapiens	IC50	nM	57.0
289122	16299930	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COc1ncccc1-n1nc2c(c1C)C(c1ccc(F)cc1F)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3654316	=	IC50	nM	130.0	CHEMBL1293289	Homo sapiens	IC50	nM	130.0
289077	16300794	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CNC(=O)n1nc(C)c2c1C(=O)N(c1cc(C)c(=O)n(C)c1)C2c1ccc(Cl)cc1		CHEMBL3654274	=	IC50	nM	330.0	CHEMBL1293289	Homo sapiens	IC50	nM	330.0
289119	16300850	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CC2)c2c1[C@@H](c1ccc(Cl)cc1F)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3654313	=	IC50	nM	28.0	CHEMBL1293289	Homo sapiens	IC50	nM	28.0
288988	16301537	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COc1ncc(-n2nc3c(c2C(F)(F)F)C(c2ccc(Cl)cc2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1		CHEMBL3650897	=	IC50	nM	210.0	CHEMBL1293289	Homo sapiens	IC50	nM	210.0
289105	16302876	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COc1ncccc1-n1nc(C)c2c1C(=O)N(c1cc(C)c3nnc(C)n3c1)C2c1ccc(F)cc1F		CHEMBL3654296	=	IC50	nM	79.0	CHEMBL1293289	Homo sapiens	IC50	nM	79.0
289015	16302980	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(-c2ccnn2C)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3650923	=	IC50	nM	71.0	CHEMBL1293289	Homo sapiens	IC50	nM	71.0
288983	16303165	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CC(C)n1cc2c(n1)C(=O)N(c1cc(Cl)c(=O)n(C)c1)C2c1ccc(Cl)cc1		CHEMBL3650893	=	IC50	nM	91.0	CHEMBL1293289	Homo sapiens	IC50	nM	91.0
289060	16303897	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CC2)c2c1[C@H](c1ccc(Cl)cc1)N(c1cc(C)c3nnc(C)n3n1)C2=O		CHEMBL3650968	=	IC50	nM	13000.0	CHEMBL1293289	Homo sapiens	IC50	nM	13000.0
289116	16305002	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCn1nc2c(c1C)C(c1ccc(Cl)cc1F)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3654309	=	IC50	nM	140.0	CHEMBL1293289	Homo sapiens	IC50	nM	140.0
288962	16305274	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3nn(C4CC4)c(C)c3C2c2ccc(Cl)cc2)cn(C)c1=O		CHEMBL3650873	=	IC50	nM	130.0	CHEMBL1293289	Homo sapiens	IC50	nM	130.0
289095	16306779	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COCc1nn(C2CC2)c2c1[C@@H](c1ccc(Cl)cc1)N(c1cc(N)c3nnc(C)n3c1)C2=O		CHEMBL3654321	=	IC50	nM	23.0	CHEMBL1293289	Homo sapiens	IC50	nM	23.0
289070	16306956	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2COC2)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3654266	=	IC50	nM	150.0	CHEMBL1293289	Homo sapiens	IC50	nM	150.0
289032	16307200	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CCC2)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3650940	=	IC50	nM	25.0	CHEMBL1293289	Homo sapiens	IC50	nM	25.0
289006	16308098	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1c2c(nn1C(C)C)C(=O)N(c1cc(Cl)c(=O)n(C)c1)C2c1ccc(Cl)cc1		CHEMBL3650914	=	IC50	nM	240.0	CHEMBL1293289	Homo sapiens	IC50	nM	240.0
289059	16308431	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CC2)c2c1[C@@H](c1ccc(Cl)cc1)N(c1cc(C)c3nnc(C)n3n1)C2=O		CHEMBL3650967	=	IC50	nM	12.0	CHEMBL1293289	Homo sapiens	IC50	nM	12.0
288975	16308923	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3c(cnn3C3CC3)C2c2ccc(Cl)cc2)cn(C)c1=O		CHEMBL3650886	=	IC50	nM	95.0	CHEMBL1293289	Homo sapiens	IC50	nM	95.0
289038	16309361	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COc1ncccc1-n1nc(C)c2c1C(=O)N(c1cc(C)c3nnc(C)n3c1)C2c1ccc(Cl)cc1		CHEMBL3650946	=	IC50	nM	43.0	CHEMBL1293289	Homo sapiens	IC50	nM	43.0
289078	16309426	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CNC(=O)n1nc2c(c1C)C(c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3654275	=	IC50	nM	160.0	CHEMBL1293289	Homo sapiens	IC50	nM	160.0
289062	16310246	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(-c2ccnn2C)c2c1[C@@H](c1ccc(Cl)cc1)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3650970	=	IC50	nM	32.0	CHEMBL1293289	Homo sapiens	IC50	nM	32.0
289120	16310855	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCn1nc(C)c2c1C(=O)N(c1cc(C)c3nnc(C)n3c1)[C@@H]2c1ccc(F)cc1F		CHEMBL3654314	=	IC50	nM	69.0	CHEMBL1293289	Homo sapiens	IC50	nM	69.0
288972	16312016	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1c2c(nn1C)C(=O)N(c1cc(F)c(=O)n(C)c1)C2c1ccc(Cl)cc1		CHEMBL3650883	=	IC50	nM	690.0	CHEMBL1293289	Homo sapiens	IC50	nM	690.0
289041	16313393	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C(C)C)c2c1[C@@H](c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3650949	=	IC50	nM	14.0	CHEMBL1293289	Homo sapiens	IC50	nM	14.0
289053	16314349	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCn1nc(C)c2c1C(=O)N(c1cc(C)c3nnc(C)n3c1)C2c1ccc(Cl)cc1		CHEMBL3650961	=	IC50	nM	36.0	CHEMBL1293289	Homo sapiens	IC50	nM	36.0
289076	16314366	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C(=O)N(C)C)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3654273	=	IC50	nM	180.0	CHEMBL1293289	Homo sapiens	IC50	nM	180.0
289043	16314367	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCc1nn(C2CC2)c2c1[C@H](c1ccc(Cl)cc1)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3650951	=	IC50	nM	2900.0	CHEMBL1293289	Homo sapiens	IC50	nM	2900.0
289052	16315304	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCn1nc2c(c1C)C(c1ccc(Cl)cc1)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3650960	=	IC50	nM	48.0	CHEMBL1293289	Homo sapiens	IC50	nM	48.0
289066	16315954	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COCc1nn(C2CC2)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3650975	=	IC50	nM	53.0	CHEMBL1293289	Homo sapiens	IC50	nM	53.0
289025	16316449	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CC2)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c3nnn(C)c3c1)C2=O		CHEMBL3650933	=	IC50	nM	24.0	CHEMBL1293289	Homo sapiens	IC50	nM	24.0
288952	16316550	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cn1cc(N2C(=O)c3n[nH]cc3C2c2ccc(Cl)cc2)cc(Cl)c1=O		CHEMBL3650862	=	IC50	nM	210.0	CHEMBL1293289	Homo sapiens	IC50	nM	210.0
288994	16317047	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COc1ncc(-n2nc(C)c3c2C(=O)N(c2cc(Cl)c(=O)n(C)c2)C3c2ccc(Cl)cc2)c(OC)n1		CHEMBL3650903	=	IC50	nM	98.0	CHEMBL1293289	Homo sapiens	IC50	nM	98.0
288958	16317112	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3nn(C)cc3[C@H]2c2ccc(Cl)cc2)cn(C)c1=O		CHEMBL3650869	=	IC50	nM	100.0	CHEMBL1293289	Homo sapiens	IC50	nM	100.0
289103	16317146	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCn1nc2c(c1C)C(c1ccc(Cl)cc1F)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3654294	=	IC50	nM	140.0	CHEMBL1293289	Homo sapiens	IC50	nM	140.0
289101	16318100	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3nn(C(C)C)c(C)c3C2c2ccc(Cl)cc2F)cn2c(C)nnc12		CHEMBL3654292	=	IC50	nM	120.0	CHEMBL1293289	Homo sapiens	IC50	nM	120.0
289064	16318155	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COc1ncccc1-n1nc(C)c2c1C(=O)N(c1cc(C)c(=O)n(C)c1)[C@@H]2c1ccc(Cl)cc1		CHEMBL3650973	=	IC50	nM	30.0	CHEMBL1293289	Homo sapiens	IC50	nM	30.0
289018	16318299	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCc1nn(CCO)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3650926	=	IC50	nM	79.0	CHEMBL1293289	Homo sapiens	IC50	nM	79.0
289013	16318704	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COc1ncccc1-n1nc(C)c2c1C(=O)N(c1cc(Cl)c(=O)n(C)c1)C2c1ccc(Cl)cc1		CHEMBL3650921	=	IC50	nM	60.0	CHEMBL1293289	Homo sapiens	IC50	nM	60.0
289106	16319307	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C(C)C)c2c1C(c1ccc(F)cc1F)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3654297	=	IC50	nM	110.0	CHEMBL1293289	Homo sapiens	IC50	nM	110.0
289069	16319609	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3nn(C4COC4)c(C)c3C2c2ccc(Cl)cc2)cn(C)c1=O		CHEMBL3654265	=	IC50	nM	190.0	CHEMBL1293289	Homo sapiens	IC50	nM	190.0
289010	16319740	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCc1nn(C2CC2)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3650918	=	IC50	nM	26.0	CHEMBL1293289	Homo sapiens	IC50	nM	26.0
289058	16320048	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(-c2ccnn2C)c2c1[C@H](c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3650966	=	IC50	nM	5300.0	CHEMBL1293289	Homo sapiens	IC50	nM	5300.0
289002	16320212	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COc1ncc(-n2nc3c(c2C(C)C)[C@H](c2ccc(Cl)cc2)N(c2cc(C)c4onc(C)c4c2)C3=O)c(OC)n1		CHEMBL3650910	>	IC50	nM	37000.0	CHEMBL1293289	Homo sapiens	IC50	nM	37000.0
289061	16320670	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(-c2ccnn2C)c2c1[C@H](c1ccc(Cl)cc1)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3650969	=	IC50	nM	29000.0	CHEMBL1293289	Homo sapiens	IC50	nM	29000.0
289063	16320827	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COc1ncccc1-n1nc(C)c2c1C(=O)N(c1cc(C)c(=O)n(C)c1)[C@H]2c1ccc(Cl)cc1		CHEMBL3650972	=	IC50	nM	4400.0	CHEMBL1293289	Homo sapiens	IC50	nM	4400.0
288978	16320903	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cn1cc(N2C(=O)c3nn(C4CC4)cc3C2c2ccc(Cl)cc2)cc(Cl)c1=O		CHEMBL3650889	=	IC50	nM	140.0	CHEMBL1293289	Homo sapiens	IC50	nM	140.0
288996	16320934	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COc1ncc(-n2nc3c(c2C)C(c2ccc(Cl)cc2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1		CHEMBL3650905	=	IC50	nM	98.0	CHEMBL1293289	Homo sapiens	IC50	nM	98.0
289100	16321065	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C(C)C)c2c1C(c1ccc(Cl)cc1F)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3654291	=	IC50	nM	71.0	CHEMBL1293289	Homo sapiens	IC50	nM	71.0
289000	16321731	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COc1nccc(-n2nc(C)c3c2C(=O)N(c2cc(C)c(=O)n(C)c2)C3c2ccc(Cl)cc2)n1		CHEMBL3650908	=	IC50	nM	610.0	CHEMBL1293289	Homo sapiens	IC50	nM	610.0
288960	16322434	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1c2c(nn1C1CC1)C(=O)N(c1cc(Cl)c(=O)n(C)c1)[C@H]2c1ccc(Cl)cc1		CHEMBL3650871	=	IC50	nM	30000.0	CHEMBL1293289	Homo sapiens	IC50	nM	30000.0
288984	16322639	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3nn(C4CC4)c(C(F)(F)F)c3C2c2ccc(Cl)cc2)cn(C)c1=O		CHEMBL3650894	=	IC50	nM	100.0	CHEMBL1293289	Homo sapiens	IC50	nM	100.0
289021	16323602	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1ncccc1-n1nc2c(c1C)C(c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3650929	=	IC50	nM	120.0	CHEMBL1293289	Homo sapiens	IC50	nM	120.0
289109	16323604	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CC2)c2c1C(c1ccc(Cl)cc1F)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3654301	=	IC50	nM	68.0	CHEMBL1293289	Homo sapiens	IC50	nM	68.0
289001	16323810	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCc1nn(-c2cnc(OC)nc2OC)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3650909	=	IC50	nM	160.0	CHEMBL1293289	Homo sapiens	IC50	nM	160.0
289005	16324730	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3nn(C(C)C)c(C)c3C2c2ccc(Cl)cc2)cn(C)c1=O		CHEMBL3650913	=	IC50	nM	180.0	CHEMBL1293289	Homo sapiens	IC50	nM	180.0
289091	16325397	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CN(C)C2)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3654286	=	IC50	nM	77.0	CHEMBL1293289	Homo sapiens	IC50	nM	77.0
289037	16326286	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COc1ncc(-n2nc(C)c3c2C(=O)N(c2cc(C)c(=O)n(C)c2)[C@@H]3c2ccc(Cl)cc2)c(OC)n1		CHEMBL3650945	=	IC50	nM	28.0	CHEMBL1293289	Homo sapiens	IC50	nM	28.0
289011	16326319	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCc1nn(C2CC2)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3650919	=	IC50	nM	31.0	CHEMBL1293289	Homo sapiens	IC50	nM	31.0
288969	16326415	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1[nH]nc2c1C(c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3650879	=	IC50	nM	310.0	CHEMBL1293289	Homo sapiens	IC50	nM	310.0
288985	16327721	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cn1cc(N2C(=O)c3c(c(C(F)(F)F)nn3C3CC3)C2c2ccc(Cl)cc2)cc(Cl)c1=O		CHEMBL3650895	=	IC50	nM	170.0	CHEMBL1293289	Homo sapiens	IC50	nM	170.0
288995	16328088	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COc1ncc(-n2nc3c(c2C(C)C)C(c2ccc(Cl)cc2)N(c2ccc4onc(C)c4c2)C3=O)c(OC)n1		CHEMBL3650904	=	IC50	nM	480.0	CHEMBL1293289	Homo sapiens	IC50	nM	480.0
288974	16328258	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1noc2ccc(N3C(=O)c4nn(C)c(C)c4C3c3ccc(Cl)cc3)cc12		CHEMBL3650885	=	IC50	nM	31200.0	CHEMBL1293289	Homo sapiens	IC50	nM	31200.0
289029	16328324	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(-c2ccnn2C)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3650937	=	IC50	nM	28.0	CHEMBL1293289	Homo sapiens	IC50	nM	28.0
289007	16328639	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C(C)C)c2c1C(c1ccc(Cl)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O		CHEMBL3650915	=	IC50	nM	160.0	CHEMBL1293289	Homo sapiens	IC50	nM	160.0
288957	16329164	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3nn(C)cc3[C@@H]2c2ccc(Cl)cc2)cn(C)c1=O		CHEMBL3650868	>	IC50	nM	6700.0	CHEMBL1293289	Homo sapiens	IC50	nM	6700.0
289028	16329468	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCc1nn(-c2ccnn2C)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3650936	=	IC50	nM	60.0	CHEMBL1293289	Homo sapiens	IC50	nM	60.0
289022	16329761	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1ncccc1-n1nc(C)c2c1C(=O)N(c1cc(C)c(=O)n(C)c1)C2c1ccc(Cl)cc1		CHEMBL3650930	=	IC50	nM	97.0	CHEMBL1293289	Homo sapiens	IC50	nM	97.0
289049	16331584	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CC2)c2c1C(c1ccc(Cl)cc1)N(c1cc(N(C)C(=O)OC(C)(C)C)c3nnc(C)n3n1)C2=O		CHEMBL3650957	>	IC50	nM	37000.0	CHEMBL1293289	Homo sapiens	IC50	nM	37000.0
288964	16332388	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3nn(C4CC4)c(C)c3[C@@H]2c2ccc(Cl)cc2)cn(C)c1=O		CHEMBL3650875	>	IC50	nM	6700.0	CHEMBL1293289	Homo sapiens	IC50	nM	6700.0
289046	16333358	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COc1ncccc1-n1nc(C)c2c1C(=O)N(c1cc(C)c3nnn(C)c3n1)C2c1ccc(Cl)cc1		CHEMBL3650954	=	IC50	nM	27.0	CHEMBL1293289	Homo sapiens	IC50	nM	27.0
288982	16333399	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3nn(C(C)C)cc3C2c2ccc(Cl)cc2)cn(C)c1=O		CHEMBL3650892	=	IC50	nM	75.0	CHEMBL1293289	Homo sapiens	IC50	nM	75.0
289102	16333568	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCn1nc(C)c2c1C(=O)N(c1cc(C)c(=O)n(C)c1)C2c1ccc(Cl)cc1F		CHEMBL3654293	=	IC50	nM	16.0	CHEMBL1293289	Homo sapiens	IC50	nM	16.0
288976	16333611	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cn1cc(N2C(=O)c3c(cnn3C3CC3)C2c2ccc(Cl)cc2)cc(Cl)c1=O		CHEMBL3650887	=	IC50	nM	140.0	CHEMBL1293289	Homo sapiens	IC50	nM	140.0
289115	16334342	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCn1nc(C)c2c1C(=O)N(c1cc(C)c3nnc(C)n3c1)C2c1ccc(Cl)cc1F		CHEMBL3654308	=	IC50	nM	71.0	CHEMBL1293289	Homo sapiens	IC50	nM	71.0
289003	16334399	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COc1ncc(-n2nc3c(c2C(C)C)[C@@H](c2ccc(Cl)cc2)N(c2cc(C)c4onc(C)c4c2)C3=O)c(OC)n1		CHEMBL3650911	=	IC50	nM	60.0	CHEMBL1293289	Homo sapiens	IC50	nM	60.0
289114	16335317	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COc1ncccc1-n1nc(C)c2c1C(=O)N(c1cc(C)c3nnc(C)n3c1)C2c1ccc(Cl)cc1F		CHEMBL3654307	=	IC50	nM	47.0	CHEMBL1293289	Homo sapiens	IC50	nM	47.0
289054	16335767	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3c(c(C4CC4)nn3-c3ccnn3C)C2c2ccc(Cl)cc2)cn2c(C)nnc12		CHEMBL3650962	=	IC50	nM	34.0	CHEMBL1293289	Homo sapiens	IC50	nM	34.0
289084	16335836	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3nn(C(=O)N(C)C)c(C)c3[C@H]2c2ccc(Cl)cc2)cn2c(C)nnc12		CHEMBL3654327	=	IC50	nM	140.0	CHEMBL1293289	Homo sapiens	IC50	nM	140.0
289125	16335982	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1[nH]nc2c1C(c1ccc(Cl)cc1F)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3654319	=	IC50	nM	270.0	CHEMBL1293289	Homo sapiens	IC50	nM	270.0
289086	16336956	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3nn(C4CNC4)c(C)c3C2c2ccc(Cl)cc2)cn2c(C)nnc12		CHEMBL3654281	=	IC50	nM	100.0	CHEMBL1293289	Homo sapiens	IC50	nM	100.0
289033	16337052	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CC2)c2c1C(c1ccc(OC(F)(F)F)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3650941	=	IC50	nM	63.0	CHEMBL1293289	Homo sapiens	IC50	nM	63.0
289048	16339910	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COc1ncccc1-n1nc(C)c2c1C(=O)N(c1cc(C)c3nnc(C)n3n1)C2c1ccc(Cl)cc1		CHEMBL3650956	=	IC50	nM	32.0	CHEMBL1293289	Homo sapiens	IC50	nM	32.0
289082	16340829	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCc1c2c(nn1C(=O)N(C)C)C(=O)N(c1cc(C)c(=O)n(C)c1)C2c1ccc(Cl)cc1		CHEMBL3654279	=	IC50	nM	220.0	CHEMBL1293289	Homo sapiens	IC50	nM	220.0
289075	16341414	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3nn(C(=O)N(C)C)c(C)c3C2c2ccc(Cl)cc2)cn(C)c1=O		CHEMBL3654272	=	IC50	nM	180.0	CHEMBL1293289	Homo sapiens	IC50	nM	180.0
289039	16341680	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CC2)c2c1C(c1ccc(Cl)cc1)N(c1ccc3nnn(C)c3n1)C2=O		CHEMBL3650947	=	IC50	nM	72.0	CHEMBL1293289	Homo sapiens	IC50	nM	72.0
289020	16341969	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCc1c2c(nn1CCO)C(=O)N(c1cc(C)c3onc(C)c3c1)C2c1ccc(Cl)cc1		CHEMBL3650928	=	IC50	nM	59.0	CHEMBL1293289	Homo sapiens	IC50	nM	59.0
289026	16342492	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCc1nn(CCOC)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3650934	=	IC50	nM	52.0	CHEMBL1293289	Homo sapiens	IC50	nM	52.0
289110	16343019	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CC2)c2c1C(c1ccc(Cl)cc1F)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3654302	=	IC50	nM	92.0	CHEMBL1293289	Homo sapiens	IC50	nM	92.0
289044	16343250	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCc1nn(C2CC2)c2c1[C@@H](c1ccc(Cl)cc1)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3650952	=	IC50	nM	14.0	CHEMBL1293289	Homo sapiens	IC50	nM	14.0
289014	16343266	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3nn(C)c(O)c3C2c2ccc(Cl)cc2)cn(C)c1=O		CHEMBL3650922	=	IC50	nM	200.0	CHEMBL1293289	Homo sapiens	IC50	nM	200.0
289096	16343277	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3c(c(C4CC4)nn3C)[C@H]2c2ccc(Cl)cc2)cn2c(C)nnc12		CHEMBL3654322	=	IC50	nM	20.0	CHEMBL1293289	Homo sapiens	IC50	nM	20.0
288961	16343817	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1c2c(nn1C1CC1)C(=O)N(c1cc(Cl)c(=O)n(C)c1)[C@@H]2c1ccc(Cl)cc1		CHEMBL3650872	=	IC50	nM	78.0	CHEMBL1293289	Homo sapiens	IC50	nM	78.0
288947	16345359	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1c2c(nn1C)C(=O)N(c1ccc(=O)n(C)c1)C2c1ccc(Cl)cc1		CHEMBL3650856	=	IC50	nM	580.0	CHEMBL1293289	Homo sapiens	IC50	nM	580.0
289121	16346313	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCn1nc(C)c2c1C(=O)N(c1cc(C)c3nnc(C)n3c1)[C@@H]2c1ccc(Cl)cc1F		CHEMBL3654315	=	IC50	nM	53.0	CHEMBL1293289	Homo sapiens	IC50	nM	53.0
289097	16346514	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1n[nH]c2c1[C@@H](c1ccc(Cl)cc1)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3654323	=	IC50	nM	17.0	CHEMBL1293289	Homo sapiens	IC50	nM	17.0
289065	16347175	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3c(c(C4CC4)nn3C)C2c2ccc(Cl)cc2)cn2c(C)nnc12		CHEMBL3650974	=	IC50	nM	40.0	CHEMBL1293289	Homo sapiens	IC50	nM	40.0
288989	16347560	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CC2)c2c1[C@H](c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3650898	>	IC50	nM	6700.0	CHEMBL1293289	Homo sapiens	IC50	nM	6700.0
289092	16347598	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3nn(C4CN(C)C4)c(C)c3C2c2ccc(Cl)cc2)cn2c(C)nnc12		CHEMBL3654287	=	IC50	nM	98.0	CHEMBL1293289	Homo sapiens	IC50	nM	98.0
288997	16349203	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COc1ncc(-n2nc3c(c2C)C(c2ccc(Cl)cc2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1		CHEMBL3650905	=	IC50	nM	69.0	CHEMBL1293289	Homo sapiens	IC50	nM	69.0
288993	16350324	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	COc1ncc(-n2nc(C)c3c2C(=O)N(c2cc(C)c(=O)n(C)c2)C3c2ccc(Cl)cc2)c(OC)n1		CHEMBL3650902	=	IC50	nM	63.0	CHEMBL1293289	Homo sapiens	IC50	nM	63.0
288992	16350951	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CC2)c2c1[C@@H](c1ccc(Cl)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O		CHEMBL3650901	=	IC50	nM	17.0	CHEMBL1293289	Homo sapiens	IC50	nM	17.0
289099	16351526	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C[C@H](O)C(F)(F)F)c2c1[C@@H](c1ccc(Cl)cc1)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3654325	=	IC50	nM	42.0	CHEMBL1293289	Homo sapiens	IC50	nM	42.0
289080	16351855	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CNC(=O)n1nc2c(c1C)C(c1ccc(Cl)cc1)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3654277	=	IC50	nM	190.0	CHEMBL1293289	Homo sapiens	IC50	nM	190.0
289016	16352294	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	CCOc1c2c(nn1C)C(=O)N(c1cc(C)c(=O)n(C)c1)C2c1ccc(Cl)cc1		CHEMBL3650924	=	IC50	nM	100.0	CHEMBL1293289	Homo sapiens	IC50	nM	100.0
288999	16352778	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C)c2c1C(c1ccc(Cl)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O		CHEMBL3650907	=	IC50	nM	560.0	CHEMBL1293289	Homo sapiens	IC50	nM	560.0
288971	16353598	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1cc(N2C(=O)c3nn(C)c(C)c3[C@@H]2c2ccc(Cl)cc2)cn(C)c1=O		CHEMBL3650881	=	IC50	nM	28000.0	CHEMBL1293289	Homo sapiens	IC50	nM	28000.0
289124	16353922	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CC2)c2c1C(c1ccc(Cl)cc1)N(c1cc(C)c3nnc(C(F)F)n3n1)C2=O		CHEMBL3654318	=	IC50	nM	20.0	CHEMBL1293289	Homo sapiens	IC50	nM	20.0
288990	16354234	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CC2)c2c1[C@@H](c1ccc(Cl)cc1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3650899	=	IC50	nM	15.0	CHEMBL1293289	Homo sapiens	IC50	nM	15.0
289056	16354607	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CC2)c2c1[C@@H](c1ccc(Cl)cc1)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3650964	=	IC50	nM	19.0	CHEMBL1293289	Homo sapiens	IC50	nM	19.0
289034	16355392	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CC2)c2c1C(c1cccc(C(F)(F)F)c1)N(c1cc(C)c(=O)n(C)c1)C2=O		CHEMBL3650942	=	IC50	nM	660.0	CHEMBL1293289	Homo sapiens	IC50	nM	660.0
289117	16355706	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1nn(C2CC2)c2c1[C@@H](c1ccc(F)cc1F)N(c1cc(C)c3nnc(C)n3c1)C2=O		CHEMBL3654311	=	IC50	nM	41.0	CHEMBL1293289	Homo sapiens	IC50	nM	41.0
288973	16355990	CHEMBL3707600	TR-FRET In-Vitro Binding Assay: All assays were performed in 384-well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, plus 16 high- and 16 low controls. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Perkin Elmer/Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO HummingBird nanodispenser (Zinsser Analytic). The assay was started by stepwise addition of 4.5 uL per well of bromo domain protein (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 45 nM His-Brd2(60-472) or 45 nM His-Brd3(20-477) or 45 nM His-Brd4(44-477) all proteins produced in-house) and 4.5 uL per well of peptide solution (50 mM HEPES, pH 7.5, 0.005% Tween20, 0.1% BSA, 50 mM NaCl, 60 nM acetyl-histone H4 (AcK 5, 8, 12, 16) (Biosyntan GmbH)). Reactions were incubated at 30 C. for 35 minutes.	B	Cc1c2c(nn1C)C(=O)N(c1ccc(=O)n(C)n1)C2c1ccc(Cl)cc1		CHEMBL3650884	=	IC50	nM	1200.0	CHEMBL1293289	Homo sapiens	IC50	nM	1200.0
Active	16411582	CHEMBL3743452	Binding affinity to human BRD2 at 10 uM by differential scanning fluorimetry	B	CC(=O)c1cc(-c2cccc3nccn23)c2cc(N3CCOCC3)ccn12		CHEMBL3740819		Activity			CHEMBL1293289	Homo sapiens	Activity		
Active	16482727	CHEMBL3772991	Inhibition of Flag-tagged BRD2 (unknown origin)-biotinylated AcH4 (Lys5, 8, 12, 16) histone peptide binding expressed in CHO cells after 60 mins by TR-FRET assay	B	COC(=O)C[C@@H]1N=C(c2ccc(-c3cccc(C#N)c3)cc2)c2c(sc(C)c2C)-n2c(C)nnc21		CHEMBL3771129		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Not Active	16482734	CHEMBL3772826	Competitive inhibition of BRD2 in PMA /ionomycin activated human Jurkat cell lysate in presence of (S)-4-{3'-Cyano-4'-[3-(3-{2-[5-((3aR,6S,6aS)-2-oxo-hexahydro-thieno[3,4-d]imidazol-6-yl)-pentanoylamino]-ethyldisulfanyl}-propionylamino)-propoxy]-biphenyl-4-yl}-2,3,9-trimethyl-6H-1-thia-5,7,8,9a-tetraaza-cyclopenta[e]azulene-6-yl]acetic acid ethyl ester/avidin-resin by pull down assay	B	COC(=O)C[C@H]1N=C(c2ccc(-c3cccc(C#N)c3)cc2)c2c(sc(C)c2C)-n2c(C)nnc21		CHEMBL3769538		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Dose-dependent effect	16482735	CHEMBL3772826	Competitive inhibition of BRD2 in PMA /ionomycin activated human Jurkat cell lysate in presence of (S)-4-{3'-Cyano-4'-[3-(3-{2-[5-((3aR,6S,6aS)-2-oxo-hexahydro-thieno[3,4-d]imidazol-6-yl)-pentanoylamino]-ethyldisulfanyl}-propionylamino)-propoxy]-biphenyl-4-yl}-2,3,9-trimethyl-6H-1-thia-5,7,8,9a-tetraaza-cyclopenta[e]azulene-6-yl]acetic acid ethyl ester/avidin-resin by pull down assay	B	COC(=O)C[C@@H]1N=C(c2ccc(-c3cccc(C#N)c3)cc2)c2c(sc(C)c2C)-n2c(C)nnc21		CHEMBL3771129		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Not Active	16491874	CHEMBL3773111	Binding affinity to biotinylated BRD2 bromodomain-1 (unknown origin) expressed in Escherichia coli at 0.2 to 1 uM by Biolayer Interferometric analysis	B	CCCOc1ccn2c(C(C)=O)cc(-c3ccccc3S(C)(=O)=O)c2c1		CHEMBL3739699		Activity			CHEMBL1293289	Homo sapiens	Activity		
Not Active	16491875	CHEMBL3773111	Binding affinity to biotinylated BRD2 bromodomain-1 (unknown origin) expressed in Escherichia coli at 0.2 to 1 uM by Biolayer Interferometric analysis	B	CCCOc1ccn2c(C(C)=O)cc(-c3cccc(OC)c3)c2c1		CHEMBL3769590		Activity			CHEMBL1293289	Homo sapiens	Activity		
Not Active	16491876	CHEMBL3773112	Binding affinity to biotinylated BRD2 bromodomain-2 (unknown origin) expressed in Escherichia coli at 0.2 to 1 uM by Biolayer Interferometric analysis	B	CCCOc1ccn2c(C(C)=O)cc(-c3ccccc3S(C)(=O)=O)c2c1		CHEMBL3739699		Activity			CHEMBL1293289	Homo sapiens	Activity		
Not Active	16491877	CHEMBL3773112	Binding affinity to biotinylated BRD2 bromodomain-2 (unknown origin) expressed in Escherichia coli at 0.2 to 1 uM by Biolayer Interferometric analysis	B	CCCOc1ccn2c(C(C)=O)cc(-c3cccc(OC)c3)c2c1		CHEMBL3769590		Activity			CHEMBL1293289	Homo sapiens	Activity		
	16492856	CHEMBL3771510	Competitive binding affinity to human BRD2 bromodomain 1 expressed in T7 phage-infected Escherichia coli BL21(DE3) cells incubated for 1 hr by bromoscan assay	B	CCOc1ccc(C(C)=O)cc1NC(=O)c1cccc(C(=O)O)c1		CHEMBL3770150	>	Kd	nM	50000.0	CHEMBL1293289	Homo sapiens	Kd	uM	50.0
	16492857	CHEMBL3771510	Competitive binding affinity to human BRD2 bromodomain 1 expressed in T7 phage-infected Escherichia coli BL21(DE3) cells incubated for 1 hr by bromoscan assay	B	CCOc1ccc(C(C)=O)cc1NC(=O)c1cc(C(=O)O)cc(-c2ccoc2)c1		CHEMBL3770598	=	Kd	nM	24000.0	CHEMBL1293289	Homo sapiens	Kd	uM	24.0
	16492858	CHEMBL3771510	Competitive binding affinity to human BRD2 bromodomain 1 expressed in T7 phage-infected Escherichia coli BL21(DE3) cells incubated for 1 hr by bromoscan assay	B	CCOc1ccc(C(C)=O)cc1NC(=O)c1cc(COC)cc(C(=O)O)c1		CHEMBL3771341	>	Kd	nM	50000.0	CHEMBL1293289	Homo sapiens	Kd	uM	50.0
	16492859	CHEMBL3771511	Competitive binding affinity to human BRD2 bromodomain 2 expressed in T7 phage-infected Escherichia coli BL21(DE3) cells incubated for 1 hr by bromoscan assay	B	CCOc1ccc(C(C)=O)cc1NC(=O)c1cccc(C(=O)O)c1		CHEMBL3770150	>	Kd	nM	50000.0	CHEMBL1293289	Homo sapiens	Kd	uM	50.0
	16492860	CHEMBL3771511	Competitive binding affinity to human BRD2 bromodomain 2 expressed in T7 phage-infected Escherichia coli BL21(DE3) cells incubated for 1 hr by bromoscan assay	B	CCOc1ccc(C(C)=O)cc1NC(=O)c1cc(C(=O)O)cc(-c2ccoc2)c1		CHEMBL3770598	=	Kd	nM	24000.0	CHEMBL1293289	Homo sapiens	Kd	uM	24.0
	16492861	CHEMBL3771511	Competitive binding affinity to human BRD2 bromodomain 2 expressed in T7 phage-infected Escherichia coli BL21(DE3) cells incubated for 1 hr by bromoscan assay	B	CCOc1ccc(C(C)=O)cc1NC(=O)c1cc(COC)cc(C(=O)O)c1		CHEMBL3771341	>	Kd	nM	50000.0	CHEMBL1293289	Homo sapiens	Kd	uM	50.0
	16493432	CHEMBL3772267	Binding affinity to BRD2 bromodomain 2 V376A mutant (unknown origin) expressed in competent Escherichia coli DH5-alpha cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461	=	Delta Tm	degrees C	1.1	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	1.1
	16493433	CHEMBL3772267	Binding affinity to BRD2 bromodomain 2 V376A mutant (unknown origin) expressed in competent Escherichia coli DH5-alpha cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	COC(=O)CC1N=C(c2ccc(Cl)cc2)c2cc(OC)cc(C)c2-n2c(C)nnc21		CHEMBL3771130	=	Delta Tm	degrees C	1.2	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	1.2
	16493434	CHEMBL3772268	Binding affinity to BRD2 bromodomain 2 L383I mutant (unknown origin) expressed in competent Escherichia coli DH5-alpha cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461	=	Delta Tm	degrees C	9.3	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	9.3
	16493435	CHEMBL3772268	Binding affinity to BRD2 bromodomain 2 L383I mutant (unknown origin) expressed in competent Escherichia coli DH5-alpha cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	COC(=O)[C@@H](C)[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL3770265	=	Delta Tm	degrees C	0.3	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	0.3
	16493442	CHEMBL3773031	Selectivity ratio of Kd for human BRD2 bromodomain 1 expressed in Escherichia coli BL21 (DE3) cells to Kd for human BRD2 bromodomain 2 expressed in Escherichia coli BL21 (DE3) cells	B	COc1cc(OC)c2c(=O)[nH]c(-c3cc(C)c(OCCO)c(C)c3)nc2c1		CHEMBL2393130	=	Selectivity ratio		23.0	CHEMBL1293289	Homo sapiens	Selectivity ratio		23.0
	16493443	CHEMBL3773030	Selectivity ratio of Kd for N-terminal His6-tagged BRD2 bromodomain 1 (unknown origin) expressed in competent Escherichia coli BL21(DE3) cells to Kd for N-terminal His6-tagged BRD2 bromodomain 2 (unknown origin) expressed in competent Escherichia coli BL21(DE3) cells	B	COC(=O)CC1N=C(c2cccc3[nH]ccc23)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL3770576	=	Selectivity ratio		20.0	CHEMBL1293289	Homo sapiens	Selectivity ratio		20.0
	16493446	CHEMBL3773027	Binding affinity to human BRD2 bromodomain 2 by isothermal titration calorimetry	B	COc1cc(OC)c2c(=O)[nH]c(-c3cc(C)c(OCCO)c(C)c3)nc2c1		CHEMBL2393130	=	Kd	nM	206.0	CHEMBL1293289	Homo sapiens	Kd	nM	206.0
	16493447	CHEMBL3773026	Binding affinity to human BRD2 bromodomain 1 by isothermal titration calorimetry	B	COc1cc(OC)c2c(=O)[nH]c(-c3cc(C)c(OCCO)c(C)c3)nc2c1		CHEMBL2393130	=	Kd	nM	16900.0	CHEMBL1293289	Homo sapiens	Kd	nM	16900.0
	16493450	CHEMBL3772867	Binding affinity to human BRD2 bromodomain 2 expressed in Escherichia coli BL21 (DE3) cells by isothermal titration calorimetry	B	COc1cc(OC)c2c(=O)[nH]c(-c3cc(C)c(OCCO)c(C)c3)nc2c1		CHEMBL2393130	=	Kd	nM	250.0	CHEMBL1293289	Homo sapiens	Kd	nM	250.0
	16493451	CHEMBL3772866	Binding affinity to human BRD2 bromodomain 1 expressed in Escherichia coli BL21 (DE3) cells by isothermal titration calorimetry	B	COc1cc(OC)c2c(=O)[nH]c(-c3cc(C)c(OCCO)c(C)c3)nc2c1		CHEMBL2393130	=	Kd	nM	5800.0	CHEMBL1293289	Homo sapiens	Kd	nM	5800.0
	16493454	CHEMBL3772863	Binding affinity to recombinant poly-His-tagged BRD2 bromodomain 2 (unknown origin) by isothermal titration calorimetry	B	CC(=O)NCCCCn1c2c(c3ccccc31)C(=O)NCC2	Outside typical range	CHEMBL3770724	>	Kd	nM	300000.0	CHEMBL1293289	Homo sapiens	Kd	nM	300000.0
	16493455	CHEMBL3772115	Binding affinity to recombinant poly-His-tagged BRD2 bromodomain 1 (unknown origin) by isothermal titration calorimetry	B	CC(=O)NCCCCn1c2c(c3ccccc31)C(=O)NCC2		CHEMBL3770724	=	Kd	nM	8600.0	CHEMBL1293289	Homo sapiens	Kd	nM	8600.0
	16493458	CHEMBL3772280	Binding affinity to full length N-terminal His6-tagged-BRD2 bromodomain 2 (unknown origin) expressed in competent Escherichia coli BL21(DE3) cells by isothermal titration calorimetry	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461	=	Kd	nM	100.0	CHEMBL1293289	Homo sapiens	Kd	nM	100.0
	16493459	CHEMBL3772279	Binding affinity to full length N-terminal His6-tagged-BRD2 bromodomain 1 (unknown origin) expressed in competent Escherichia coli BL21(DE3) cells by isothermal titration calorimetry	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461	=	Kd	nM	230.0	CHEMBL1293289	Homo sapiens	Kd	nM	230.0
	16493462	CHEMBL3772276	Binding affinity to BRD2 bromodomain 2 L383A mutant (unknown origin) expressed in competent Escherichia coli DH5-alpha cells by isothermal titration calorimetry	B	COC(=O)[C@H](C)[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL3769729	=	Kd	nM	22.0	CHEMBL1293289	Homo sapiens	Kd	nM	22.0
	16493463	CHEMBL3772274	Binding affinity to BRD2 bromodomain 2 L383I mutant (unknown origin) expressed in competent Escherichia coli DH5-alpha cells by isothermal titration calorimetry	B	COC(=O)[C@H](C)[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL3769729	=	Kd	nM	27.0	CHEMBL1293289	Homo sapiens	Kd	nM	27.0
	16493464	CHEMBL3772275	Binding affinity to N-terminal His6-tagged BRD2 bromodomain 2 (unknown origin) expressed in competent Escherichia coli BL21(DE3) cells by isothermal titration calorimetry	B	COC(=O)CC1N=C(c2cccc3[nH]ccc23)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL3770576	=	Kd	nM	45.0	CHEMBL1293289	Homo sapiens	Kd	nM	45.0
	16493466	CHEMBL3772275	Binding affinity to N-terminal His6-tagged BRD2 bromodomain 2 (unknown origin) expressed in competent Escherichia coli BL21(DE3) cells by isothermal titration calorimetry	B	COC(=O)[C@H](C)[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL3769729	=	Kd	nM	300.0	CHEMBL1293289	Homo sapiens	Kd	nM	300.0
	16493467	CHEMBL3772273	Binding affinity to BRD2 bromodomain 1 L110A mutant (unknown origin) expressed in competent Escherichia coli DH5-alpha cells by isothermal titration calorimetry	B	COC(=O)[C@H](C)[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL3769729	=	Kd	nM	17.0	CHEMBL1293289	Homo sapiens	Kd	nM	17.0
	16493468	CHEMBL3772272	Binding affinity to BRD2 bromodomain 1 L110I mutant (unknown origin) expressed in competent Escherichia coli DH5-alpha cells by isothermal titration calorimetry	B	COC(=O)[C@H](C)[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL3769729	=	Kd	nM	260.0	CHEMBL1293289	Homo sapiens	Kd	nM	260.0
	16493469	CHEMBL3772116	Binding affinity to N-terminal His6-tagged BRD2 bromodomain 1 (unknown origin) expressed in competent Escherichia coli BL21(DE3) cells by isothermal titration calorimetry	B	COC(=O)CC1N=C(c2cccc3[nH]ccc23)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL3770576	=	Kd	nM	780.0	CHEMBL1293289	Homo sapiens	Kd	nM	780.0
	16493470	CHEMBL3772116	Binding affinity to N-terminal His6-tagged BRD2 bromodomain 1 (unknown origin) expressed in competent Escherichia coli BL21(DE3) cells by isothermal titration calorimetry	B	COC(=O)[C@H](C)[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL3769729	=	Kd	nM	1470.0	CHEMBL1293289	Homo sapiens	Kd	nM	1470.0
	16493471	CHEMBL3772271	Binding affinity to BRD2 bromodomain 2 W370H mutant (unknown origin) expressed in competent Escherichia coli DH5-alpha cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	COC(=O)CC1N=C(c2cccc3[nH]ccc23)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL3770576	=	Delta Tm	degrees C	2.7	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	2.7
	16493472	CHEMBL3772271	Binding affinity to BRD2 bromodomain 2 W370H mutant (unknown origin) expressed in competent Escherichia coli DH5-alpha cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	COC(=O)CC1N=C(c2cc(Cl)ccc2Cl)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL3769953	=	Delta Tm	degrees C	-0.4	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	-0.4
	16493473	CHEMBL3772271	Binding affinity to BRD2 bromodomain 2 W370H mutant (unknown origin) expressed in competent Escherichia coli DH5-alpha cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	COC(=O)CC1N=C(c2cc(C)ccc2C)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL3771205	=	Delta Tm	degrees C	-0.1	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	-0.1
	16493474	CHEMBL3772271	Binding affinity to BRD2 bromodomain 2 W370H mutant (unknown origin) expressed in competent Escherichia coli DH5-alpha cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	COC(=O)CC1N=C(c2ccc(Cl)c(C)c2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL3769577	=	Delta Tm	degrees C	1.0	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	1.0
	16493475	CHEMBL3772271	Binding affinity to BRD2 bromodomain 2 W370H mutant (unknown origin) expressed in competent Escherichia coli DH5-alpha cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	COC(=O)CC1N=C(c2ccc(Cl)cc2C)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL3769779	=	Delta Tm	degrees C	1.1	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	1.1
	16493476	CHEMBL3772271	Binding affinity to BRD2 bromodomain 2 W370H mutant (unknown origin) expressed in competent Escherichia coli DH5-alpha cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461	=	Delta Tm	degrees C	1.7	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	1.7
	16493477	CHEMBL3772270	Binding affinity to BRD2 bromodomain 2 W370F mutant (unknown origin) expressed in competent Escherichia coli DH5-alpha cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	COC(=O)CC1N=C(c2cccc3[nH]ccc23)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL3770576	=	Delta Tm	degrees C	5.2	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	5.2
	16493478	CHEMBL3772270	Binding affinity to BRD2 bromodomain 2 W370F mutant (unknown origin) expressed in competent Escherichia coli DH5-alpha cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	COC(=O)CC1N=C(c2cc(Cl)ccc2Cl)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL3769953	=	Delta Tm	degrees C	0.3	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	0.3
	16493479	CHEMBL3772270	Binding affinity to BRD2 bromodomain 2 W370F mutant (unknown origin) expressed in competent Escherichia coli DH5-alpha cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	COC(=O)CC1N=C(c2cc(C)ccc2C)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL3771205	=	Delta Tm	degrees C	0.6	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	0.6
	16493480	CHEMBL3772270	Binding affinity to BRD2 bromodomain 2 W370F mutant (unknown origin) expressed in competent Escherichia coli DH5-alpha cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	COC(=O)CC1N=C(c2ccc(Cl)c(C)c2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL3769577	=	Delta Tm	degrees C	1.5	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	1.5
	16493481	CHEMBL3772270	Binding affinity to BRD2 bromodomain 2 W370F mutant (unknown origin) expressed in competent Escherichia coli DH5-alpha cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	COC(=O)CC1N=C(c2ccc(Cl)cc2C)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL3769779	=	Delta Tm	degrees C	2.8	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	2.8
	16493482	CHEMBL3772270	Binding affinity to BRD2 bromodomain 2 W370F mutant (unknown origin) expressed in competent Escherichia coli DH5-alpha cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461	=	Delta Tm	degrees C	2.1	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	2.1
	16493483	CHEMBL3772269	Binding affinity to BRD2 bromodomain 2 L383A mutant (unknown origin) expressed in competent Escherichia coli DH5-alpha cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	COC(=O)[C@H](C)[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL3769729	=	Delta Tm	degrees C	9.3	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	9.3
	16493484	CHEMBL3772269	Binding affinity to BRD2 bromodomain 2 L383A mutant (unknown origin) expressed in competent Escherichia coli DH5-alpha cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	COC(=O)[C@@H](C)[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL3770265	=	Delta Tm	degrees C	0.8	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	0.8
	16493485	CHEMBL3772269	Binding affinity to BRD2 bromodomain 2 L383A mutant (unknown origin) expressed in competent Escherichia coli DH5-alpha cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461	=	Delta Tm	degrees C	6.4	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	6.4
	16493486	CHEMBL3772268	Binding affinity to BRD2 bromodomain 2 L383I mutant (unknown origin) expressed in competent Escherichia coli DH5-alpha cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	COC(=O)[C@H](C)[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL3769729	=	Delta Tm	degrees C	9.6	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	9.6
	16493487	CHEMBL3772266	Binding affinity to N-terminal His6-tagged BRD2 bromodomain 2 (unknown origin) expressed in competent Escherichia coli BL21(DE3) cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	COC(=O)CC1N=C(c2cccc3[nH]ccc23)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL3770576	=	Delta Tm	degrees C	7.7	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	7.7
	16493488	CHEMBL3772266	Binding affinity to N-terminal His6-tagged BRD2 bromodomain 2 (unknown origin) expressed in competent Escherichia coli BL21(DE3) cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	COC(=O)CC1N=C(c2cc(Cl)ccc2Cl)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL3769953	=	Delta Tm	degrees C	2.5	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	2.5
	16493489	CHEMBL3772266	Binding affinity to N-terminal His6-tagged BRD2 bromodomain 2 (unknown origin) expressed in competent Escherichia coli BL21(DE3) cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	COC(=O)CC1N=C(c2cc(C)ccc2C)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL3771205	=	Delta Tm	degrees C	3.5	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	3.5
	16493490	CHEMBL3772266	Binding affinity to N-terminal His6-tagged BRD2 bromodomain 2 (unknown origin) expressed in competent Escherichia coli BL21(DE3) cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	COC(=O)CC1N=C(c2ccc(Cl)c(C)c2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL3769577	=	Delta Tm	degrees C	3.2	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	3.2
	16493491	CHEMBL3772266	Binding affinity to N-terminal His6-tagged BRD2 bromodomain 2 (unknown origin) expressed in competent Escherichia coli BL21(DE3) cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	COC(=O)CC1N=C(c2ccc(Cl)cc2C)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL3769779	=	Delta Tm	degrees C	6.6	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	6.6
	16493492	CHEMBL3772266	Binding affinity to N-terminal His6-tagged BRD2 bromodomain 2 (unknown origin) expressed in competent Escherichia coli BL21(DE3) cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	COC(=O)[C@H](C)[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL3769729	=	Delta Tm	degrees C	5.6	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	5.6
	16493493	CHEMBL3772266	Binding affinity to N-terminal His6-tagged BRD2 bromodomain 2 (unknown origin) expressed in competent Escherichia coli BL21(DE3) cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	COC(=O)[C@@H](C)[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL3770265	=	Delta Tm	degrees C	0.2	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	0.2
	16493494	CHEMBL3772266	Binding affinity to N-terminal His6-tagged BRD2 bromodomain 2 (unknown origin) expressed in competent Escherichia coli BL21(DE3) cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	COC(=O)CC1N=C(c2ccc(Cl)cc2)c2cc(OC)cc(C)c2-n2c(C)nnc21		CHEMBL3771130	=	Delta Tm	degrees C	4.0	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	4.0
	16493495	CHEMBL3772266	Binding affinity to N-terminal His6-tagged BRD2 bromodomain 2 (unknown origin) expressed in competent Escherichia coli BL21(DE3) cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461	=	Delta Tm	degrees C	8.3	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	8.3
	16493496	CHEMBL3772265	Binding affinity to BRD2 bromodomain 1 W097H mutant (unknown origin) expressed in competent Escherichia coli DH5-alpha cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	COC(=O)CC1N=C(c2cccc3[nH]ccc23)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL3770576	=	Delta Tm	degrees C	0.6	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	0.6
	16493497	CHEMBL3772265	Binding affinity to BRD2 bromodomain 1 W097H mutant (unknown origin) expressed in competent Escherichia coli DH5-alpha cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	COC(=O)CC1N=C(c2cc(Cl)ccc2Cl)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL3769953	=	Delta Tm	degrees C	-0.4	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	-0.4
	16493498	CHEMBL3772265	Binding affinity to BRD2 bromodomain 1 W097H mutant (unknown origin) expressed in competent Escherichia coli DH5-alpha cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	COC(=O)CC1N=C(c2cc(C)ccc2C)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL3771205	=	Delta Tm	degrees C	-0.4	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	-0.4
	16493499	CHEMBL3772265	Binding affinity to BRD2 bromodomain 1 W097H mutant (unknown origin) expressed in competent Escherichia coli DH5-alpha cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	COC(=O)CC1N=C(c2ccc(Cl)c(C)c2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL3769577	=	Delta Tm	degrees C	0.2	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	0.2
	16493500	CHEMBL3772265	Binding affinity to BRD2 bromodomain 1 W097H mutant (unknown origin) expressed in competent Escherichia coli DH5-alpha cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	COC(=O)CC1N=C(c2ccc(Cl)cc2C)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL3769779	=	Delta Tm	degrees C	0.9	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	0.9
	16493501	CHEMBL3772265	Binding affinity to BRD2 bromodomain 1 W097H mutant (unknown origin) expressed in competent Escherichia coli DH5-alpha cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461	=	Delta Tm	degrees C	0.7	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	0.7
	16493502	CHEMBL3772121	Binding affinity to BRD2 bromodomain 1 W097F mutant (unknown origin) expressed in competent Escherichia coli DH5-alpha cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	COC(=O)CC1N=C(c2cccc3[nH]ccc23)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL3770576	=	Delta Tm	degrees C	1.9	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	1.9
	16493503	CHEMBL3772121	Binding affinity to BRD2 bromodomain 1 W097F mutant (unknown origin) expressed in competent Escherichia coli DH5-alpha cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	COC(=O)CC1N=C(c2cc(Cl)ccc2Cl)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL3769953	=	Delta Tm	degrees C	0.0	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	0.0
	16493504	CHEMBL3772121	Binding affinity to BRD2 bromodomain 1 W097F mutant (unknown origin) expressed in competent Escherichia coli DH5-alpha cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	COC(=O)CC1N=C(c2cc(C)ccc2C)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL3771205	=	Delta Tm	degrees C	0.1	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	0.1
	16493505	CHEMBL3772121	Binding affinity to BRD2 bromodomain 1 W097F mutant (unknown origin) expressed in competent Escherichia coli DH5-alpha cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	COC(=O)CC1N=C(c2ccc(Cl)c(C)c2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL3769577	=	Delta Tm	degrees C	-0.1	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	-0.1
	16493506	CHEMBL3772121	Binding affinity to BRD2 bromodomain 1 W097F mutant (unknown origin) expressed in competent Escherichia coli DH5-alpha cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	COC(=O)CC1N=C(c2ccc(Cl)cc2C)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL3769779	=	Delta Tm	degrees C	1.4	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	1.4
	16493507	CHEMBL3772121	Binding affinity to BRD2 bromodomain 1 W097F mutant (unknown origin) expressed in competent Escherichia coli DH5-alpha cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461	=	Delta Tm	degrees C	0.4	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	0.4
	16493508	CHEMBL3772120	Binding affinity to BRD2 bromodomain 1 L110A mutant (unknown origin) expressed in competent Escherichia coli DH5-alpha cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	COC(=O)[C@H](C)[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL3769729	=	Delta Tm	degrees C	7.9	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	7.9
	16493509	CHEMBL3772120	Binding affinity to BRD2 bromodomain 1 L110A mutant (unknown origin) expressed in competent Escherichia coli DH5-alpha cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	COC(=O)[C@@H](C)[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL3770265	=	Delta Tm	degrees C	1.6	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	1.6
	16493510	CHEMBL3772120	Binding affinity to BRD2 bromodomain 1 L110A mutant (unknown origin) expressed in competent Escherichia coli DH5-alpha cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461	=	Delta Tm	degrees C	3.1	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	3.1
	16493511	CHEMBL3772119	Binding affinity to BRD2 bromodomain 1 L110I mutant (unknown origin) expressed in competent Escherichia coli DH5-alpha cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	COC(=O)[C@H](C)[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL3769729	=	Delta Tm	degrees C	5.7	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	5.7
	16493512	CHEMBL3772119	Binding affinity to BRD2 bromodomain 1 L110I mutant (unknown origin) expressed in competent Escherichia coli DH5-alpha cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	COC(=O)[C@@H](C)[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL3770265	=	Delta Tm	degrees C	0.0	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	0.0
	16493513	CHEMBL3772119	Binding affinity to BRD2 bromodomain 1 L110I mutant (unknown origin) expressed in competent Escherichia coli DH5-alpha cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461	=	Delta Tm	degrees C	6.7	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	6.7
	16493514	CHEMBL3772118	Binding affinity to BRD2 bromodomain 1 V103A mutant (unknown origin) expressed in competent Escherichia coli DH5-alpha cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	COC(=O)CC1N=C(c2ccc(Cl)cc2)c2cc(OC)cc(C)c2-n2c(C)nnc21		CHEMBL3771130	=	Delta Tm	degrees C	0.5	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	0.5
	16493515	CHEMBL3772118	Binding affinity to BRD2 bromodomain 1 V103A mutant (unknown origin) expressed in competent Escherichia coli DH5-alpha cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461	=	Delta Tm	degrees C	0.1	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	0.1
	16493516	CHEMBL3772117	Binding affinity to N-terminal His6-tagged BRD2 bromodomain 1 (unknown origin) expressed in competent Escherichia coli BL21(DE3) cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	COC(=O)CC1N=C(c2cccc3[nH]ccc23)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL3770576	=	Delta Tm	degrees C	6.8	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	6.8
	16493517	CHEMBL3772117	Binding affinity to N-terminal His6-tagged BRD2 bromodomain 1 (unknown origin) expressed in competent Escherichia coli BL21(DE3) cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	COC(=O)CC1N=C(c2cc(Cl)ccc2Cl)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL3769953	=	Delta Tm	degrees C	1.2	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	1.2
	16493518	CHEMBL3772117	Binding affinity to N-terminal His6-tagged BRD2 bromodomain 1 (unknown origin) expressed in competent Escherichia coli BL21(DE3) cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	COC(=O)CC1N=C(c2cc(C)ccc2C)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL3771205	=	Delta Tm	degrees C	1.8	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	1.8
	16493519	CHEMBL3772117	Binding affinity to N-terminal His6-tagged BRD2 bromodomain 1 (unknown origin) expressed in competent Escherichia coli BL21(DE3) cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	COC(=O)CC1N=C(c2ccc(Cl)c(C)c2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL3769577	=	Delta Tm	degrees C	1.5	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	1.5
	16493520	CHEMBL3772117	Binding affinity to N-terminal His6-tagged BRD2 bromodomain 1 (unknown origin) expressed in competent Escherichia coli BL21(DE3) cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	COC(=O)CC1N=C(c2ccc(Cl)cc2C)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL3769779	=	Delta Tm	degrees C	6.3	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	6.3
	16493521	CHEMBL3772117	Binding affinity to N-terminal His6-tagged BRD2 bromodomain 1 (unknown origin) expressed in competent Escherichia coli BL21(DE3) cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	COC(=O)[C@H](C)[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL3769729	=	Delta Tm	degrees C	3.2	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	3.2
	16493522	CHEMBL3772117	Binding affinity to N-terminal His6-tagged BRD2 bromodomain 1 (unknown origin) expressed in competent Escherichia coli BL21(DE3) cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	COC(=O)[C@@H](C)[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL3770265	=	Delta Tm	degrees C	-0.3	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	-0.3
	16493523	CHEMBL3772117	Binding affinity to N-terminal His6-tagged BRD2 bromodomain 1 (unknown origin) expressed in competent Escherichia coli BL21(DE3) cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	COC(=O)CC1N=C(c2ccc(Cl)cc2)c2cc(OC)cc(C)c2-n2c(C)nnc21		CHEMBL3771130	=	Delta Tm	degrees C	0.7	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	0.7
	16493524	CHEMBL3772117	Binding affinity to N-terminal His6-tagged BRD2 bromodomain 1 (unknown origin) expressed in competent Escherichia coli BL21(DE3) cells using acetylated H4 histone peptide substrate at 10 uM by SYPRO orange staining based differential scanning fluorimetry	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461	=	Delta Tm	degrees C	5.4	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	5.4
	16495917	CHEMBL3778791	Inhibition of GST-tagged human BRD2 bromodomain1 using H4KAc 5/8/12/16 peptide as substrate incubated overnight by HTRF assay	B	CCCCc1c(C)nc2nc(SCc3nc4c(c(=O)[nH]c(=O)n4CCCC)n3CC)nn2c1C		CHEMBL3774931	=	IC50	nM	59000.0	CHEMBL1293289	Homo sapiens	IC50	uM	59.0
	16495926	CHEMBL3778791	Inhibition of GST-tagged human BRD2 bromodomain1 using H4KAc 5/8/12/16 peptide as substrate incubated overnight by HTRF assay	B	CCCCn1c(=O)[nH]c(=O)c2c1ncn2CC		CHEMBL3775270	=	IC50	nM	18800.0	CHEMBL1293289	Homo sapiens	IC50	uM	18.8
	16495930	CHEMBL3778795	Inhibition of GST-tagged human BRD2 bromodomain2 using H4KAc 5/8/12/16 peptide as substrate incubated overnight by HTRF assay	B	CCCCn1c(=O)[nH]c(=O)c2c1ncn2CC		CHEMBL3775270	=	IC50	nM	6600.0	CHEMBL1293289	Homo sapiens	IC50	uM	6.6
	16495934	CHEMBL3778791	Inhibition of GST-tagged human BRD2 bromodomain1 using H4KAc 5/8/12/16 peptide as substrate incubated overnight by HTRF assay	B	CCn1cnc2c1c(=O)[nH]c(=O)n2Cc1ccc(Cl)cc1		CHEMBL3775058	=	IC50	nM	4700.0	CHEMBL1293289	Homo sapiens	IC50	uM	4.7
	16495938	CHEMBL3778795	Inhibition of GST-tagged human BRD2 bromodomain2 using H4KAc 5/8/12/16 peptide as substrate incubated overnight by HTRF assay	B	CCn1cnc2c1c(=O)[nH]c(=O)n2Cc1ccc(Cl)cc1		CHEMBL3775058	=	IC50	nM	1600.0	CHEMBL1293289	Homo sapiens	IC50	uM	1.6
	16495942	CHEMBL3778791	Inhibition of GST-tagged human BRD2 bromodomain1 using H4KAc 5/8/12/16 peptide as substrate incubated overnight by HTRF assay	B	CCn1c(CSc2n[nH]c(N)n2)nc2c1c(=O)[nH]c(=O)n2Cc1ccc(Cl)cc1		CHEMBL3774900	=	IC50	nM	30000.0	CHEMBL1293289	Homo sapiens	IC50	uM	30.0
	16505768	CHEMBL3776807	Inhibition of recombinant human BRD2 isoform 1 bromodomain 2 expressed in bacterial system assessed as residual activity at 1 uM by bromoscan assay relative to control	B	CCCOc1cc(OCCCCN(C)C)cc(Oc2cc3c(cc2NS(=O)(=O)c2ccc(OC)c(OC)c2)n(C)c(=O)n3C)c1		CHEMBL3774575	>	Activity	%	35.0	CHEMBL1293289	Homo sapiens	Activity	%	35.0
	16505784	CHEMBL3777039	Inhibition of recombinant human BRD2 isoform 1 bromodomain 1 expressed in bacterial system assessed as residual activity at 1 uM by bromoscan assay relative to control	B	CCCOc1cc(OCCCCN(C)C)cc(Oc2cc3c(cc2NS(=O)(=O)c2ccc(OC)c(OC)c2)n(C)c(=O)n3C)c1		CHEMBL3774575	>	Activity	%	35.0	CHEMBL1293289	Homo sapiens	Activity	%	35.0
	16522453	CHEMBL3782667	Binding affinity to human His6-tagged BRD2 bromodomain 1 (K77 to N194 residues) expressed in Escherichia coli BL21(DE3) cells at 200 uM incubated for 30 mins by SYPRO orange staining based fluorescence thermal shift assay	B	CCN1C(=O)c2cccc3c(S(=O)(=O)Nc4ccccc4C(=O)O)ccc1c23		CHEMBL3780508	=	Delta Tm	degrees C	3.2	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	3.2
	16522454	CHEMBL3782667	Binding affinity to human His6-tagged BRD2 bromodomain 1 (K77 to N194 residues) expressed in Escherichia coli BL21(DE3) cells at 200 uM incubated for 30 mins by SYPRO orange staining based fluorescence thermal shift assay	B	CCN1C(=O)c2cccc3c(S(=O)(=O)Nc4ccc(F)cc4)ccc1c23		CHEMBL3780398	=	Delta Tm	degrees C	3.3	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	3.3
	16522455	CHEMBL3782667	Binding affinity to human His6-tagged BRD2 bromodomain 1 (K77 to N194 residues) expressed in Escherichia coli BL21(DE3) cells at 200 uM incubated for 30 mins by SYPRO orange staining based fluorescence thermal shift assay	B	CCCNS(=O)(=O)c1ccc2c3c(cccc13)C(=O)N2CC		CHEMBL3781449	=	Delta Tm	degrees C	4.7	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	4.7
	16522456	CHEMBL3782667	Binding affinity to human His6-tagged BRD2 bromodomain 1 (K77 to N194 residues) expressed in Escherichia coli BL21(DE3) cells at 200 uM incubated for 30 mins by SYPRO orange staining based fluorescence thermal shift assay	B	CCN1C(=O)c2cccc3c(S(=O)(=O)NCCCCNC(=O)OC(C)(C)C)ccc1c23		CHEMBL3782048	=	Delta Tm	degrees C	3.2	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	3.2
	16522457	CHEMBL3782667	Binding affinity to human His6-tagged BRD2 bromodomain 1 (K77 to N194 residues) expressed in Escherichia coli BL21(DE3) cells at 200 uM incubated for 30 mins by SYPRO orange staining based fluorescence thermal shift assay	B	CCN1C(=O)c2cccc3c(S(=O)(=O)NC4CCCCC4)ccc1c23		CHEMBL3781471	=	Delta Tm	degrees C	5.9	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	5.9
	16522458	CHEMBL3782667	Binding affinity to human His6-tagged BRD2 bromodomain 1 (K77 to N194 residues) expressed in Escherichia coli BL21(DE3) cells at 200 uM incubated for 30 mins by SYPRO orange staining based fluorescence thermal shift assay	B	CCN1C(=O)c2cccc3c(S(=O)(=O)NCC4CCN(C(C)=O)CC4)ccc1c23		CHEMBL3234253	=	Delta Tm	degrees C	1.4	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	1.4
	16522459	CHEMBL3782667	Binding affinity to human His6-tagged BRD2 bromodomain 1 (K77 to N194 residues) expressed in Escherichia coli BL21(DE3) cells at 200 uM incubated for 30 mins by SYPRO orange staining based fluorescence thermal shift assay	B	CCN1C(=O)c2cccc3c(S(=O)(=O)NCCCN4CCN(C)CC4)ccc1c23		CHEMBL3780381	=	Delta Tm	degrees C	2.0	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	2.0
	16522460	CHEMBL3782667	Binding affinity to human His6-tagged BRD2 bromodomain 1 (K77 to N194 residues) expressed in Escherichia coli BL21(DE3) cells at 200 uM incubated for 30 mins by SYPRO orange staining based fluorescence thermal shift assay	B	CCCCS(=O)(=O)Nc1ccc2c3c(cccc13)C(=O)N2CC		CHEMBL3780901	=	Delta Tm	degrees C	5.0	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	5.0
	16522461	CHEMBL3782667	Binding affinity to human His6-tagged BRD2 bromodomain 1 (K77 to N194 residues) expressed in Escherichia coli BL21(DE3) cells at 200 uM incubated for 30 mins by SYPRO orange staining based fluorescence thermal shift assay	B	CCN1C(=O)c2cccc3c(NS(=O)(=O)C4CCCCC4)ccc1c23		CHEMBL3781254	=	Delta Tm	degrees C	5.8	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	5.8
	16522462	CHEMBL3782667	Binding affinity to human His6-tagged BRD2 bromodomain 1 (K77 to N194 residues) expressed in Escherichia coli BL21(DE3) cells at 200 uM incubated for 30 mins by SYPRO orange staining based fluorescence thermal shift assay	B	CCN1C(=O)c2cccc3c(NS(=O)(=O)c4ccc(F)cc4)ccc1c23		CHEMBL3780128	=	Delta Tm	degrees C	5.1	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	5.1
	16522463	CHEMBL3782667	Binding affinity to human His6-tagged BRD2 bromodomain 1 (K77 to N194 residues) expressed in Escherichia coli BL21(DE3) cells at 200 uM incubated for 30 mins by SYPRO orange staining based fluorescence thermal shift assay	B	CCN1C(=O)c2cccc3c(NS(=O)(=O)c4ccc(F)cc4F)ccc1c23		CHEMBL3780059	=	Delta Tm	degrees C	5.5	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	5.5
	16522464	CHEMBL3782667	Binding affinity to human His6-tagged BRD2 bromodomain 1 (K77 to N194 residues) expressed in Escherichia coli BL21(DE3) cells at 200 uM incubated for 30 mins by SYPRO orange staining based fluorescence thermal shift assay	B	CCN1C(=O)c2cccc3c(NS(=O)(=O)c4cc(Cl)ccc4OC)ccc1c23		CHEMBL3779929	=	Delta Tm	degrees C	5.9	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	5.9
	16522465	CHEMBL3782667	Binding affinity to human His6-tagged BRD2 bromodomain 1 (K77 to N194 residues) expressed in Escherichia coli BL21(DE3) cells at 200 uM incubated for 30 mins by SYPRO orange staining based fluorescence thermal shift assay	B	CCN1C(=O)c2cccc3c(NS(=O)(=O)c4cc(Br)ccc4OC)ccc1c23		CHEMBL3780429	=	Delta Tm	degrees C	5.6	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	5.6
	16522466	CHEMBL3782667	Binding affinity to human His6-tagged BRD2 bromodomain 1 (K77 to N194 residues) expressed in Escherichia coli BL21(DE3) cells at 200 uM incubated for 30 mins by SYPRO orange staining based fluorescence thermal shift assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	Delta Tm	degrees C	8.7	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	8.7
	16522467	CHEMBL3782667	Binding affinity to human His6-tagged BRD2 bromodomain 1 (K77 to N194 residues) expressed in Escherichia coli BL21(DE3) cells at 200 uM incubated for 30 mins by SYPRO orange staining based fluorescence thermal shift assay	B	CCOC(=O)Nc1cc(-c2ccc(C)c(NS(C)(=O)=O)c2)nn2c(C)nnc12		CHEMBL3133807	=	Delta Tm	degrees C	6.9	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	6.9
	16522468	CHEMBL3782667	Binding affinity to human His6-tagged BRD2 bromodomain 1 (K77 to N194 residues) expressed in Escherichia coli BL21(DE3) cells at 200 uM incubated for 30 mins by SYPRO orange staining based fluorescence thermal shift assay	B	COc1ccc(CCc2nc3cc(-c4c(C)noc4C)ccc3n2C[C@H](C)N2CCOCC2)cc1Cl		CHEMBL3622373	=	Delta Tm	degrees C	2.4	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	2.4
	16633138	CHEMBL3825270	Binding affinity to human BRD2 assessed as thermal shift difference at 10 uM by DSF analysis	B	COc1cc(-c2cn(C)c(=O)c3cnccc23)c(OC)cc1CN(C)C		CHEMBL3823101	<	Delta Tm	degrees C	1.0	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	1.0
	16633139	CHEMBL3825270	Binding affinity to human BRD2 assessed as thermal shift difference at 10 uM by DSF analysis	B	COc1cc(-c2cn(C)c(=O)c3cnccc23)cc(OC)c1CN(C)C		CHEMBL3823478	<	Delta Tm	degrees C	1.0	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	1.0
Not Active	16633153	CHEMBL3825276	Activity at human BRD2 up to 100 uM by by AlphaScreen assay	B	COc1cc(-c2cn(C)c(=O)c3cnccc23)cc(OC)c1CN(C)C		CHEMBL3823478		Activity			CHEMBL1293289	Homo sapiens	Activity		
	16633170	CHEMBL3826479	Inhibition of human N-terminal GST-tagged BRD2-BD1 expressed in Escherichia coli using tetra-acetylated histone H4 measured after 60 mins by AlphaScreen assay	B	COc1cc(-c2cn(C)c(=O)c3ccccc23)c(OC)cc1CN(C)C		CHEMBL3824133	=	IC50	nM	21687.0	CHEMBL1293289	Homo sapiens	IC50	nM	21687.0
	16633171	CHEMBL3826479	Inhibition of human N-terminal GST-tagged BRD2-BD1 expressed in Escherichia coli using tetra-acetylated histone H4 measured after 60 mins by AlphaScreen assay	B	COc1cc(-c2cn(C)c(=O)c3cnccc23)c(OC)cc1CN(C)C		CHEMBL3823101	>	IC50	nM	100000.0	CHEMBL1293289	Homo sapiens	IC50	nM	100000.0
	16633172	CHEMBL3826479	Inhibition of human N-terminal GST-tagged BRD2-BD1 expressed in Escherichia coli using tetra-acetylated histone H4 measured after 60 mins by AlphaScreen assay	B	COc1cc(-c2cn(C)c(=O)c(C)c2C)c(OC)cc1CN(C)C		CHEMBL3823551	=	IC50	nM	30330.0	CHEMBL1293289	Homo sapiens	IC50	nM	30330.0
	16633173	CHEMBL3826479	Inhibition of human N-terminal GST-tagged BRD2-BD1 expressed in Escherichia coli using tetra-acetylated histone H4 measured after 60 mins by AlphaScreen assay	B	COc1cc(-c2cc(C)c(=O)n(C)c2C)c(OC)cc1CN(C)C		CHEMBL3824351	=	IC50	nM	59555.0	CHEMBL1293289	Homo sapiens	IC50	nM	59555.0
	16633174	CHEMBL3826479	Inhibition of human N-terminal GST-tagged BRD2-BD1 expressed in Escherichia coli using tetra-acetylated histone H4 measured after 60 mins by AlphaScreen assay	B	COc1cc(-c2cn(C)c(=O)c3cncnc23)cc(OC)c1CN(C)C		CHEMBL3824312	>	IC50	nM	100000.0	CHEMBL1293289	Homo sapiens	IC50	nM	100000.0
	16633175	CHEMBL3826479	Inhibition of human N-terminal GST-tagged BRD2-BD1 expressed in Escherichia coli using tetra-acetylated histone H4 measured after 60 mins by AlphaScreen assay	B	COc1cc(-c2cn(C)c(=O)c3cccnc23)cc(OC)c1CN(C)C		CHEMBL3822539	>	IC50	nM	100000.0	CHEMBL1293289	Homo sapiens	IC50	nM	100000.0
	16633176	CHEMBL3826479	Inhibition of human N-terminal GST-tagged BRD2-BD1 expressed in Escherichia coli using tetra-acetylated histone H4 measured after 60 mins by AlphaScreen assay	B	COc1cc(-c2cn(C)c(=O)c3ccncc23)cc(OC)c1CN(C)C		CHEMBL3823859	>	IC50	nM	100000.0	CHEMBL1293289	Homo sapiens	IC50	nM	100000.0
	16633177	CHEMBL3826479	Inhibition of human N-terminal GST-tagged BRD2-BD1 expressed in Escherichia coli using tetra-acetylated histone H4 measured after 60 mins by AlphaScreen assay	B	COc1cc(-c2cn(C)c(=O)c3cnccc23)cc(OC)c1CN(C)C		CHEMBL3823478	>	IC50	nM	100000.0	CHEMBL1293289	Homo sapiens	IC50	nM	100000.0
	16633178	CHEMBL3826479	Inhibition of human N-terminal GST-tagged BRD2-BD1 expressed in Escherichia coli using tetra-acetylated histone H4 measured after 60 mins by AlphaScreen assay	B	COc1cc(-c2cn(C)c(=O)c3ncccc23)cc(OC)c1CN(C)C		CHEMBL3822909	>	IC50	nM	100000.0	CHEMBL1293289	Homo sapiens	IC50	nM	100000.0
	16633179	CHEMBL3826479	Inhibition of human N-terminal GST-tagged BRD2-BD1 expressed in Escherichia coli using tetra-acetylated histone H4 measured after 60 mins by AlphaScreen assay	B	COc1cc(-c2cn(C)c(=O)c3ccccc23)cc(OC)c1CN(C)C		CHEMBL3824146	=	IC50	nM	50857.0	CHEMBL1293289	Homo sapiens	IC50	nM	50857.0
	16633180	CHEMBL3826479	Inhibition of human N-terminal GST-tagged BRD2-BD1 expressed in Escherichia coli using tetra-acetylated histone H4 measured after 60 mins by AlphaScreen assay	B	COc1cc(-c2cn(C)c(=O)c(C)c2C)cc(OC)c1CN(C)C		CHEMBL3823599	=	IC50	nM	16654.0	CHEMBL1293289	Homo sapiens	IC50	nM	16654.0
	16633181	CHEMBL3826479	Inhibition of human N-terminal GST-tagged BRD2-BD1 expressed in Escherichia coli using tetra-acetylated histone H4 measured after 60 mins by AlphaScreen assay	B	COc1cc(-c2cc(C)c(=O)n(C)c2C)cc(OC)c1CN(C)C		CHEMBL3823697	=	IC50	nM	33234.0	CHEMBL1293289	Homo sapiens	IC50	nM	33234.0
	16633182	CHEMBL3826479	Inhibition of human N-terminal GST-tagged BRD2-BD1 expressed in Escherichia coli using tetra-acetylated histone H4 measured after 60 mins by AlphaScreen assay	B	COc1cc(-c2cc(C)c(=O)n(C)c2)cc(OC)c1CN(C)C		CHEMBL3822990	=	IC50	nM	5876.0	CHEMBL1293289	Homo sapiens	IC50	nM	5876.0
	16844170	CHEMBL3877202	Inhibition of immobilized N-LY294002 bead binding to BRD2 (unknown origin) expressed in HEK293T cell nuclear extract incubated for 1 hr by LC-MS/MS analysis	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	IC50	nM	10300.0	CHEMBL1293289	Homo sapiens	IC50	uM	10.3
	16844171	CHEMBL3877202	Inhibition of immobilized N-LY294002 bead binding to BRD2 (unknown origin) expressed in HEK293T cell nuclear extract incubated for 1 hr by LC-MS/MS analysis	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	IC50	nM	7400.0	CHEMBL1293289	Homo sapiens	IC50	uM	7.4
413840	17777801	CHEMBL3888742	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The assay was carried out in binding mixtures of the bromodomain protein, 0-10 M compounds and tetra-acetylated histone peptide (SGRGAC.KGGAC.KGLGAC.KGGAAC.KRHGSGSK-biotin) in buffer containing 25 mM HEPES pH 7.5, 100 mM NaCl, 0.1% BSA, 0.05% CHAPS, and detection reagents. The detection reagents, including streptavidin-labeled Tb cryptate and XL665-labeled anti-6His antibody, were added after binding equilibrium was achieved for protein, compound and peptide. Upon further incubation for 1 hr, the TR-FRET signals were recorded on a BMG PHERAstar FS instrument.	B	Cc1noc(C)c1-c1ccc2c(c1)C(O)(C1CCOCC1)C(=O)N2		CHEMBL3963603	=	IC50	nM	380.0	CHEMBL1293289	Homo sapiens	IC50	nM	380.0
413841	17777802	CHEMBL3888742	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The assay was carried out in binding mixtures of the bromodomain protein, 0-10 M compounds and tetra-acetylated histone peptide (SGRGAC.KGGAC.KGLGAC.KGGAAC.KRHGSGSK-biotin) in buffer containing 25 mM HEPES pH 7.5, 100 mM NaCl, 0.1% BSA, 0.05% CHAPS, and detection reagents. The detection reagents, including streptavidin-labeled Tb cryptate and XL665-labeled anti-6His antibody, were added after binding equilibrium was achieved for protein, compound and peptide. Upon further incubation for 1 hr, the TR-FRET signals were recorded on a BMG PHERAstar FS instrument.	B	Cc1noc(C)c1-c1ccc2c(c1)C(O)(C1CCCCC1=O)C(=O)N2		CHEMBL3929288	=	IC50	nM	52.0	CHEMBL1293289	Homo sapiens	IC50	nM	52.0
413842	17777803	CHEMBL3888742	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The assay was carried out in binding mixtures of the bromodomain protein, 0-10 M compounds and tetra-acetylated histone peptide (SGRGAC.KGGAC.KGLGAC.KGGAAC.KRHGSGSK-biotin) in buffer containing 25 mM HEPES pH 7.5, 100 mM NaCl, 0.1% BSA, 0.05% CHAPS, and detection reagents. The detection reagents, including streptavidin-labeled Tb cryptate and XL665-labeled anti-6His antibody, were added after binding equilibrium was achieved for protein, compound and peptide. Upon further incubation for 1 hr, the TR-FRET signals were recorded on a BMG PHERAstar FS instrument.	B	Cc1noc(C)c1-c1ccc2c(c1)C(N)(c1ccccc1)C(=O)N2		CHEMBL3955162	=	IC50	nM	55.0	CHEMBL1293289	Homo sapiens	IC50	nM	55.0
413843	17777804	CHEMBL3888742	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The assay was carried out in binding mixtures of the bromodomain protein, 0-10 M compounds and tetra-acetylated histone peptide (SGRGAC.KGGAC.KGLGAC.KGGAAC.KRHGSGSK-biotin) in buffer containing 25 mM HEPES pH 7.5, 100 mM NaCl, 0.1% BSA, 0.05% CHAPS, and detection reagents. The detection reagents, including streptavidin-labeled Tb cryptate and XL665-labeled anti-6His antibody, were added after binding equilibrium was achieved for protein, compound and peptide. Upon further incubation for 1 hr, the TR-FRET signals were recorded on a BMG PHERAstar FS instrument.	B	Cc1noc(C)c1-c1ccc2c(c1)C(N[C@H](C)CO)(c1ccccc1)C(=O)N2		CHEMBL3910920	=	IC50	nM	24.0	CHEMBL1293289	Homo sapiens	IC50	nM	24.0
413844	17777805	CHEMBL3888742	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The assay was carried out in binding mixtures of the bromodomain protein, 0-10 M compounds and tetra-acetylated histone peptide (SGRGAC.KGGAC.KGLGAC.KGGAAC.KRHGSGSK-biotin) in buffer containing 25 mM HEPES pH 7.5, 100 mM NaCl, 0.1% BSA, 0.05% CHAPS, and detection reagents. The detection reagents, including streptavidin-labeled Tb cryptate and XL665-labeled anti-6His antibody, were added after binding equilibrium was achieved for protein, compound and peptide. Upon further incubation for 1 hr, the TR-FRET signals were recorded on a BMG PHERAstar FS instrument.	B	Cc1noc(C)c1-c1ccc2c(c1)C(c1ccccc1)(N1CCC[C@H](O)C1)C(=O)N2		CHEMBL3903717	=	IC50	nM	9.6	CHEMBL1293289	Homo sapiens	IC50	nM	9.6
413845	17777806	CHEMBL3888742	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The assay was carried out in binding mixtures of the bromodomain protein, 0-10 M compounds and tetra-acetylated histone peptide (SGRGAC.KGGAC.KGLGAC.KGGAAC.KRHGSGSK-biotin) in buffer containing 25 mM HEPES pH 7.5, 100 mM NaCl, 0.1% BSA, 0.05% CHAPS, and detection reagents. The detection reagents, including streptavidin-labeled Tb cryptate and XL665-labeled anti-6His antibody, were added after binding equilibrium was achieved for protein, compound and peptide. Upon further incubation for 1 hr, the TR-FRET signals were recorded on a BMG PHERAstar FS instrument.	B	Cc1noc(C)c1-c1ccc2c(c1)C(NC[C@@H](C)O)(C1CCCCC1)C(=O)N2		CHEMBL3910409	=	IC50	nM	32.0	CHEMBL1293289	Homo sapiens	IC50	nM	32.0
413846	17777807	CHEMBL3888742	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The assay was carried out in binding mixtures of the bromodomain protein, 0-10 M compounds and tetra-acetylated histone peptide (SGRGAC.KGGAC.KGLGAC.KGGAAC.KRHGSGSK-biotin) in buffer containing 25 mM HEPES pH 7.5, 100 mM NaCl, 0.1% BSA, 0.05% CHAPS, and detection reagents. The detection reagents, including streptavidin-labeled Tb cryptate and XL665-labeled anti-6His antibody, were added after binding equilibrium was achieved for protein, compound and peptide. Upon further incubation for 1 hr, the TR-FRET signals were recorded on a BMG PHERAstar FS instrument.	B	Cc1noc(C)c1-c1ccc2c(c1)C(c1ccccc1)(N1CCC[C@H](N)C1)C(=O)N2		CHEMBL3895413	=	IC50	nM	6.6	CHEMBL1293289	Homo sapiens	IC50	nM	6.6
413847	17777808	CHEMBL3888742	Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay: The assay was carried out in binding mixtures of the bromodomain protein, 0-10 M compounds and tetra-acetylated histone peptide (SGRGAC.KGGAC.KGLGAC.KGGAAC.KRHGSGSK-biotin) in buffer containing 25 mM HEPES pH 7.5, 100 mM NaCl, 0.1% BSA, 0.05% CHAPS, and detection reagents. The detection reagents, including streptavidin-labeled Tb cryptate and XL665-labeled anti-6His antibody, were added after binding equilibrium was achieved for protein, compound and peptide. Upon further incubation for 1 hr, the TR-FRET signals were recorded on a BMG PHERAstar FS instrument.	B	Cc1noc(C)c1-c1ccc2c(c1)C(O)(c1ccsc1)C(=O)N2		CHEMBL3895277	=	IC50	nM	18.0	CHEMBL1293289	Homo sapiens	IC50	nM	18.0
	18092548	CHEMBL4020255	Binding affinity to BRD2 BD1 to BD2 (G73 to A560 residues) (unknown origin)	B	CCS(=O)(=O)Nc1ccc(Oc2ccc(F)cc2F)c(-c2cn(C)c(=O)c3[nH]ccc23)c1		CHEMBL3987016	=	Ki	nM	1.0	CHEMBL1293289	Homo sapiens	Ki	nM	1.0
	18149242	CHEMBL4033153	Inhibition of recombinant human N-terminal GST-tagged BRD2 bromodomain-1 (65 to 187 residues) expressed in Escherichia coli expression system after 120 mins by TR-FRET assay	B	Cc1cc(-c2nc3sc4c(c3c(=O)[nH]2)CCN(C)C4)cc(C)c1O		CHEMBL4077274	=	IC50	nM	24600.0	CHEMBL1293289	Homo sapiens	IC50	uM	24.6
	18149243	CHEMBL4033153	Inhibition of recombinant human N-terminal GST-tagged BRD2 bromodomain-1 (65 to 187 residues) expressed in Escherichia coli expression system after 120 mins by TR-FRET assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=NC(CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL2132936	=	IC50	nM	144.0	CHEMBL1293289	Homo sapiens	IC50	uM	0.144
	18149244	CHEMBL4033190	Inhibition of recombinant human N-terminal GST-tagged BRD2 bromodomain-2 (339 to 459 residues) expressed in Escherichia coli expression system after 120 mins by TR-FRET assay	B	Cc1cc(-c2nc3sc4c(c3c(=O)[nH]2)CCN(C)C4)cc(C)c1O		CHEMBL4077274	>	IC50	nM	100000.0	CHEMBL1293289	Homo sapiens	IC50	uM	100.0
	18149245	CHEMBL4033190	Inhibition of recombinant human N-terminal GST-tagged BRD2 bromodomain-2 (339 to 459 residues) expressed in Escherichia coli expression system after 120 mins by TR-FRET assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=NC(CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL2132936	=	IC50	nM	17.0	CHEMBL1293289	Homo sapiens	IC50	uM	0.017
	18173807	CHEMBL4038422	Binding affinity to BRD2 BD1-BD2 (G73 to A560 residues) (unknown origin) after 1 hr by Alexa-647-conjugated probe based TR-FRET assay	B	Cc1[nH]c(-c2cc(NS(C)(=O)=O)ccc2Oc2ccccc2)c2c1C(=O)CCC2		CHEMBL4063051	=	Ki	nM	14.0	CHEMBL1293289	Homo sapiens	Ki	nM	14.0
	18173808	CHEMBL4038422	Binding affinity to BRD2 BD1-BD2 (G73 to A560 residues) (unknown origin) after 1 hr by Alexa-647-conjugated probe based TR-FRET assay	B	Cc1[nH]c(-c2cc(S(C)(=O)=O)ccc2Oc2ccc(F)cc2F)c2c1C(=O)NCC2		CHEMBL3786012	=	Ki	nM	27.0	CHEMBL1293289	Homo sapiens	Ki	nM	27.0
	18173809	CHEMBL4038422	Binding affinity to BRD2 BD1-BD2 (G73 to A560 residues) (unknown origin) after 1 hr by Alexa-647-conjugated probe based TR-FRET assay	B	Cn1cc(-c2cc(S(C)(=O)=O)ccc2Oc2ccc(F)cc2F)c2cc[nH]c(=O)c21		CHEMBL4088466	=	Ki	nM	160.0	CHEMBL1293289	Homo sapiens	Ki	nM	160.0
	18201139	CHEMBL4043460	Inhibition of recombinant human His6-tagged BRD2 bromodomain 1 expressed in Escherichia coli BL21(DE3)-R3-pRARE2 cells	B	COc1cc(OC)c2c(=O)[nH]c(-c3cc(C)c(OCCO)c(C)c3)nc2c1		CHEMBL2393130	=	Kd	nM	5780.0	CHEMBL1293289	Homo sapiens	Kd	nM	5780.0
	18201141	CHEMBL4043462	Inhibition of recombinant human His6-tagged BRD2 bromodomain 2 expressed in Escherichia coli BL21(DE3)-R3-pRARE2 cells	B	COc1cc(OC)c2c(=O)[nH]c(-c3cc(C)c(OCCO)c(C)c3)nc2c1		CHEMBL2393130	=	Kd	nM	251.0	CHEMBL1293289	Homo sapiens	Kd	nM	251.0
	18201150	CHEMBL4043471	Inhibition of poly-His tagged BRD2 bromodomain 1 (unknown origin) expressed in Escherichia coli BL21(DE3) by fluorescence anisotropy assay	B	CC(=O)NCCCCn1c2c(c3ccccc31)C(=O)NCC2		CHEMBL3770724	=	Kd	nM	8600.0	CHEMBL1293289	Homo sapiens	Kd	uM	8.6
	18201151	CHEMBL4043472	Inhibition of poly-His tagged BRD2 bromodomain 2 (unknown origin) expressed in Escherichia coli BL21(DE3) by fluorescence anisotropy assay	B	CC(=O)NCCCCn1c2c(c3ccccc31)C(=O)NCC2	Outside typical range	CHEMBL3770724	>	Kd	nM	300000.0	CHEMBL1293289	Homo sapiens	Kd	uM	300.0
	18201156	CHEMBL4043477	Inhibition of acetylated H4 binding to BRD2 (unknown origin)	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)Nc1ccc(O)cc1)c1nnc(C)n1-2		CHEMBL3581647	=	IC50	nM	92.0	CHEMBL1293289	Homo sapiens	IC50	nM	92.0
	18220508	CHEMBL4047530	Inhibition of human partial length BRD2 BD1 (K71 to N194 residues) expressed in bacterial expression system assessed as residual activity at 500 nM relative to control by BROMOscan assay	B	Cc1nnc2c(Nc3cccc(CNC(=O)C(C)C)c3)nc3ccccc3n12		CHEMBL4083840	=	Activity	%	11.0	CHEMBL1293289	Homo sapiens	Activity	%	11.0
	18220509	CHEMBL4047529	Inhibition of human partial length BRD2 BD2 (E348 to D455 residues) expressed in bacterial expression system assessed as residual activity at 500 nM relative to control by BROMOscan assay	B	Cc1nnc2c(Nc3cccc(CNC(=O)C(C)C)c3)nc3ccccc3n12		CHEMBL4083840	=	Activity	%	19.0	CHEMBL1293289	Homo sapiens	Activity	%	19.0
	18237743	CHEMBL4051549	Inhibition of BRD2 BD1 (unknown origin) assessed as change in melting temperature at 10 uM by SYPRO Orange-dye based fluorescence thermal shift assay	B	Cc1cc2c(cc1N1C(=O)c3cccc4c(CCCO)ccc(c34)C1=O)n(C)c(=O)n2C	Non standard unit for type	CHEMBL4086276	=	deltaTm	K	3.2	CHEMBL1293289	Homo sapiens	deltaTm	K	3.2
	18237744	CHEMBL4051550	Inhibition of BRD2 BD2 (unknown origin) assessed as change in melting temperature at 10 uM by SYPRO Orange-dye based fluorescence thermal shift assay	B	Cc1cc2c(cc1N1C(=O)c3cccc4c(CCCO)ccc(c34)C1=O)n(C)c(=O)n2C	Non standard unit for type	CHEMBL4086276	=	deltaTm	K	1.3	CHEMBL1293289	Homo sapiens	deltaTm	K	1.3
	18294806	CHEMBL4123276	Inhibition of human partial length BRD2 bromodomain 1 (K71 to N194 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by BROMOscan assay relative to control	B	Cc1noc(C)c1-c1cc(O)cc(C(O)c2ccccc2)c1		CHEMBL2335143	=	Activity	%	1.4	CHEMBL1293289	Homo sapiens	Activity	%	1.4
	18294807	CHEMBL4123276	Inhibition of human partial length BRD2 bromodomain 1 (K71 to N194 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by BROMOscan assay relative to control	B	Cc1noc(C)c1-c1cc(O)cc(C(O)c2cccnc2)c1		CHEMBL4129171	=	Activity	%	1.8	CHEMBL1293289	Homo sapiens	Activity	%	1.8
	18306698	CHEMBL4130854	Inhibition of human partial length BRD2 bromodomain 2 isoform 1 (E348 to D455 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1 uM after 1 hr by qPCR method relative to control	B	Cc1ccc([C@H](C)Nc2ccc3c(c2)N(C2CC2)[C@H](C)C(=O)N3C)c(C)c1		CHEMBL4168169	=	Activity	%	0.0	CHEMBL1293289	Homo sapiens	Activity	%	0.0
	18306699	CHEMBL4130853	Inhibition of human partial length BRD2 bromodomain 1 long isoform (K71 to N194 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1 uM after 1 hr by qPCR method relative to control	B	Cc1ccc([C@H](C)Nc2ccc3c(c2)N(C2CC2)[C@H](C)C(=O)N3C)c(C)c1		CHEMBL4168169	=	Activity	%	0.9	CHEMBL1293289	Homo sapiens	Activity	%	0.9
	18373920	CHEMBL4144031	Inhibition of human His-tagged Brd2 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=NC(CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL2132936	=	IC50	nM	26.1	CHEMBL1293289	Homo sapiens	IC50	nM	26.1
	18373921	CHEMBL4144031	Inhibition of human His-tagged Brd2 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccccc1N(c1ccccc1)CC2		CHEMBL4164698	=	IC50	nM	263.5	CHEMBL1293289	Homo sapiens	IC50	nM	263.5
	18373922	CHEMBL4144031	Inhibition of human His-tagged Brd2 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccccc1N(Cc1ccccc1)CC2		CHEMBL4167034	>	IC50	nM	999.0	CHEMBL1293289	Homo sapiens	IC50	nM	999.0
	18373923	CHEMBL4144031	Inhibition of human His-tagged Brd2 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccccc1N(Cc1cccc(Br)c1)CC2		CHEMBL4174918	=	IC50	nM	129.0	CHEMBL1293289	Homo sapiens	IC50	nM	129.0
	18373924	CHEMBL4144031	Inhibition of human His-tagged Brd2 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccccc1N(c1ccc(Cl)cc1)CC2		CHEMBL4169877	=	IC50	nM	129.0	CHEMBL1293289	Homo sapiens	IC50	nM	129.0
	18373925	CHEMBL4144031	Inhibition of human His-tagged Brd2 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccc(Cn3cccn3)cc1N(c1ccc(Cl)cc1)CC2		CHEMBL4161952	=	IC50	nM	273.0	CHEMBL1293289	Homo sapiens	IC50	nM	273.0
	18373926	CHEMBL4144031	Inhibition of human His-tagged Brd2 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccc(CO)cc1N(c1ccc(Cl)cc1)CC2		CHEMBL4166455	=	IC50	nM	388.0	CHEMBL1293289	Homo sapiens	IC50	nM	388.0
	18373927	CHEMBL4144031	Inhibition of human His-tagged Brd2 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccc(-c3cc[nH]n3)cc1N(c1ccc(Cl)cc1)CC2		CHEMBL4177080	=	IC50	nM	35.0	CHEMBL1293289	Homo sapiens	IC50	nM	35.0
	18373928	CHEMBL4144031	Inhibition of human His-tagged Brd2 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccc(-c3cnc(N)nc3)cc1N(c1ccc(Cl)cc1)CC2		CHEMBL4176672	=	IC50	nM	64.0	CHEMBL1293289	Homo sapiens	IC50	nM	64.0
	18373929	CHEMBL4144031	Inhibition of human His-tagged Brd2 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccc(-c3ccc(N)nc3)cc1N(c1ccc(Cl)cc1)CC2		CHEMBL4168815	=	IC50	nM	33.0	CHEMBL1293289	Homo sapiens	IC50	nM	33.0
	18373930	CHEMBL4144031	Inhibition of human His-tagged Brd2 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1ccc(-c2ccc3c(c2)N(c2ccc(Cl)cc2)CCn2nnc(C)c2-3)cn1		CHEMBL4173305	=	IC50	nM	53.0	CHEMBL1293289	Homo sapiens	IC50	nM	53.0
	18373931	CHEMBL4144031	Inhibition of human His-tagged Brd2 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccc(-c3nn[nH]n3)cc1N(c1ccc(Cl)cc1)CC2		CHEMBL4165389	=	IC50	nM	6.0	CHEMBL1293289	Homo sapiens	IC50	nM	6.0
	18373932	CHEMBL4144031	Inhibition of human His-tagged Brd2 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	COC(=O)c1ccc2c(c1)N(c1ccc(Cl)cc1)CCn1nnc(C)c1-2		CHEMBL4174764	=	IC50	nM	116.0	CHEMBL1293289	Homo sapiens	IC50	nM	116.0
	18373933	CHEMBL4144031	Inhibition of human His-tagged Brd2 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccc(C(=O)O)cc1N(c1ccc(Cl)cc1)CC2		CHEMBL4166861	=	IC50	nM	185.0	CHEMBL1293289	Homo sapiens	IC50	nM	185.0
	18373934	CHEMBL4144031	Inhibition of human His-tagged Brd2 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccc(C(N)=O)cc1N(c1ccc(Cl)cc1)CC2		CHEMBL4161767	=	IC50	nM	34.0	CHEMBL1293289	Homo sapiens	IC50	nM	34.0
	18373935	CHEMBL4144031	Inhibition of human His-tagged Brd2 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccc(C(=O)Nc3ccccc3)cc1N(c1ccc(Cl)cc1)CC2		CHEMBL4169698	=	IC50	nM	79.0	CHEMBL1293289	Homo sapiens	IC50	nM	79.0
	18373936	CHEMBL4144031	Inhibition of human His-tagged Brd2 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccc(C(O)C(F)(F)F)cc1N(c1ccc(Cl)cc1)CC2		CHEMBL4165200	=	IC50	nM	204.0	CHEMBL1293289	Homo sapiens	IC50	nM	204.0
	18373937	CHEMBL4144031	Inhibition of human His-tagged Brd2 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccc(C#N)cc1N(c1ccc(Cl)cc1)CC2		CHEMBL4173105	=	IC50	nM	56.0	CHEMBL1293289	Homo sapiens	IC50	nM	56.0
	18373938	CHEMBL4144031	Inhibition of human His-tagged Brd2 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccc(C(=O)N[C@@H](C)c3ccc(F)cc3)cc1N(c1ccc(Cl)cc1)CC2		CHEMBL4173537	=	IC50	nM	95.0	CHEMBL1293289	Homo sapiens	IC50	nM	95.0
	18373939	CHEMBL4144031	Inhibition of human His-tagged Brd2 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccc(C(=O)N[C@@H](C)c3ccccc3)cc1N(c1ccc(Cl)cc1)CC2		CHEMBL4162832	=	IC50	nM	51.0	CHEMBL1293289	Homo sapiens	IC50	nM	51.0
	18373940	CHEMBL4144031	Inhibition of human His-tagged Brd2 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccc(C(=O)N[C@H](C)c3ccccc3)cc1N(c1ccc(Cl)cc1)CC2		CHEMBL4176902	=	IC50	nM	68.0	CHEMBL1293289	Homo sapiens	IC50	nM	68.0
	18373941	CHEMBL4144031	Inhibition of human His-tagged Brd2 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccc(C(=O)NCc3ccccc3)cc1N(c1ccc(Cl)cc1)CC2		CHEMBL4166286	=	IC50	nM	136.0	CHEMBL1293289	Homo sapiens	IC50	nM	136.0
	18373942	CHEMBL4144031	Inhibition of human His-tagged Brd2 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccc(C(=O)NC(c3ccccc3)c3ccccc3)cc1N(c1ccc(Cl)cc1)CC2		CHEMBL4166671	=	IC50	nM	151.0	CHEMBL1293289	Homo sapiens	IC50	nM	151.0
	18373943	CHEMBL4144031	Inhibition of human His-tagged Brd2 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccc(C(=O)NS(=O)(=O)c3ccccc3)cc1N(c1ccc(Cl)cc1)CC2		CHEMBL4174587	=	IC50	nM	54.0	CHEMBL1293289	Homo sapiens	IC50	nM	54.0
	18373944	CHEMBL4144031	Inhibition of human His-tagged Brd2 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccc(C(=O)NS(C)(=O)=O)cc1N(c1ccc(Cl)cc1)CC2		CHEMBL4167362	=	IC50	nM	44.0	CHEMBL1293289	Homo sapiens	IC50	nM	44.0
	18373945	CHEMBL4144031	Inhibition of human His-tagged Brd2 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccccc1N(c1ccc(Cl)cc1)C[C@@H]2C		CHEMBL4159455	=	IC50	nM	53.0	CHEMBL1293289	Homo sapiens	IC50	nM	53.0
	18373946	CHEMBL4144031	Inhibition of human His-tagged Brd2 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccccc1N(c1ccc(Cl)cc1)C[C@H]2C		CHEMBL4170756	=	IC50	nM	38.0	CHEMBL1293289	Homo sapiens	IC50	nM	38.0
	18373947	CHEMBL4144031	Inhibition of human His-tagged Brd2 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccccc1N(c1ccc(Cl)cc1)CC2CCO		CHEMBL4162818	=	IC50	nM	340.0	CHEMBL1293289	Homo sapiens	IC50	nM	340.0
	18373948	CHEMBL4144031	Inhibition of human His-tagged Brd2 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccccc1N(c1ccccc1)C(=O)C2		CHEMBL4160537	>	IC50	nM	10000.0	CHEMBL1293289	Homo sapiens	IC50	uM	10.0
	18373949	CHEMBL4144032	Inhibition of human His-tagged Brd2 bromodomain 2 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=NC(CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL2132936	=	IC50	nM	16.0	CHEMBL1293289	Homo sapiens	IC50	nM	16.0
	18373950	CHEMBL4144032	Inhibition of human His-tagged Brd2 bromodomain 2 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccccc1N(c1ccccc1)CC2		CHEMBL4164698	=	IC50	nM	39.0	CHEMBL1293289	Homo sapiens	IC50	nM	39.0
	18373951	CHEMBL4144032	Inhibition of human His-tagged Brd2 bromodomain 2 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccccc1N(Cc1ccccc1)CC2		CHEMBL4167034	>	IC50	nM	999.0	CHEMBL1293289	Homo sapiens	IC50	nM	999.0
	18373952	CHEMBL4144032	Inhibition of human His-tagged Brd2 bromodomain 2 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccccc1N(Cc1cccc(Br)c1)CC2		CHEMBL4174918	=	IC50	nM	44.0	CHEMBL1293289	Homo sapiens	IC50	nM	44.0
	18373953	CHEMBL4144032	Inhibition of human His-tagged Brd2 bromodomain 2 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccccc1N(c1ccc(Cl)cc1)CC2		CHEMBL4169877	=	IC50	nM	43.0	CHEMBL1293289	Homo sapiens	IC50	nM	43.0
	18373954	CHEMBL4144032	Inhibition of human His-tagged Brd2 bromodomain 2 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccc(Cn3cccn3)cc1N(c1ccc(Cl)cc1)CC2		CHEMBL4161952	=	IC50	nM	147.0	CHEMBL1293289	Homo sapiens	IC50	nM	147.0
	18373955	CHEMBL4144032	Inhibition of human His-tagged Brd2 bromodomain 2 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccc(CO)cc1N(c1ccc(Cl)cc1)CC2		CHEMBL4166455	=	IC50	nM	40.0	CHEMBL1293289	Homo sapiens	IC50	nM	40.0
	18373956	CHEMBL4144032	Inhibition of human His-tagged Brd2 bromodomain 2 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccc(-c3cc[nH]n3)cc1N(c1ccc(Cl)cc1)CC2		CHEMBL4177080	=	IC50	nM	25.0	CHEMBL1293289	Homo sapiens	IC50	nM	25.0
	18373957	CHEMBL4144032	Inhibition of human His-tagged Brd2 bromodomain 2 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccc(-c3cnc(N)nc3)cc1N(c1ccc(Cl)cc1)CC2		CHEMBL4176672	=	IC50	nM	38.0	CHEMBL1293289	Homo sapiens	IC50	nM	38.0
	18373958	CHEMBL4144032	Inhibition of human His-tagged Brd2 bromodomain 2 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccc(-c3ccc(N)nc3)cc1N(c1ccc(Cl)cc1)CC2		CHEMBL4168815	=	IC50	nM	21.0	CHEMBL1293289	Homo sapiens	IC50	nM	21.0
	18373959	CHEMBL4144032	Inhibition of human His-tagged Brd2 bromodomain 2 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1ccc(-c2ccc3c(c2)N(c2ccc(Cl)cc2)CCn2nnc(C)c2-3)cn1		CHEMBL4173305	=	IC50	nM	28.0	CHEMBL1293289	Homo sapiens	IC50	nM	28.0
	18373960	CHEMBL4144032	Inhibition of human His-tagged Brd2 bromodomain 2 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccc(-c3nn[nH]n3)cc1N(c1ccc(Cl)cc1)CC2		CHEMBL4165389	=	IC50	nM	7.0	CHEMBL1293289	Homo sapiens	IC50	nM	7.0
	18373961	CHEMBL4144032	Inhibition of human His-tagged Brd2 bromodomain 2 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	COC(=O)c1ccc2c(c1)N(c1ccc(Cl)cc1)CCn1nnc(C)c1-2		CHEMBL4174764	=	IC50	nM	52.0	CHEMBL1293289	Homo sapiens	IC50	nM	52.0
	18373962	CHEMBL4144032	Inhibition of human His-tagged Brd2 bromodomain 2 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccc(C(=O)O)cc1N(c1ccc(Cl)cc1)CC2		CHEMBL4166861	=	IC50	nM	50.0	CHEMBL1293289	Homo sapiens	IC50	nM	50.0
	18373963	CHEMBL4144032	Inhibition of human His-tagged Brd2 bromodomain 2 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccc(C(N)=O)cc1N(c1ccc(Cl)cc1)CC2		CHEMBL4161767	=	IC50	nM	17.0	CHEMBL1293289	Homo sapiens	IC50	nM	17.0
	18373964	CHEMBL4144032	Inhibition of human His-tagged Brd2 bromodomain 2 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccc(C(=O)Nc3ccccc3)cc1N(c1ccc(Cl)cc1)CC2		CHEMBL4169698	=	IC50	nM	18.0	CHEMBL1293289	Homo sapiens	IC50	nM	18.0
	18373965	CHEMBL4144032	Inhibition of human His-tagged Brd2 bromodomain 2 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccc(C(O)C(F)(F)F)cc1N(c1ccc(Cl)cc1)CC2		CHEMBL4165200	=	IC50	nM	370.0	CHEMBL1293289	Homo sapiens	IC50	nM	370.0
	18373966	CHEMBL4144032	Inhibition of human His-tagged Brd2 bromodomain 2 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccc(C#N)cc1N(c1ccc(Cl)cc1)CC2		CHEMBL4173105	=	IC50	nM	24.0	CHEMBL1293289	Homo sapiens	IC50	nM	24.0
	18373967	CHEMBL4144032	Inhibition of human His-tagged Brd2 bromodomain 2 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccc(C(=O)N[C@@H](C)c3ccc(F)cc3)cc1N(c1ccc(Cl)cc1)CC2		CHEMBL4173537	=	IC50	nM	4.0	CHEMBL1293289	Homo sapiens	IC50	nM	4.0
	18373968	CHEMBL4144032	Inhibition of human His-tagged Brd2 bromodomain 2 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccc(C(=O)N[C@@H](C)c3ccccc3)cc1N(c1ccc(Cl)cc1)CC2		CHEMBL4162832	=	IC50	nM	3.0	CHEMBL1293289	Homo sapiens	IC50	nM	3.0
	18373969	CHEMBL4144032	Inhibition of human His-tagged Brd2 bromodomain 2 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccc(C(=O)N[C@H](C)c3ccccc3)cc1N(c1ccc(Cl)cc1)CC2		CHEMBL4176902	=	IC50	nM	20.0	CHEMBL1293289	Homo sapiens	IC50	nM	20.0
	18373970	CHEMBL4144032	Inhibition of human His-tagged Brd2 bromodomain 2 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccc(C(=O)NCc3ccccc3)cc1N(c1ccc(Cl)cc1)CC2		CHEMBL4166286	=	IC50	nM	37.0	CHEMBL1293289	Homo sapiens	IC50	nM	37.0
	18373971	CHEMBL4144032	Inhibition of human His-tagged Brd2 bromodomain 2 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccc(C(=O)NC(c3ccccc3)c3ccccc3)cc1N(c1ccc(Cl)cc1)CC2		CHEMBL4166671	=	IC50	nM	44.0	CHEMBL1293289	Homo sapiens	IC50	nM	44.0
	18373972	CHEMBL4144032	Inhibition of human His-tagged Brd2 bromodomain 2 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccc(C(=O)NS(=O)(=O)c3ccccc3)cc1N(c1ccc(Cl)cc1)CC2		CHEMBL4174587	=	IC50	nM	25.0	CHEMBL1293289	Homo sapiens	IC50	nM	25.0
	18373973	CHEMBL4144032	Inhibition of human His-tagged Brd2 bromodomain 2 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccc(C(=O)NS(C)(=O)=O)cc1N(c1ccc(Cl)cc1)CC2		CHEMBL4167362	=	IC50	nM	25.0	CHEMBL1293289	Homo sapiens	IC50	nM	25.0
	18373974	CHEMBL4144032	Inhibition of human His-tagged Brd2 bromodomain 2 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccccc1N(c1ccc(Cl)cc1)C[C@@H]2C		CHEMBL4159455	=	IC50	nM	34.0	CHEMBL1293289	Homo sapiens	IC50	nM	34.0
	18373975	CHEMBL4144032	Inhibition of human His-tagged Brd2 bromodomain 2 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccccc1N(c1ccc(Cl)cc1)C[C@H]2C		CHEMBL4170756	=	IC50	nM	25.0	CHEMBL1293289	Homo sapiens	IC50	nM	25.0
	18373976	CHEMBL4144032	Inhibition of human His-tagged Brd2 bromodomain 2 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccccc1N(c1ccc(Cl)cc1)CC2CCO		CHEMBL4162818	=	IC50	nM	45.0	CHEMBL1293289	Homo sapiens	IC50	nM	45.0
	18373977	CHEMBL4144032	Inhibition of human His-tagged Brd2 bromodomain 2 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinylated acetyl-histone H4 peptide and measured after 1 hr by AlphaScreen assay	B	Cc1nnn2c1-c1ccccc1N(c1ccccc1)C(=O)C2		CHEMBL4160537	>	IC50	nM	10000.0	CHEMBL1293289	Homo sapiens	IC50	uM	10.0
	18374059	CHEMBL4144036	Binding affinity to His-tagged human Brd2 bromodomain 1 (1 to 473 residues) assessed as dissociation rate constant by surface plasmon resonance assay	B	Cc1nnn2c1-c1ccc(-c3ccc(N)nc3)cc1N(c1ccc(Cl)cc1)CC2	Non standard unit for type	CHEMBL4168815	=	Kd	/s	0.13	CHEMBL1293289	Homo sapiens	Kd	/s	0.13
	18374060	CHEMBL4144037	Binding affinity to His-tagged human Brd2 bromodomain 2 (1 to 473 residues) assessed as dissociation rate constant by surface plasmon resonance assay	B	Cc1nnn2c1-c1ccc(-c3ccc(N)nc3)cc1N(c1ccc(Cl)cc1)CC2	Non standard unit for type	CHEMBL4168815	=	Kd	/s	0.039	CHEMBL1293289	Homo sapiens	Kd	/s	0.039
	18374061	CHEMBL4144038	Binding affinity to His-tagged human Brd2 bromodomain 1 (1 to 473 residues) assessed as association rate constant by suface plasmon resonance assay	B	Cc1nnn2c1-c1ccc(-c3ccc(N)nc3)cc1N(c1ccc(Cl)cc1)CC2		CHEMBL4168815	=	Ka	10'5/M/s	2.9	CHEMBL1293289	Homo sapiens	Ka	10'5/M/s	2.9
	18374062	CHEMBL4144039	Binding affinity to His-tagged human Brd2 bromodomain 2 (1 to 473 residues) assessed as association rate constant by surface plasmon resonance assay	B	Cc1nnn2c1-c1ccc(-c3ccc(N)nc3)cc1N(c1ccc(Cl)cc1)CC2		CHEMBL4168815	=	Ka	10'5/M/s	2.62	CHEMBL1293289	Homo sapiens	Ka	10'5/M/s	2.62
	18374118	CHEMBL4144065	Ratio of dissociation rate constant for His-tagged human Brd2 bromodomain 1 (1 to 473 residues) to dissociation rate constant for His-tagged human Brd2 bromodomain 2 (1 to 473 residues)	B	Cc1nnn2c1-c1ccc(-c3ccc(N)nc3)cc1N(c1ccc(Cl)cc1)CC2		CHEMBL4168815	=	Ratio		3.0	CHEMBL1293289	Homo sapiens	Ratio		3.0
	18406497	CHEMBL4151014	Binding affinity to human BRD2 bromodomain 1 (K71 to N194 residues) expressed in bacterial expression system by BROMOscan assay	B	COc1cc2c(cc1-c1c(C)noc1C)[nH]c1nc(C)nc(Nc3cc(C4CC4)nn3C)c12		CHEMBL4173488	=	Kd	nM	1.1	CHEMBL1293289	Homo sapiens	Kd	nM	1.1
	18406498	CHEMBL4151015	Binding affinity to human BRD2 bromodomain 2 (E348 to D455 residues) expressed in bacterial expression system by BROMOscan assay	B	COc1cc2c(cc1-c1c(C)noc1C)[nH]c1nc(C)nc(Nc3cc(C4CC4)nn3C)c12		CHEMBL4173488	=	Kd	nM	0.6	CHEMBL1293289	Homo sapiens	Kd	nM	0.6
	18416356	CHEMBL4153120	Inhibition of BRD2 BD1 (unknown origin) after 1 hr by TR-FRET assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	IC50	nM	78.0	CHEMBL1293289	Homo sapiens	IC50	nM	78.0
	18416357	CHEMBL4153120	Inhibition of BRD2 BD1 (unknown origin) after 1 hr by TR-FRET assay	B	Cc1cc(/N=N/c2ccc3c(c2)CCC(=O)N3)c(N)cc1O		CHEMBL4176038	=	IC50	nM	803.0	CHEMBL1293289	Homo sapiens	IC50	nM	803.0
	18416358	CHEMBL4153120	Inhibition of BRD2 BD1 (unknown origin) after 1 hr by TR-FRET assay	B	Cc1cc(/N=N/c2ccc(S(=O)(=O)NC3CCCC3)cc2)c(N)cc1O		CHEMBL4159382	=	IC50	nM	772.0	CHEMBL1293289	Homo sapiens	IC50	nM	772.0
	18416359	CHEMBL4153120	Inhibition of BRD2 BD1 (unknown origin) after 1 hr by TR-FRET assay	B	COc1cc(OC)c2c(=O)[nH]c(-c3cc(C)c(OCCO)c(C)c3)nc2c1		CHEMBL2393130	=	IC50	nM	5780.0	CHEMBL1293289	Homo sapiens	IC50	nM	5780.0
	18416360	CHEMBL4153121	Inhibition of BRD2 BD2 (unknown origin) after 1 hr by TR-FRET assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	IC50	nM	52.0	CHEMBL1293289	Homo sapiens	IC50	nM	52.0
	18416361	CHEMBL4153121	Inhibition of BRD2 BD2 (unknown origin) after 1 hr by TR-FRET assay	B	Cc1cc(/N=N/c2ccc3c(c2)CCC(=O)N3)c(N)cc1O		CHEMBL4176038	=	IC50	nM	1736.0	CHEMBL1293289	Homo sapiens	IC50	nM	1736.0
	18416362	CHEMBL4153121	Inhibition of BRD2 BD2 (unknown origin) after 1 hr by TR-FRET assay	B	Cc1cc(/N=N/c2ccc(S(=O)(=O)NC3CCCC3)cc2)c(N)cc1O		CHEMBL4159382	=	IC50	nM	1836.0	CHEMBL1293289	Homo sapiens	IC50	nM	1836.0
	18416363	CHEMBL4153121	Inhibition of BRD2 BD2 (unknown origin) after 1 hr by TR-FRET assay	B	COc1cc(OC)c2c(=O)[nH]c(-c3cc(C)c(OCCO)c(C)c3)nc2c1		CHEMBL2393130	=	IC50	nM	251.0	CHEMBL1293289	Homo sapiens	IC50	nM	251.0
	18426563	CHEMBL4154873	Binding affinity to His6-tagged human BRD2 bromodomain-1 (K77 to N194 residues) expressed in Escherichia coli BL21(DE3) assessed as change in melting temperature at 200 uM by SYPRO orange dye based fluorescence assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	Delta Tm	degrees C	7.5	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	7.5
	18426564	CHEMBL4154873	Binding affinity to His6-tagged human BRD2 bromodomain-1 (K77 to N194 residues) expressed in Escherichia coli BL21(DE3) assessed as change in melting temperature at 200 uM by SYPRO orange dye based fluorescence assay	B	Cc1noc(C)c1-c1ccc2c(c1)OC(c1ccccc1)C(=O)N2		CHEMBL4163057	=	Delta Tm	degrees C	5.4	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	5.4
	18426565	CHEMBL4154873	Binding affinity to His6-tagged human BRD2 bromodomain-1 (K77 to N194 residues) expressed in Escherichia coli BL21(DE3) assessed as change in melting temperature at 200 uM by SYPRO orange dye based fluorescence assay	B	Cc1noc(C)c1-c1ccc2c(c1)OC(c1ccccc1F)C(=O)N2		CHEMBL4161994	=	Delta Tm	degrees C	4.8	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	4.8
	18426566	CHEMBL4154873	Binding affinity to His6-tagged human BRD2 bromodomain-1 (K77 to N194 residues) expressed in Escherichia coli BL21(DE3) assessed as change in melting temperature at 200 uM by SYPRO orange dye based fluorescence assay	B	Cc1noc(C)c1-c1ccc2c(c1)O[C@H](CC(C)C)C(=O)N2		CHEMBL4167192	=	Delta Tm	degrees C	6.6	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	6.6
	18426567	CHEMBL4154873	Binding affinity to His6-tagged human BRD2 bromodomain-1 (K77 to N194 residues) expressed in Escherichia coli BL21(DE3) assessed as change in melting temperature at 200 uM by SYPRO orange dye based fluorescence assay	B	Cc1noc(C)c1-c1ccc2c(c1)O[C@H](CC1CC1)C(=O)N2		CHEMBL4175060	=	Delta Tm	degrees C	5.7	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	5.7
	18426568	CHEMBL4154873	Binding affinity to His6-tagged human BRD2 bromodomain-1 (K77 to N194 residues) expressed in Escherichia coli BL21(DE3) assessed as change in melting temperature at 200 uM by SYPRO orange dye based fluorescence assay	B	CCN1C(=O)[C@@H](CC2CC2)Oc2cc(-c3c(C)noc3C)ccc21		CHEMBL4168278	=	Delta Tm	degrees C	4.8	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	4.8
	18426569	CHEMBL4154873	Binding affinity to His6-tagged human BRD2 bromodomain-1 (K77 to N194 residues) expressed in Escherichia coli BL21(DE3) assessed as change in melting temperature at 200 uM by SYPRO orange dye based fluorescence assay	B	Cc1noc(C)c1-c1ccc2c(c1)O[C@H](CC1CC1)C(=O)N2CCN1CCOCC1		CHEMBL4177288	=	Delta Tm	degrees C	4.8	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	4.8
	18426570	CHEMBL4154874	Binding affinity to His6-tagged human BRD2 bromodomain-2 expressed in Escherichia coli BL21(DE3) assessed as change in melting temperature at 200 uM by SYPRO orange dye based fluorescence assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	Delta Tm	degrees C	12.0	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	12.0
	18426571	CHEMBL4154874	Binding affinity to His6-tagged human BRD2 bromodomain-2 expressed in Escherichia coli BL21(DE3) assessed as change in melting temperature at 200 uM by SYPRO orange dye based fluorescence assay	B	Cc1noc(C)c1-c1ccc2c(c1)OC(c1ccccc1)C(=O)N2		CHEMBL4163057	=	Delta Tm	degrees C	10.2	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	10.2
	18426572	CHEMBL4154874	Binding affinity to His6-tagged human BRD2 bromodomain-2 expressed in Escherichia coli BL21(DE3) assessed as change in melting temperature at 200 uM by SYPRO orange dye based fluorescence assay	B	Cc1noc(C)c1-c1ccc2c(c1)OC(c1ccccc1F)C(=O)N2		CHEMBL4161994	=	Delta Tm	degrees C	9.3	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	9.3
	18426573	CHEMBL4154874	Binding affinity to His6-tagged human BRD2 bromodomain-2 expressed in Escherichia coli BL21(DE3) assessed as change in melting temperature at 200 uM by SYPRO orange dye based fluorescence assay	B	Cc1noc(C)c1-c1ccc2c(c1)O[C@H](CC(C)C)C(=O)N2		CHEMBL4167192	=	Delta Tm	degrees C	9.0	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	9.0
	18426574	CHEMBL4154874	Binding affinity to His6-tagged human BRD2 bromodomain-2 expressed in Escherichia coli BL21(DE3) assessed as change in melting temperature at 200 uM by SYPRO orange dye based fluorescence assay	B	Cc1noc(C)c1-c1ccc2c(c1)O[C@H](CC1CC1)C(=O)N2		CHEMBL4175060	=	Delta Tm	degrees C	7.8	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	7.8
	18426575	CHEMBL4154874	Binding affinity to His6-tagged human BRD2 bromodomain-2 expressed in Escherichia coli BL21(DE3) assessed as change in melting temperature at 200 uM by SYPRO orange dye based fluorescence assay	B	CCN1C(=O)[C@@H](CC2CC2)Oc2cc(-c3c(C)noc3C)ccc21		CHEMBL4168278	=	Delta Tm	degrees C	5.4	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	5.4
	18426576	CHEMBL4154874	Binding affinity to His6-tagged human BRD2 bromodomain-2 expressed in Escherichia coli BL21(DE3) assessed as change in melting temperature at 200 uM by SYPRO orange dye based fluorescence assay	B	Cc1noc(C)c1-c1ccc2c(c1)O[C@H](CC1CC1)C(=O)N2CCN1CCOCC1		CHEMBL4177288	=	Delta Tm	degrees C	6.3	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	6.3
	18469106	CHEMBL4182256	Inhibition of recombinant human BRD2 bromodomain 2 (342 to 460 residues) using biotin labeled peptide substrate preincubated for 15 mins followed by substrate addition measured after 1 hr by TR-FRET assay	B	CC(=O)N1c2ccc(-c3ccc(C(=O)O)cc3)cc2[C@H](Nc2ccc(Cl)cc2)C[C@@H]1C		CHEMBL2177300	=	IC50	nM	30.0	CHEMBL1293289	Homo sapiens	IC50	uM	0.03
	18469107	CHEMBL4182255	Inhibition of recombinant human BRD2 bromodomain 1 (49 to 170 residues) using biotin labeled peptide substrate preincubated for 15 mins followed by substrate addition measured after 1 hr by TR-FRET assay	A	CC(=O)N1c2ccc(-c3ccc(C(=O)O)cc3)cc2[C@H](Nc2ccc(Cl)cc2)C[C@@H]1C		CHEMBL2177300	=	IC50	nM	720.0	CHEMBL1293289	Homo sapiens	IC50	uM	0.72
	18469117	CHEMBL4182262	Binding affinity to BRD2 bromodomain 2 (348 to 455 residues) (unknown origin) by ITC	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	Kd	nM	112.14	CHEMBL1293289	Homo sapiens	Kd	nM	112.14
	18469118	CHEMBL4182261	Binding affinity to BRD2 bromodomain 1 (74 to 194 residues) (unknown origin) by ITC	A	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	Kd	nM	88.99	CHEMBL1293289	Homo sapiens	Kd	nM	88.99
	18469120	CHEMBL4182259	Binding affinity to His-tagged BRD2 bromodomain 2 (unknown origin) by SPR assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	Kd	nM	116.0	CHEMBL1293289	Homo sapiens	Kd	nM	116.0
	18469121	CHEMBL4182258	Binding affinity to His-tagged BRD2 bromodomain 1 (unknown origin) by SPR assay	A	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	Kd	nM	104.0	CHEMBL1293289	Homo sapiens	Kd	nM	104.0
	18469123	CHEMBL4182256	Inhibition of recombinant human BRD2 bromodomain 2 (342 to 460 residues) using biotin labeled peptide substrate preincubated for 15 mins followed by substrate addition measured after 1 hr by TR-FRET assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	IC50	nM	170.0	CHEMBL1293289	Homo sapiens	IC50	uM	0.17
	18469124	CHEMBL4182255	Inhibition of recombinant human BRD2 bromodomain 1 (49 to 170 residues) using biotin labeled peptide substrate preincubated for 15 mins followed by substrate addition measured after 1 hr by TR-FRET assay	A	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	IC50	nM	370.0	CHEMBL1293289	Homo sapiens	IC50	uM	0.37
	18469125	CHEMBL4182255	Inhibition of recombinant human BRD2 bromodomain 1 (49 to 170 residues) using biotin labeled peptide substrate preincubated for 15 mins followed by substrate addition measured after 1 hr by TR-FRET assay	A	CC(=O)N1c2ccc(-c3ccco3)cc2[C@H](NC(=O)OC(C)C)C[C@@H]1C		CHEMBL4209110	=	IC50	nM	2020.0	CHEMBL1293289	Homo sapiens	IC50	uM	2.02
	18469126	CHEMBL4182256	Inhibition of recombinant human BRD2 bromodomain 2 (342 to 460 residues) using biotin labeled peptide substrate preincubated for 15 mins followed by substrate addition measured after 1 hr by TR-FRET assay	B	CC(=O)N1c2ccc(-c3ccco3)cc2[C@H](NC(=O)OC(C)C)C[C@@H]1C		CHEMBL4209110	=	IC50	nM	610.0	CHEMBL1293289	Homo sapiens	IC50	uM	0.61
	18469128	CHEMBL4182258	Binding affinity to His-tagged BRD2 bromodomain 1 (unknown origin) by SPR assay	A	CC(=O)N1c2ccc(-c3ccco3)cc2[C@H](NC(=O)OC(C)C)C[C@@H]1C		CHEMBL4209110	=	Kd	nM	80.0	CHEMBL1293289	Homo sapiens	Kd	nM	80.0
	18469129	CHEMBL4182259	Binding affinity to His-tagged BRD2 bromodomain 2 (unknown origin) by SPR assay	B	CC(=O)N1c2ccc(-c3ccco3)cc2[C@H](NC(=O)OC(C)C)C[C@@H]1C		CHEMBL4209110	=	Kd	nM	47.0	CHEMBL1293289	Homo sapiens	Kd	nM	47.0
	18469131	CHEMBL4182261	Binding affinity to BRD2 bromodomain 1 (74 to 194 residues) (unknown origin) by ITC	A	CC(=O)N1c2ccc(-c3ccco3)cc2[C@H](NC(=O)OC(C)C)C[C@@H]1C		CHEMBL4209110	=	Kd	nM	2188.61	CHEMBL1293289	Homo sapiens	Kd	nM	2188.61
	18469132	CHEMBL4182262	Binding affinity to BRD2 bromodomain 2 (348 to 455 residues) (unknown origin) by ITC	B	CC(=O)N1c2ccc(-c3ccco3)cc2[C@H](NC(=O)OC(C)C)C[C@@H]1C		CHEMBL4209110	=	Kd	nM	280.44	CHEMBL1293289	Homo sapiens	Kd	nM	280.44
	18469142	CHEMBL4182272	Inhibition of BRD2 in human HD-MB03 cells assessed as reduction in c-Myc protein expression after 72 hrs by Hoechst 33342 staining based immunofluorescence assay	B	CC(=O)N1c2ccc(-c3ccco3)cc2[C@H](NC(=O)OC(C)C)C[C@@H]1C		CHEMBL4209110	=	EC50	nM	480.0	CHEMBL1293289	Homo sapiens	EC50	nM	480.0
	18469143	CHEMBL4182255	Inhibition of recombinant human BRD2 bromodomain 1 (49 to 170 residues) using biotin labeled peptide substrate preincubated for 15 mins followed by substrate addition measured after 1 hr by TR-FRET assay	A	CC(=O)N1c2ccc(-c3cccs3)cc2[C@H](NC(=O)OC(C)C)C[C@@H]1C		CHEMBL4205876	=	IC50	nM	1770.0	CHEMBL1293289	Homo sapiens	IC50	uM	1.77
	18469144	CHEMBL4182256	Inhibition of recombinant human BRD2 bromodomain 2 (342 to 460 residues) using biotin labeled peptide substrate preincubated for 15 mins followed by substrate addition measured after 1 hr by TR-FRET assay	B	CC(=O)N1c2ccc(-c3cccs3)cc2[C@H](NC(=O)OC(C)C)C[C@@H]1C		CHEMBL4205876	=	IC50	nM	830.0	CHEMBL1293289	Homo sapiens	IC50	uM	0.83
	18469146	CHEMBL4182258	Binding affinity to His-tagged BRD2 bromodomain 1 (unknown origin) by SPR assay	A	CC(=O)N1c2ccc(-c3cccs3)cc2[C@H](NC(=O)OC(C)C)C[C@@H]1C		CHEMBL4205876	=	Kd	nM	66.0	CHEMBL1293289	Homo sapiens	Kd	nM	66.0
	18469147	CHEMBL4182259	Binding affinity to His-tagged BRD2 bromodomain 2 (unknown origin) by SPR assay	B	CC(=O)N1c2ccc(-c3cccs3)cc2[C@H](NC(=O)OC(C)C)C[C@@H]1C		CHEMBL4205876	=	Kd	nM	61.0	CHEMBL1293289	Homo sapiens	Kd	nM	61.0
	18469149	CHEMBL4182261	Binding affinity to BRD2 bromodomain 1 (74 to 194 residues) (unknown origin) by ITC	A	CC(=O)N1c2ccc(-c3cccs3)cc2[C@H](NC(=O)OC(C)C)C[C@@H]1C		CHEMBL4205876	=	Kd	nM	61.26	CHEMBL1293289	Homo sapiens	Kd	nM	61.26
	18469150	CHEMBL4182262	Binding affinity to BRD2 bromodomain 2 (348 to 455 residues) (unknown origin) by ITC	B	CC(=O)N1c2ccc(-c3cccs3)cc2[C@H](NC(=O)OC(C)C)C[C@@H]1C		CHEMBL4205876	=	Kd	nM	20.87	CHEMBL1293289	Homo sapiens	Kd	nM	20.87
	18469152	CHEMBL4182255	Inhibition of recombinant human BRD2 bromodomain 1 (49 to 170 residues) using biotin labeled peptide substrate preincubated for 15 mins followed by substrate addition measured after 1 hr by TR-FRET assay	A	CC(=O)N1c2ccc(-c3ccc[nH]3)cc2[C@H](NC(=O)OC(C)C)C[C@@H]1C		CHEMBL4202664	=	IC50	nM	1400.0	CHEMBL1293289	Homo sapiens	IC50	uM	1.4
	18469153	CHEMBL4182256	Inhibition of recombinant human BRD2 bromodomain 2 (342 to 460 residues) using biotin labeled peptide substrate preincubated for 15 mins followed by substrate addition measured after 1 hr by TR-FRET assay	B	CC(=O)N1c2ccc(-c3ccc[nH]3)cc2[C@H](NC(=O)OC(C)C)C[C@@H]1C		CHEMBL4202664	=	IC50	nM	1400.0	CHEMBL1293289	Homo sapiens	IC50	uM	1.4
	18469155	CHEMBL4182258	Binding affinity to His-tagged BRD2 bromodomain 1 (unknown origin) by SPR assay	A	CC(=O)N1c2ccc(-c3ccc[nH]3)cc2[C@H](NC(=O)OC(C)C)C[C@@H]1C		CHEMBL4202664	=	Kd	nM	99.0	CHEMBL1293289	Homo sapiens	Kd	nM	99.0
	18469156	CHEMBL4182259	Binding affinity to His-tagged BRD2 bromodomain 2 (unknown origin) by SPR assay	B	CC(=O)N1c2ccc(-c3ccc[nH]3)cc2[C@H](NC(=O)OC(C)C)C[C@@H]1C		CHEMBL4202664	=	Kd	nM	74.0	CHEMBL1293289	Homo sapiens	Kd	nM	74.0
	18469158	CHEMBL4182261	Binding affinity to BRD2 bromodomain 1 (74 to 194 residues) (unknown origin) by ITC	A	CC(=O)N1c2ccc(-c3ccc[nH]3)cc2[C@H](NC(=O)OC(C)C)C[C@@H]1C		CHEMBL4202664	=	Kd	nM	131.22	CHEMBL1293289	Homo sapiens	Kd	nM	131.22
	18469159	CHEMBL4182262	Binding affinity to BRD2 bromodomain 2 (348 to 455 residues) (unknown origin) by ITC	B	CC(=O)N1c2ccc(-c3ccc[nH]3)cc2[C@H](NC(=O)OC(C)C)C[C@@H]1C		CHEMBL4202664	=	Kd	nM	35.86	CHEMBL1293289	Homo sapiens	Kd	nM	35.86
	18469161	CHEMBL4182255	Inhibition of recombinant human BRD2 bromodomain 1 (49 to 170 residues) using biotin labeled peptide substrate preincubated for 15 mins followed by substrate addition measured after 1 hr by TR-FRET assay	A	CC(=O)N1c2ccc(-c3ccoc3)cc2[C@H](NC(=O)OC(C)C)C[C@@H]1C		CHEMBL4207106	=	IC50	nM	5800.0	CHEMBL1293289	Homo sapiens	IC50	uM	5.8
	18469162	CHEMBL4182256	Inhibition of recombinant human BRD2 bromodomain 2 (342 to 460 residues) using biotin labeled peptide substrate preincubated for 15 mins followed by substrate addition measured after 1 hr by TR-FRET assay	B	CC(=O)N1c2ccc(-c3ccoc3)cc2[C@H](NC(=O)OC(C)C)C[C@@H]1C		CHEMBL4207106	=	IC50	nM	1910.0	CHEMBL1293289	Homo sapiens	IC50	uM	1.91
	18469164	CHEMBL4182258	Binding affinity to His-tagged BRD2 bromodomain 1 (unknown origin) by SPR assay	A	CC(=O)N1c2ccc(-c3ccoc3)cc2[C@H](NC(=O)OC(C)C)C[C@@H]1C		CHEMBL4207106	=	Kd	nM	245.0	CHEMBL1293289	Homo sapiens	Kd	nM	245.0
	18469165	CHEMBL4182259	Binding affinity to His-tagged BRD2 bromodomain 2 (unknown origin) by SPR assay	B	CC(=O)N1c2ccc(-c3ccoc3)cc2[C@H](NC(=O)OC(C)C)C[C@@H]1C		CHEMBL4207106	=	Kd	nM	148.0	CHEMBL1293289	Homo sapiens	Kd	nM	148.0
	18469167	CHEMBL4182261	Binding affinity to BRD2 bromodomain 1 (74 to 194 residues) (unknown origin) by ITC	A	CC(=O)N1c2ccc(-c3ccoc3)cc2[C@H](NC(=O)OC(C)C)C[C@@H]1C		CHEMBL4207106	=	Kd	nM	162.47	CHEMBL1293289	Homo sapiens	Kd	nM	162.47
	18469168	CHEMBL4182262	Binding affinity to BRD2 bromodomain 2 (348 to 455 residues) (unknown origin) by ITC	B	CC(=O)N1c2ccc(-c3ccoc3)cc2[C@H](NC(=O)OC(C)C)C[C@@H]1C		CHEMBL4207106	=	Kd	nM	299.51	CHEMBL1293289	Homo sapiens	Kd	nM	299.51
	18469170	CHEMBL4182255	Inhibition of recombinant human BRD2 bromodomain 1 (49 to 170 residues) using biotin labeled peptide substrate preincubated for 15 mins followed by substrate addition measured after 1 hr by TR-FRET assay	A	CC(=O)N1c2ccc(-c3ccsc3)cc2[C@H](NC(=O)OC(C)C)C[C@@H]1C		CHEMBL4210405	=	IC50	nM	5210.0	CHEMBL1293289	Homo sapiens	IC50	uM	5.21
	18469171	CHEMBL4182256	Inhibition of recombinant human BRD2 bromodomain 2 (342 to 460 residues) using biotin labeled peptide substrate preincubated for 15 mins followed by substrate addition measured after 1 hr by TR-FRET assay	B	CC(=O)N1c2ccc(-c3ccsc3)cc2[C@H](NC(=O)OC(C)C)C[C@@H]1C		CHEMBL4210405	=	IC50	nM	1080.0	CHEMBL1293289	Homo sapiens	IC50	uM	1.08
	18469173	CHEMBL4182258	Binding affinity to His-tagged BRD2 bromodomain 1 (unknown origin) by SPR assay	A	CC(=O)N1c2ccc(-c3ccsc3)cc2[C@H](NC(=O)OC(C)C)C[C@@H]1C		CHEMBL4210405	=	Kd	nM	105.0	CHEMBL1293289	Homo sapiens	Kd	nM	105.0
	18469174	CHEMBL4182259	Binding affinity to His-tagged BRD2 bromodomain 2 (unknown origin) by SPR assay	B	CC(=O)N1c2ccc(-c3ccsc3)cc2[C@H](NC(=O)OC(C)C)C[C@@H]1C		CHEMBL4210405	=	Kd	nM	72.0	CHEMBL1293289	Homo sapiens	Kd	nM	72.0
	18469176	CHEMBL4182261	Binding affinity to BRD2 bromodomain 1 (74 to 194 residues) (unknown origin) by ITC	A	CC(=O)N1c2ccc(-c3ccsc3)cc2[C@H](NC(=O)OC(C)C)C[C@@H]1C		CHEMBL4210405	=	Kd	nM	71.65	CHEMBL1293289	Homo sapiens	Kd	nM	71.65
	18469177	CHEMBL4182262	Binding affinity to BRD2 bromodomain 2 (348 to 455 residues) (unknown origin) by ITC	B	CC(=O)N1c2ccc(-c3ccsc3)cc2[C@H](NC(=O)OC(C)C)C[C@@H]1C		CHEMBL4210405	=	Kd	nM	17.12	CHEMBL1293289	Homo sapiens	Kd	nM	17.12
	18469179	CHEMBL4182255	Inhibition of recombinant human BRD2 bromodomain 1 (49 to 170 residues) using biotin labeled peptide substrate preincubated for 15 mins followed by substrate addition measured after 1 hr by TR-FRET assay	A	CC(=O)N1c2ccc(-c3cc[nH]c3)cc2[C@H](NC(=O)OC(C)C)C[C@@H]1C		CHEMBL4206677	=	IC50	nM	2480.0	CHEMBL1293289	Homo sapiens	IC50	uM	2.48
	18469180	CHEMBL4182256	Inhibition of recombinant human BRD2 bromodomain 2 (342 to 460 residues) using biotin labeled peptide substrate preincubated for 15 mins followed by substrate addition measured after 1 hr by TR-FRET assay	B	CC(=O)N1c2ccc(-c3cc[nH]c3)cc2[C@H](NC(=O)OC(C)C)C[C@@H]1C		CHEMBL4206677	=	IC50	nM	410.0	CHEMBL1293289	Homo sapiens	IC50	uM	0.41
	18469182	CHEMBL4182258	Binding affinity to His-tagged BRD2 bromodomain 1 (unknown origin) by SPR assay	A	CC(=O)N1c2ccc(-c3cc[nH]c3)cc2[C@H](NC(=O)OC(C)C)C[C@@H]1C		CHEMBL4206677	=	Kd	nM	104.0	CHEMBL1293289	Homo sapiens	Kd	nM	104.0
	18469183	CHEMBL4182259	Binding affinity to His-tagged BRD2 bromodomain 2 (unknown origin) by SPR assay	B	CC(=O)N1c2ccc(-c3cc[nH]c3)cc2[C@H](NC(=O)OC(C)C)C[C@@H]1C		CHEMBL4206677	=	Kd	nM	77.0	CHEMBL1293289	Homo sapiens	Kd	nM	77.0
	18469185	CHEMBL4182261	Binding affinity to BRD2 bromodomain 1 (74 to 194 residues) (unknown origin) by ITC	A	CC(=O)N1c2ccc(-c3cc[nH]c3)cc2[C@H](NC(=O)OC(C)C)C[C@@H]1C		CHEMBL4206677	=	Kd	nM	91.53	CHEMBL1293289	Homo sapiens	Kd	nM	91.53
	18469186	CHEMBL4182262	Binding affinity to BRD2 bromodomain 2 (348 to 455 residues) (unknown origin) by ITC	B	CC(=O)N1c2ccc(-c3cc[nH]c3)cc2[C@H](NC(=O)OC(C)C)C[C@@H]1C		CHEMBL4206677	=	Kd	nM	19.94	CHEMBL1293289	Homo sapiens	Kd	nM	19.94
Dose-dependent effect	18469204	CHEMBL4182272	Inhibition of BRD2 in human HD-MB03 cells assessed as reduction in c-Myc protein expression after 72 hrs by Hoechst 33342 staining based immunofluorescence assay	B	CC(=O)N1c2ccc(-c3ccco3)cc2[C@H](NC(=O)OC(C)C)C[C@@H]1C		CHEMBL4209110		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
	18483679	CHEMBL4185433	Binding affinity to human partial length BRD2 bromodomain 1 long isoform (72 to 205 residues) expressed in bacterial expression system by BROMOscan assay	B	COc1cc2c(cc1-c1c(C)noc1C)[nH]c1nc(C)nc(-c3ccnc4ccccc34)c12		CHEMBL4171228	=	Kd	nM	4.5	CHEMBL1293289	Homo sapiens	Kd	nM	4.5
	18483680	CHEMBL4185434	Binding affinity to human partial length BRD2 bromodomain 2 isoform 1 (349 to 460 residues) expressed in bacterial expression system by BROMOscan assay	B	COc1cc2c(cc1-c1c(C)noc1C)[nH]c1nc(C)nc(-c3ccnc4ccccc34)c12		CHEMBL4171228	=	Kd	nM	0.9	CHEMBL1293289	Homo sapiens	Kd	nM	0.9
	18483681	CHEMBL4185435	Binding affinity to human partial length BRD2 bromodomain 1/2 isoform 1 (K71 to D455 residues) by BROMOscan assay	B	COc1cc2c(cc1-c1c(C)noc1C)[nH]c1nc(C)nc(-c3ccnc4ccccc34)c12		CHEMBL4171228	=	Kd	nM	1.1	CHEMBL1293289	Homo sapiens	Kd	nM	1.1
	18486691	CHEMBL4186409	Binding affinity to human partial length BRD2 bromodomain 1 long isoform (K71 to N194 residues) expressed in bacterial expression system by BROMOscan assay	B	CNC(=O)c1ccc(-c2cc3cccc(-c4nn(C5CCOCC5)c5c4CN(C(C)=O)CC5)c3cn2)cn1		CHEMBL4208820	=	Kd	nM	1800.0	CHEMBL1293289	Homo sapiens	Kd	nM	1800.0
	18486692	CHEMBL4186410	Binding affinity to human partial length BRD2 bromodomain 1/2 isoform 1 (K71 to D455 residues) by BROMOscan assay	B	CNC(=O)c1ccc(-c2cc3cccc(-c4nn(C5CCOCC5)c5c4CN(C(C)=O)CC5)c3cn2)cn1		CHEMBL4208820	=	Kd	nM	8200.0	CHEMBL1293289	Homo sapiens	Kd	nM	8200.0
	18486693	CHEMBL4186411	Binding affinity to human partial length BRD2 bromodomain 2 isoform 1 (E348 to D455 residues) expressed in bacterial expression system by BROMOscan assay	B	CNC(=O)c1ccc(-c2cc3cccc(-c4nn(C5CCOCC5)c5c4CN(C(C)=O)CC5)c3cn2)cn1		CHEMBL4208820	>	Kd	nM	10000.0	CHEMBL1293289	Homo sapiens	Kd	nM	10000.0
	18501172	CHEMBL4189288	Inhibition of human BRD2 BD1 after 30 mins by TR-FRET assay	B	CC(=O)N1c2ccc(-c3cnc(C(N)=O)nc3)cc2N(Cc2ccccc2CO)C[C@@H]1C1CC1		CHEMBL4213809	=	IC50	nM	1584.89	CHEMBL1293289	Homo sapiens	pIC50		5.8
	18501173	CHEMBL4189289	Inhibition of human BRD2 BD2 after 30 mins by TR-FRET assay	B	CC(=O)N1c2ccc(-c3cnc(C(N)=O)nc3)cc2N(Cc2ccccc2CO)C[C@@H]1C1CC1		CHEMBL4213809	=	IC50	nM	100.0	CHEMBL1293289	Homo sapiens	pIC50		7.0
	18501190	CHEMBL4189288	Inhibition of human BRD2 BD1 after 30 mins by TR-FRET assay	B	CC(=O)N1c2ccc(C3=CCNCC3)cc2N(Cc2ccccc2CO)C[C@@H]1C1CC1		CHEMBL4218735	=	IC50	nM	2511.89	CHEMBL1293289	Homo sapiens	pIC50		5.6
	18501191	CHEMBL4189289	Inhibition of human BRD2 BD2 after 30 mins by TR-FRET assay	B	CC(=O)N1c2ccc(C3=CCNCC3)cc2N(Cc2ccccc2CO)C[C@@H]1C1CC1		CHEMBL4218735	=	IC50	nM	316.23	CHEMBL1293289	Homo sapiens	pIC50		6.5
	18501206	CHEMBL4189304	Binding affinity to human partial length DNA-tagged BRD2 isoform 1 BD1 expressed in bacterial by BROMOscan method	B	CC(=O)N1c2ccc(C3=CCNCC3)cc2N(Cc2ccccc2CO)C[C@@H]1C1CC1		CHEMBL4218735	=	Kd	nM	1318.26	CHEMBL1293289	Homo sapiens	pKd		5.88
	18501207	CHEMBL4189305	Binding affinity to human partial length DNA-tagged BRD2 isoform 1 BD2 expressed in bacterial by BROMOscan method	B	CC(=O)N1c2ccc(C3=CCNCC3)cc2N(Cc2ccccc2CO)C[C@@H]1C1CC1		CHEMBL4218735	=	Kd	nM	32.36	CHEMBL1293289	Homo sapiens	pKd		7.49
	18501238	CHEMBL4189336	Selectivity ratio of Kd for human partial length DNA-tagged BRD2 isoform 1 BD1 to Kd for human partial length DNA-tagged BRD2 isoform 1 BD2	B	CC(=O)N1c2ccc(C3=CCNCC3)cc2N(Cc2ccccc2CO)C[C@@H]1C1CC1		CHEMBL4218735	=	Selectivity ratio		41.0	CHEMBL1293289	Homo sapiens	Selectivity ratio		41.0
	18528505	CHEMBL4194904	Binding affinity to BRD2 bromodomain 1 to 2 (G73 to A560 amino acids) (unknown origin) using Alexa647-labeled BET-inhibitor as fluorescent probe by bromodomain TR-FRET binding assay	B	Cn1cc2c3c(c[nH]c3c1=O)CN(c1ccc(F)cc1F)c1ccc(CS(C)(=O)=O)cc1-2		CHEMBL4217457	=	Ki	nM	2.5	CHEMBL1293289	Homo sapiens	Ki	nM	2.5
	18528506	CHEMBL4194904	Binding affinity to BRD2 bromodomain 1 to 2 (G73 to A560 amino acids) (unknown origin) using Alexa647-labeled BET-inhibitor as fluorescent probe by bromodomain TR-FRET binding assay	B	Cn1cc2c3c(c[nH]c3c1=O)CN(c1ccccn1)c1ccc(CS(C)(=O)=O)cc1-2		CHEMBL4208129	=	Ki	nM	0.48	CHEMBL1293289	Homo sapiens	Ki	nM	0.48
	18528507	CHEMBL4194904	Binding affinity to BRD2 bromodomain 1 to 2 (G73 to A560 amino acids) (unknown origin) using Alexa647-labeled BET-inhibitor as fluorescent probe by bromodomain TR-FRET binding assay	B	Cn1cc2c3c(c[nH]c(=O)c31)-c1cc(CS(C)(=O)=O)ccc1N(c1ccc(F)cc1)C2		CHEMBL4215988	=	Ki	nM	2.6	CHEMBL1293289	Homo sapiens	Ki	nM	2.6
	18532368	CHEMBL4195569	Inhibition of recombinant human BRD2 bromodomain1/bromodomain2 expressed in Escherichia coli at 10 uM relative to control	B	COc1cc2c(NCC3CCN(C)CC3)cc(-c3ccc(C)o3)nc2cc1OCCCN1CCCC1		CHEMBL4208004	<	Inhibition	%	50.0	CHEMBL1293289	Homo sapiens	INH	%	50.0
	18532369	CHEMBL4195569	Inhibition of recombinant human BRD2 bromodomain1/bromodomain2 expressed in Escherichia coli at 10 uM relative to control	B	CCc1ccc(-c2cc(NCC3CCN(C)CC3)c3cc(OC)c(OCCCN4CCCC4)cc3n2)o1		CHEMBL4212905	<	Inhibition	%	50.0	CHEMBL1293289	Homo sapiens	INH	%	50.0
	18532370	CHEMBL4195569	Inhibition of recombinant human BRD2 bromodomain1/bromodomain2 expressed in Escherichia coli at 10 uM relative to control	B	COc1cc2c(NC3CCN(C)CC3)cc(-c3ccc(C)o3)nc2cc1OC1CC2(C1)CN(C)C2		CHEMBL4215326	<	Inhibition	%	50.0	CHEMBL1293289	Homo sapiens	INH	%	50.0
	18546716	CHEMBL4198510	Inhibition of human BRD2 bromodomain 1 (K71 to N194 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1 uM after 1 hr by BROMOScan assay relative to control	B	Cc1ccc(NC(=O)c2ccc3c(c2)N(C2CC2)C(C)C(=O)N3C)c(C)c1		CHEMBL4204052	=	Activity	%	0.7	CHEMBL1293289	Homo sapiens	Activity	%	0.7
	18546717	CHEMBL4198511	Inhibition of human BRD2 bromodomain 2 (E348 to D455 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1 uM after 1 hr by BROMOScan assay relative to control	B	Cc1ccc(NC(=O)c2ccc3c(c2)N(C2CC2)C(C)C(=O)N3C)c(C)c1		CHEMBL4204052	=	Activity	%	0.0	CHEMBL1293289	Homo sapiens	Activity	%	0.0
	18564908	CHEMBL4219277	Inhibition of FAM-labeled ZBA248 binding to recombinant N-terminal His6-tagged BRD2 bromodomain 2 (349 to 460 residues) (unknown origin) expressed in Escherichia coli Rosetta2 DE3 after 30 mins by fluorescence polarization assay	B	CNC(=O)c1ncc2c(n1)[nH]c1cc(-c3c(C)noc3C)c(OC)cc12		CHEMBL4228904	=	Ki	nM	57.3	CHEMBL1293289	Homo sapiens	Ki	nM	57.3
	18564909	CHEMBL4219277	Inhibition of FAM-labeled ZBA248 binding to recombinant N-terminal His6-tagged BRD2 bromodomain 2 (349 to 460 residues) (unknown origin) expressed in Escherichia coli Rosetta2 DE3 after 30 mins by fluorescence polarization assay	B	CCn1nc(C2CC2)cc1Nc1nc(C(=O)NC)nc2[nH]c3cc(-c4c(C)noc4C)c(OC)cc3c12		CHEMBL4228445	=	Ki	nM	0.27	CHEMBL1293289	Homo sapiens	Ki	nM	0.27
	18564910	CHEMBL4219277	Inhibition of FAM-labeled ZBA248 binding to recombinant N-terminal His6-tagged BRD2 bromodomain 2 (349 to 460 residues) (unknown origin) expressed in Escherichia coli Rosetta2 DE3 after 30 mins by fluorescence polarization assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)Nc1ccc(O)cc1)c1nnc(C)n1-2		CHEMBL3581647	=	Ki	nM	5.4	CHEMBL1293289	Homo sapiens	Ki	nM	5.4
	18564911	CHEMBL4219277	Inhibition of FAM-labeled ZBA248 binding to recombinant N-terminal His6-tagged BRD2 bromodomain 2 (349 to 460 residues) (unknown origin) expressed in Escherichia coli Rosetta2 DE3 after 30 mins by fluorescence polarization assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	Ki	nM	12.5	CHEMBL1293289	Homo sapiens	Ki	nM	12.5
	18564912	CHEMBL4219277	Inhibition of FAM-labeled ZBA248 binding to recombinant N-terminal His6-tagged BRD2 bromodomain 2 (349 to 460 residues) (unknown origin) expressed in Escherichia coli Rosetta2 DE3 after 30 mins by fluorescence polarization assay	B	CNC(=O)c1ncc2c(n1)[nH]c1cc(-c3c(C)noc3C)c(OC)cc12		CHEMBL4228904	=	IC50	nM	224.0	CHEMBL1293289	Homo sapiens	IC50	nM	224.0
	18564913	CHEMBL4219277	Inhibition of FAM-labeled ZBA248 binding to recombinant N-terminal His6-tagged BRD2 bromodomain 2 (349 to 460 residues) (unknown origin) expressed in Escherichia coli Rosetta2 DE3 after 30 mins by fluorescence polarization assay	B	CCn1nc(C2CC2)cc1Nc1nc(C(=O)NC)nc2[nH]c3cc(-c4c(C)noc4C)c(OC)cc3c12		CHEMBL4228445	=	IC50	nM	3.9	CHEMBL1293289	Homo sapiens	IC50	nM	3.9
	18564914	CHEMBL4219277	Inhibition of FAM-labeled ZBA248 binding to recombinant N-terminal His6-tagged BRD2 bromodomain 2 (349 to 460 residues) (unknown origin) expressed in Escherichia coli Rosetta2 DE3 after 30 mins by fluorescence polarization assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)Nc1ccc(O)cc1)c1nnc(C)n1-2		CHEMBL3581647	=	IC50	nM	24.8	CHEMBL1293289	Homo sapiens	IC50	nM	24.8
	18564915	CHEMBL4219277	Inhibition of FAM-labeled ZBA248 binding to recombinant N-terminal His6-tagged BRD2 bromodomain 2 (349 to 460 residues) (unknown origin) expressed in Escherichia coli Rosetta2 DE3 after 30 mins by fluorescence polarization assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	IC50	nM	53.3	CHEMBL1293289	Homo sapiens	IC50	nM	53.3
	18564916	CHEMBL4219276	Inhibition of FAM-labeled ZBA248 binding to recombinant N-terminal His6-tagged BRD2 bromodomain 1 (72 to 205 residues) (unknown origin) expressed in Escherichia coli Rosetta2 DE3 after 30 mins by fluorescence polarization assay	B	CNC(=O)c1ncc2c(n1)[nH]c1cc(-c3c(C)noc3C)c(OC)cc12		CHEMBL4228904	=	Ki	nM	101.0	CHEMBL1293289	Homo sapiens	Ki	nM	101.0
	18564917	CHEMBL4219276	Inhibition of FAM-labeled ZBA248 binding to recombinant N-terminal His6-tagged BRD2 bromodomain 1 (72 to 205 residues) (unknown origin) expressed in Escherichia coli Rosetta2 DE3 after 30 mins by fluorescence polarization assay	B	CCn1nc(C2CC2)cc1Nc1nc(C(=O)NC)nc2[nH]c3cc(-c4c(C)noc4C)c(OC)cc3c12		CHEMBL4228445	=	Ki	nM	0.9	CHEMBL1293289	Homo sapiens	Ki	nM	0.9
	18564918	CHEMBL4219276	Inhibition of FAM-labeled ZBA248 binding to recombinant N-terminal His6-tagged BRD2 bromodomain 1 (72 to 205 residues) (unknown origin) expressed in Escherichia coli Rosetta2 DE3 after 30 mins by fluorescence polarization assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)Nc1ccc(O)cc1)c1nnc(C)n1-2		CHEMBL3581647	=	Ki	nM	16.6	CHEMBL1293289	Homo sapiens	Ki	nM	16.6
	18564919	CHEMBL4219276	Inhibition of FAM-labeled ZBA248 binding to recombinant N-terminal His6-tagged BRD2 bromodomain 1 (72 to 205 residues) (unknown origin) expressed in Escherichia coli Rosetta2 DE3 after 30 mins by fluorescence polarization assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	Ki	nM	13.2	CHEMBL1293289	Homo sapiens	Ki	nM	13.2
	18564920	CHEMBL4219276	Inhibition of FAM-labeled ZBA248 binding to recombinant N-terminal His6-tagged BRD2 bromodomain 1 (72 to 205 residues) (unknown origin) expressed in Escherichia coli Rosetta2 DE3 after 30 mins by fluorescence polarization assay	B	CNC(=O)c1ncc2c(n1)[nH]c1cc(-c3c(C)noc3C)c(OC)cc12		CHEMBL4228904	=	IC50	nM	218.0	CHEMBL1293289	Homo sapiens	IC50	nM	218.0
	18564921	CHEMBL4219276	Inhibition of FAM-labeled ZBA248 binding to recombinant N-terminal His6-tagged BRD2 bromodomain 1 (72 to 205 residues) (unknown origin) expressed in Escherichia coli Rosetta2 DE3 after 30 mins by fluorescence polarization assay	B	CCn1nc(C2CC2)cc1Nc1nc(C(=O)NC)nc2[nH]c3cc(-c4c(C)noc4C)c(OC)cc3c12		CHEMBL4228445	=	IC50	nM	3.1	CHEMBL1293289	Homo sapiens	IC50	nM	3.1
	18564922	CHEMBL4219276	Inhibition of FAM-labeled ZBA248 binding to recombinant N-terminal His6-tagged BRD2 bromodomain 1 (72 to 205 residues) (unknown origin) expressed in Escherichia coli Rosetta2 DE3 after 30 mins by fluorescence polarization assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)Nc1ccc(O)cc1)c1nnc(C)n1-2		CHEMBL3581647	=	IC50	nM	33.3	CHEMBL1293289	Homo sapiens	IC50	nM	33.3
	18564923	CHEMBL4219276	Inhibition of FAM-labeled ZBA248 binding to recombinant N-terminal His6-tagged BRD2 bromodomain 1 (72 to 205 residues) (unknown origin) expressed in Escherichia coli Rosetta2 DE3 after 30 mins by fluorescence polarization assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	IC50	nM	36.1	CHEMBL1293289	Homo sapiens	IC50	nM	36.1
	18752401	CHEMBL4264629	Displacement of biotinylated acetylated peptide from recombinant human partial length BRD2 isoform 1 bromodomain 1 (K71 to N194 residues) expressed in Escherichia coli BL21 measured after 1 hr by Bromoscan method	B	CN(C)CCN1CCN(c2nc(NCc3cccc(Cl)c3)c3cc(-c4ccc(=O)n(C)c4)ccc3n2)CC1		CHEMBL4288569	=	Kd	nM	33.0	CHEMBL1293289	Homo sapiens	Kd	nM	33.0
	18752402	CHEMBL4264630	Displacement of biotinylated acetylated peptide from recombinant human partial length BRD2 isoform 1 bromodomain 1/2 (K71 to D455 residues) expressed in Escherichia coli BL21 measured after 1 hr by Bromoscan method	B	CN(C)CCN1CCN(c2nc(NCc3cccc(Cl)c3)c3cc(-c4ccc(=O)n(C)c4)ccc3n2)CC1		CHEMBL4288569	=	Kd	nM	27.0	CHEMBL1293289	Homo sapiens	Kd	nM	27.0
	18752403	CHEMBL4264631	Displacement of biotinylated acetylated peptide from recombinant human partial length BRD2 isoform 1 bromodomain 2 (E348 to D455 residues) expressed in Escherichia coli BL21 measured after 1 hr by Bromoscan method	B	CN(C)CCN1CCN(c2nc(NCc3cccc(Cl)c3)c3cc(-c4ccc(=O)n(C)c4)ccc3n2)CC1		CHEMBL4288569	=	Kd	nM	24.0	CHEMBL1293289	Homo sapiens	Kd	nM	24.0
	18871528	CHEMBL4310088	Inhibition of human 6x-His-tagged BRD2 bromodomain 1 expressed in Escherichia coli	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	Kd	nM	130.0	CHEMBL1293289	Homo sapiens	Kd	uM	0.13
	18871529	CHEMBL4310088	Inhibition of human 6x-His-tagged BRD2 bromodomain 1 expressed in Escherichia coli	B	Cc1cc(-c2nc3sc4c(c3c(=O)[nH]2)CCN(C)C4)cc(C)c1O		CHEMBL4077274	=	IC50	nM	24600.0	CHEMBL1293289	Homo sapiens	IC50	uM	24.6
	18871530	CHEMBL4310088	Inhibition of human 6x-His-tagged BRD2 bromodomain 1 expressed in Escherichia coli	B	COc1cc(OC)c2c(=O)[nH]c(-c3cc(C)c(OCCO)c(C)c3)nc2c1		CHEMBL2393130	=	Kd	nM	5800.0	CHEMBL1293289	Homo sapiens	Kd	uM	5.8
	18871531	CHEMBL4310088	Inhibition of human 6x-His-tagged BRD2 bromodomain 1 expressed in Escherichia coli	B	CC(=O)NCCCCn1c2c(c3ccccc31)C(=O)NCC2		CHEMBL3770724	=	Kd	nM	8600.0	CHEMBL1293289	Homo sapiens	Kd	uM	8.6
Not Determined	18871532	CHEMBL4310089	Inhibition of human 6x-His-tagged BRD2 bromodomain 2 expressed in Escherichia coli	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266		Kd			CHEMBL1293289	Homo sapiens	Kd		
	18871533	CHEMBL4310089	Inhibition of human 6x-His-tagged BRD2 bromodomain 2 expressed in Escherichia coli	B	Cc1cc(-c2nc3sc4c(c3c(=O)[nH]2)CCN(C)C4)cc(C)c1O		CHEMBL4077274	>	IC50	nM	100000.0	CHEMBL1293289	Homo sapiens	IC50	uM	100.0
	18871534	CHEMBL4310089	Inhibition of human 6x-His-tagged BRD2 bromodomain 2 expressed in Escherichia coli	B	COc1cc(OC)c2c(=O)[nH]c(-c3cc(C)c(OCCO)c(C)c3)nc2c1		CHEMBL2393130	=	Kd	nM	250.0	CHEMBL1293289	Homo sapiens	Kd	uM	0.25
	18871535	CHEMBL4310089	Inhibition of human 6x-His-tagged BRD2 bromodomain 2 expressed in Escherichia coli	B	CC(=O)NCCCCn1c2c(c3ccccc31)C(=O)NCC2		CHEMBL3770724	>	Kd	nM	75000.0	CHEMBL1293289	Homo sapiens	Kd	uM	75.0
	18871581	CHEMBL4310093	Inhibition of BRD2 N-terminal bromodomain 1 (unknown origin) expressed in Escherichia coli Bl21(DE3) by alpha-screen assay	B	Cc1cc(C)cc(Nc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1		CHEMBL4521096	=	IC50	nM	29000.0	CHEMBL1293289	Homo sapiens	IC50	uM	29.0
	18871582	CHEMBL4310093	Inhibition of BRD2 N-terminal bromodomain 1 (unknown origin) expressed in Escherichia coli Bl21(DE3) by alpha-screen assay	B	Cc1cc(C)cc(Nc2nccc(-c3c(-c4ccc(F)cc4)nnn3C3CCNCC3)n2)c1		CHEMBL4475135	=	IC50	nM	43000.0	CHEMBL1293289	Homo sapiens	IC50	uM	43.0
	18871583	CHEMBL4310093	Inhibition of BRD2 N-terminal bromodomain 1 (unknown origin) expressed in Escherichia coli Bl21(DE3) by alpha-screen assay	B	Cc1cc(C)cc(Nc2nccc(-c3c(CO)nnn3C3CCNCC3)n2)c1	Outside typical range	CHEMBL4533090	>	IC50	nM	250000.0	CHEMBL1293289	Homo sapiens	IC50	uM	250.0
	18871584	CHEMBL4310093	Inhibition of BRD2 N-terminal bromodomain 1 (unknown origin) expressed in Escherichia coli Bl21(DE3) by alpha-screen assay	B	Cc1cc(C)cc(Nc2nccc(-c3c(C)nnn3C3CCNCC3)n2)c1		CHEMBL4441390	=	IC50	nM	1800.0	CHEMBL1293289	Homo sapiens	IC50	uM	1.8
	18871585	CHEMBL4310094	Inhibition of BRD2 C-terminal bromodomain 2 (unknown origin) expressed in Escherichia coli Bl21(DE3) by alpha-screen assay	B	Cc1cc(C)cc(Nc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1		CHEMBL4521096	=	IC50	nM	67000.0	CHEMBL1293289	Homo sapiens	IC50	uM	67.0
	18871586	CHEMBL4310094	Inhibition of BRD2 C-terminal bromodomain 2 (unknown origin) expressed in Escherichia coli Bl21(DE3) by alpha-screen assay	B	Cc1cc(C)cc(Nc2nccc(-c3c(-c4ccc(F)cc4)nnn3C3CCNCC3)n2)c1		CHEMBL4475135	=	IC50	nM	30000.0	CHEMBL1293289	Homo sapiens	IC50	uM	30.0
	18871587	CHEMBL4310094	Inhibition of BRD2 C-terminal bromodomain 2 (unknown origin) expressed in Escherichia coli Bl21(DE3) by alpha-screen assay	B	Cc1cc(C)cc(Nc2nccc(-c3c(CO)nnn3C3CCNCC3)n2)c1	Outside typical range	CHEMBL4533090	=	IC50	nM	260000.0	CHEMBL1293289	Homo sapiens	IC50	uM	260.0
	18871588	CHEMBL4310094	Inhibition of BRD2 C-terminal bromodomain 2 (unknown origin) expressed in Escherichia coli Bl21(DE3) by alpha-screen assay	B	Cc1cc(C)cc(Nc2nccc(-c3c(C)nnn3C3CCNCC3)n2)c1		CHEMBL4441390	=	IC50	nM	12000.0	CHEMBL1293289	Homo sapiens	IC50	uM	12.0
	18881155	CHEMBL4312045	Inhibition of BRD2 (unknown origin) by TR-FRET assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	IC50	nM	19.0	CHEMBL1293289	Homo sapiens	IC50	uM	0.019
	18881156	CHEMBL4312045	Inhibition of BRD2 (unknown origin) by TR-FRET assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)NCCOCCOCCNC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL4436481	=	IC50	nM	35.0	CHEMBL1293289	Homo sapiens	IC50	uM	0.035
	18881157	CHEMBL4312045	Inhibition of BRD2 (unknown origin) by TR-FRET assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)NCCOCCOCCN)c1nnc(C)n1-2		CHEMBL4577491	=	IC50	nM	16.0	CHEMBL1293289	Homo sapiens	IC50	uM	0.016
	18881158	CHEMBL4312045	Inhibition of BRD2 (unknown origin) by TR-FRET assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)NCCOCCOCCNC(=O)CCCCCC1(C)C(/C=C/C=C/C=C3/N(CCCS(=O)(=O)O)c4ccc(S(=O)(=O)O)cc4C3(C)C)=[N+](CCCS(=O)(=O)[O-])c3ccc(S(=O)(=O)O)cc31)c1nnc(C)n1-2		CHEMBL4580852	>	IC50	nM	45000.0	CHEMBL1293289	Homo sapiens	IC50	uM	45.0
	18881159	CHEMBL4312045	Inhibition of BRD2 (unknown origin) by TR-FRET assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)NCCOCCOCCNC(=O)CS(=O)(=O)O)c1nnc(C)n1-2		CHEMBL4576135	=	IC50	nM	78.0	CHEMBL1293289	Homo sapiens	IC50	uM	0.078
	18881160	CHEMBL4312045	Inhibition of BRD2 (unknown origin) by TR-FRET assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)NCCOCCOCCNC(=O)C1C(C(=O)O)C(C(=O)O)C1C(=O)O)c1nnc(C)n1-2		CHEMBL4474387	=	IC50	nM	997.0	CHEMBL1293289	Homo sapiens	IC50	uM	0.997
	18885637	CHEMBL4313220	Displacement of Alexa Fluor 647 labelled ligand from His6-tagged BRD2 BD1 (1 to 473 residues)/BD2 Y386A mutant (unknown origin) after 30 mins by TR-FRET assay	B	CC1(C2CC2)NC(=O)N(CC(=O)Nc2ccc(Br)c(S(=O)(=O)N3CCCCC3)c2)C1=O		CHEMBL4583297	<	IC50	nM	50118.72	CHEMBL1293289	Homo sapiens	pIC50		4.3
	18885638	CHEMBL4313221	Displacement of Alexa Fluor 647 labelled ligand from His6-tagged BRD2 BD2 (1 to 473 residues)/BD1 Y113A mutant (unknown origin) after 30 mins by TR-FRET assay	B	CC1(C2CC2)NC(=O)N(CC(=O)Nc2ccc(Br)c(S(=O)(=O)N3CCCCC3)c2)C1=O		CHEMBL4583297	=	IC50	nM	19952.62	CHEMBL1293289	Homo sapiens	pIC50		4.7
	18956449	CHEMBL4332479	Binding affinity to recombinant human N-terminal TEV-cleavable hexa-histidine tagged BRD2 bromodomain2 assessed as change in melting temperature at 30 uM measured after 30 mins by SYPRO orange dye based differential scanning fluorimetry	B	COc1cc2c(cc1-c1c(C)noc1C)ncc1[nH]c(=O)n([C@H](C)c3ccccn3)c12		CHEMBL2017291	=	Delta Tm	degrees C	4.4	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	4.4
	18956450	CHEMBL4332479	Binding affinity to recombinant human N-terminal TEV-cleavable hexa-histidine tagged BRD2 bromodomain2 assessed as change in melting temperature at 30 uM measured after 30 mins by SYPRO orange dye based differential scanning fluorimetry	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461	=	Delta Tm	degrees C	6.3	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	6.3
	18956451	CHEMBL4332479	Binding affinity to recombinant human N-terminal TEV-cleavable hexa-histidine tagged BRD2 bromodomain2 assessed as change in melting temperature at 30 uM measured after 30 mins by SYPRO orange dye based differential scanning fluorimetry	B	Cc1ccc2ncccc2c1-c1cc(-c2c(C)noc2C)cc2nc(C3CC3)[nH]c12		CHEMBL3926851	=	Delta Tm	degrees C	10.6	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	10.6
	18956452	CHEMBL4332478	Binding affinity to recombinant human N-terminal TEV-cleavable hexa-histidine tagged BRD2 bromodomain1 assessed as change in melting temperature at 30 uM measured after 30 mins by SYPRO orange dye based differential scanning fluorimetry	B	COc1cc2c(cc1-c1c(C)noc1C)ncc1[nH]c(=O)n([C@H](C)c3ccccn3)c12		CHEMBL2017291	=	Delta Tm	degrees C	5.0	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	5.0
	18956453	CHEMBL4332478	Binding affinity to recombinant human N-terminal TEV-cleavable hexa-histidine tagged BRD2 bromodomain1 assessed as change in melting temperature at 30 uM measured after 30 mins by SYPRO orange dye based differential scanning fluorimetry	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461	=	Delta Tm	degrees C	3.9	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	3.9
	18956454	CHEMBL4332478	Binding affinity to recombinant human N-terminal TEV-cleavable hexa-histidine tagged BRD2 bromodomain1 assessed as change in melting temperature at 30 uM measured after 30 mins by SYPRO orange dye based differential scanning fluorimetry	B	Cc1ccc2ncccc2c1-c1cc(-c2c(C)noc2C)cc2nc(C3CC3)[nH]c12		CHEMBL3926851	=	Delta Tm	degrees C	9.6	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	9.6
	18956517	CHEMBL4332517	Binding affinity to human partial length BRD2 bromodomain 1 long isoform (K71 to N194 residues) expressed in bacterial expression system after 1 hr by bromoscan assay	B	Cc1ccc2ncccc2c1-c1cc(-c2c(C)noc2C)cc2nc(C3CC3)[nH]c12		CHEMBL3926851	=	Kd	nM	2.5	CHEMBL1293289	Homo sapiens	Kd	nM	2.5
	18956518	CHEMBL4332518	Binding affinity to BRD2 bromodomain 1/2 (unknown origin) after 1 hr by bromoscan assay	B	Cc1ccc2ncccc2c1-c1cc(-c2c(C)noc2C)cc2nc(C3CC3)[nH]c12		CHEMBL3926851	=	Kd	nM	1.1	CHEMBL1293289	Homo sapiens	Kd	nM	1.1
	18956519	CHEMBL4332519	Binding affinity to human partial length BRD2 bromodomain 2 isoform 1 (E348 to D455 residues) expressed in bacterial expression system after 1 hr by bromoscan assay	B	Cc1ccc2ncccc2c1-c1cc(-c2c(C)noc2C)cc2nc(C3CC3)[nH]c12		CHEMBL3926851	=	Kd	nM	0.59	CHEMBL1293289	Homo sapiens	Kd	nM	0.59
	19007181	CHEMBL4344652	Inhibition of human recombinant His-tagged BRD2 BD1 domain expressed in Escherichia coli BL21(DE3)-R3-pRARE2 cells by AlphaScreen assay	B	Cc1cc(-c2nc3sc4c(c3c(=O)[nH]2)CCN(C)C4)cc(C)c1OCCCCCC(=O)NO		CHEMBL4514808	=	IC50	nM	16400.0	CHEMBL1293289	Homo sapiens	IC50	uM	16.4
	19007182	CHEMBL4344652	Inhibition of human recombinant His-tagged BRD2 BD1 domain expressed in Escherichia coli BL21(DE3)-R3-pRARE2 cells by AlphaScreen assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	IC50	nM	155.0	CHEMBL1293289	Homo sapiens	IC50	uM	0.155
Not Determined	19007183	CHEMBL4344652	Inhibition of human recombinant His-tagged BRD2 BD1 domain expressed in Escherichia coli BL21(DE3)-R3-pRARE2 cells by AlphaScreen assay	B	O=C(CCCCCCC(=O)Nc1ccccc1)NO		CHEMBL98		IC50			CHEMBL1293289	Homo sapiens	IC50		
	19007184	CHEMBL4344651	Inhibition of human recombinant His-tagged BRD2 BD2 domain expressed in Escherichia coli BL21(DE3)-R3-pRARE2 cells by AlphaScreen assay	B	Cc1cc(-c2nc3sc4c(c3c(=O)[nH]2)CCN(C)C4)cc(C)c1OCCCCCC(=O)NO		CHEMBL4514808	>	IC50	nM	20000.0	CHEMBL1293289	Homo sapiens	IC50	uM	20.0
	19007185	CHEMBL4344651	Inhibition of human recombinant His-tagged BRD2 BD2 domain expressed in Escherichia coli BL21(DE3)-R3-pRARE2 cells by AlphaScreen assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	IC50	nM	17.0	CHEMBL1293289	Homo sapiens	IC50	uM	0.017
Not Determined	19007186	CHEMBL4344651	Inhibition of human recombinant His-tagged BRD2 BD2 domain expressed in Escherichia coli BL21(DE3)-R3-pRARE2 cells by AlphaScreen assay	B	O=C(CCCCCCC(=O)Nc1ccccc1)NO		CHEMBL98		IC50			CHEMBL1293289	Homo sapiens	IC50		
	19014778	CHEMBL4346370	Inhibition of N-terminal His6-tagged human BRD2 BD1 (73 to 194 residues) after 1 hr by TR-FRET assay	B	CCNC(=O)c1cc2c(-c3cc(C(C)(C)O)ccc3Oc3c(C)cc(F)cc3C)cn(C)c(=O)c2[nH]1		CHEMBL4297454	=	Ki	nM	1162.0	CHEMBL1293289	Homo sapiens	Ki	nM	1162.0
	19014779	CHEMBL4346371	Inhibition of N-terminal His6-tagged human BRD2 BD2 (348 to 455 residues) after 1 hr by TR-FRET assay	B	CCNC(=O)c1cc2c(-c3cc(C(C)(C)O)ccc3Oc3c(C)cc(F)cc3C)cn(C)c(=O)c2[nH]1		CHEMBL4297454	=	Ki	nM	4.6	CHEMBL1293289	Homo sapiens	Ki	nM	4.6
Not Active	19039958	CHEMBL4351640	Binding affinity to human partial length BRD2 bromodomain 2 isoform 1 (E348 to D455 residues) expressed in bacterial expression system at 1 uM by BROMOscan assay	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Activity			CHEMBL1293289	Homo sapiens	Activity		
Not Active	19039959	CHEMBL4351639	Binding affinity to human partial length BRD2 bromodomain 1 long isoform (K71 to N194 residues) expressed in bacterial expression system at 1 uM by BROMOscan assay	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Activity			CHEMBL1293289	Homo sapiens	Activity		
	19049590	CHEMBL4354446	Binding affinity to BRD2 bromodomain 1 (unknown origin) at 20 uM by Alpha screen assay relative to control	B	COc1ccc(Cl)cc1S(=O)(=O)Nc1ccc2[nH]c(=O)c3ccccc3c2c1		CHEMBL4469223	>	Activity	%	70.0	CHEMBL1293289	Homo sapiens	Activity	%	70.0
	19049591	CHEMBL4354447	Binding affinity to BRD2 bromodomain 2 (unknown origin) at 20 uM by Alpha screen assay relative to control	B	COc1ccc(Cl)cc1S(=O)(=O)Nc1ccc2[nH]c(=O)c3ccccc3c2c1		CHEMBL4469223	>	Activity	%	70.0	CHEMBL1293289	Homo sapiens	Activity	%	70.0
	19057643	CHEMBL4357129	Displacement of tetra-acetylated histone H4 peptide (1-21) from BRD2 BD1 (unknown origin) incubated for 30 mins followed by further incubation with tetra-acetylated histone H4 peptide (1-21) for 30 mins by Alphascreen assay	B	COc1ccccc1S(=O)(=O)Nc1ccc2c3c(cc(-n4cnc(C)c4)nc13)C(=O)N2C		CHEMBL4446421	=	IC50	nM	8948.0	CHEMBL1293289	Homo sapiens	IC50	nM	8948.0
	19057646	CHEMBL4357132	Displacement of tetra-acetylated histone H4 peptide (1-21) from BRD2 BD2 (unknown origin) incubated for 30 mins followed by further incubation with tetra-acetylated histone H4 peptide (1-21) for 30 mins by Alphascreen assay	B	COc1ccccc1S(=O)(=O)Nc1ccc2c3c(cc(-n4cnc(C)c4)nc13)C(=O)N2C		CHEMBL4446421	=	IC50	nM	21450.0	CHEMBL1293289	Homo sapiens	IC50	nM	21450.0
	19079068	CHEMBL4363364	Binding affinity to human recombinant BRD2 BD1 (72 to 205 residues) by fluorescence polarization assay	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461	=	Ki	nM	150.0	CHEMBL1293289	Homo sapiens	Ki	nM	150.0
	19079069	CHEMBL4363364	Binding affinity to human recombinant BRD2 BD1 (72 to 205 residues) by fluorescence polarization assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)Nc1ccc(O)cc1)c1nnc(C)n1-2		CHEMBL3581647	=	Ki	nM	33.2	CHEMBL1293289	Homo sapiens	Ki	nM	33.2
	19079070	CHEMBL4363364	Binding affinity to human recombinant BRD2 BD1 (72 to 205 residues) by fluorescence polarization assay	B	Cc1nnc2n1-c1ccc(-c3cnn(C)c3)cc1C(Nc1ccc(Cl)cc1)CC2		CHEMBL4471776	=	Ki	nM	275.0	CHEMBL1293289	Homo sapiens	Ki	nM	275.0
	19079071	CHEMBL4363364	Binding affinity to human recombinant BRD2 BD1 (72 to 205 residues) by fluorescence polarization assay	B	CCn1cc(-c2ccc3c(c2)C(Nc2ccc(Cl)cc2)CCc2nnc(C)n2-3)cn1		CHEMBL4438006	=	Ki	nM	193.0	CHEMBL1293289	Homo sapiens	Ki	nM	193.0
	19079072	CHEMBL4363364	Binding affinity to human recombinant BRD2 BD1 (72 to 205 residues) by fluorescence polarization assay	B	Cc1nnc2n1-c1ccc(-c3cn[nH]c3)cc1C(Nc1ccc(Cl)cc1)CC2		CHEMBL4533303	=	Ki	nM	270.0	CHEMBL1293289	Homo sapiens	Ki	nM	270.0
	19079073	CHEMBL4363364	Binding affinity to human recombinant BRD2 BD1 (72 to 205 residues) by fluorescence polarization assay	B	Cc1nnc2n1-c1ccc(-c3cnn(C)c3)cc1[C@H](Nc1ccc(Cl)cc1)CC2		CHEMBL4528047	=	Ki	nM	95.5	CHEMBL1293289	Homo sapiens	Ki	nM	95.5
	19079074	CHEMBL4363365	Binding affinity to human recombinant BRD2 BD2 (349 to 460 residues) by fluorescence polarization assay	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461	=	Ki	nM	74.0	CHEMBL1293289	Homo sapiens	Ki	nM	74.0
	19079075	CHEMBL4363365	Binding affinity to human recombinant BRD2 BD2 (349 to 460 residues) by fluorescence polarization assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)Nc1ccc(O)cc1)c1nnc(C)n1-2		CHEMBL3581647	=	Ki	nM	10.3	CHEMBL1293289	Homo sapiens	Ki	nM	10.3
	19079076	CHEMBL4363365	Binding affinity to human recombinant BRD2 BD2 (349 to 460 residues) by fluorescence polarization assay	B	Cc1nnc2n1-c1ccc(-c3cnn(C)c3)cc1C(Nc1ccc(Cl)cc1)CC2		CHEMBL4471776	=	Ki	nM	9.1	CHEMBL1293289	Homo sapiens	Ki	nM	9.1
	19079077	CHEMBL4363365	Binding affinity to human recombinant BRD2 BD2 (349 to 460 residues) by fluorescence polarization assay	B	CCn1cc(-c2ccc3c(c2)C(Nc2ccc(Cl)cc2)CCc2nnc(C)n2-3)cn1		CHEMBL4438006	=	Ki	nM	8.9	CHEMBL1293289	Homo sapiens	Ki	nM	8.9
	19079078	CHEMBL4363365	Binding affinity to human recombinant BRD2 BD2 (349 to 460 residues) by fluorescence polarization assay	B	Cc1nnc2n1-c1ccc(-c3cn[nH]c3)cc1C(Nc1ccc(Cl)cc1)CC2		CHEMBL4533303	=	Ki	nM	19.1	CHEMBL1293289	Homo sapiens	Ki	nM	19.1
	19079079	CHEMBL4363365	Binding affinity to human recombinant BRD2 BD2 (349 to 460 residues) by fluorescence polarization assay	B	Cc1nnc2n1-c1ccc(-c3cnn(C)c3)cc1[C@H](Nc1ccc(Cl)cc1)CC2		CHEMBL4528047	=	Ki	nM	3.1	CHEMBL1293289	Homo sapiens	Ki	nM	3.1
	19079173	CHEMBL4363368	Selectivity index, ratio of Ki for human recombinant BRD2 BD1 (72 to 205 residues) to Ki for human recombinant BRD2 BD2 (349 to 460 residues)	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461	=	Ratio Ki		2.0	CHEMBL1293289	Homo sapiens	Ratio Ki		2.0
	19079174	CHEMBL4363368	Selectivity index, ratio of Ki for human recombinant BRD2 BD1 (72 to 205 residues) to Ki for human recombinant BRD2 BD2 (349 to 460 residues)	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)Nc1ccc(O)cc1)c1nnc(C)n1-2		CHEMBL3581647	=	Ratio Ki		3.0	CHEMBL1293289	Homo sapiens	Ratio Ki		3.0
	19079175	CHEMBL4363368	Selectivity index, ratio of Ki for human recombinant BRD2 BD1 (72 to 205 residues) to Ki for human recombinant BRD2 BD2 (349 to 460 residues)	B	Cc1nnc2n1-c1ccc(-c3cnn(C)c3)cc1C(Nc1ccc(Cl)cc1)CC2		CHEMBL4471776	=	Ratio Ki		30.0	CHEMBL1293289	Homo sapiens	Ratio Ki		30.0
	19079176	CHEMBL4363368	Selectivity index, ratio of Ki for human recombinant BRD2 BD1 (72 to 205 residues) to Ki for human recombinant BRD2 BD2 (349 to 460 residues)	B	CCn1cc(-c2ccc3c(c2)C(Nc2ccc(Cl)cc2)CCc2nnc(C)n2-3)cn1		CHEMBL4438006	=	Ratio Ki		22.0	CHEMBL1293289	Homo sapiens	Ratio Ki		22.0
	19079177	CHEMBL4363368	Selectivity index, ratio of Ki for human recombinant BRD2 BD1 (72 to 205 residues) to Ki for human recombinant BRD2 BD2 (349 to 460 residues)	B	Cc1nnc2n1-c1ccc(-c3cn[nH]c3)cc1C(Nc1ccc(Cl)cc1)CC2		CHEMBL4533303	=	Ratio Ki		14.0	CHEMBL1293289	Homo sapiens	Ratio Ki		14.0
	19079178	CHEMBL4363368	Selectivity index, ratio of Ki for human recombinant BRD2 BD1 (72 to 205 residues) to Ki for human recombinant BRD2 BD2 (349 to 460 residues)	B	Cc1nnc2n1-c1ccc(-c3cnn(C)c3)cc1[C@H](Nc1ccc(Cl)cc1)CC2		CHEMBL4528047	=	Ratio Ki		31.0	CHEMBL1293289	Homo sapiens	Ratio Ki		31.0
	19079183	CHEMBL4363370	Binding affinity to human partial length BRD2 BD1 isoform 1 (K71 to N194 residues) expressed in bacterial expression system by bromoscan assay	B	Cc1nnc2n1-c1ccc(-c3cnn(C)c3)cc1[C@H](Nc1ccc(Cl)cc1)CC2		CHEMBL4528047	=	Kd	nM	45.0	CHEMBL1293289	Homo sapiens	Kd	nM	45.0
	19079184	CHEMBL4363371	Binding affinity to human partial length BRD2 BD2 isoform 1 (E348 to D455 residues) expressed in bacterial expression system by bromoscan assay	B	Cc1nnc2n1-c1ccc(-c3cnn(C)c3)cc1[C@H](Nc1ccc(Cl)cc1)CC2		CHEMBL4528047	=	Kd	nM	1.2	CHEMBL1293289	Homo sapiens	Kd	nM	1.2
	19079191	CHEMBL4363378	Selectivity ratio of Kd for human partial length BRD2 BD1 isoform 1 (K71 to N194 residues) expressed in bacterial expression system to Kd for human partial length BRD2 BD2 isoform 1 (E348 to D455 residues) expressed in bacterial expression system	B	Cc1nnc2n1-c1ccc(-c3cnn(C)c3)cc1[C@H](Nc1ccc(Cl)cc1)CC2		CHEMBL4528047	=	Selectivity ratio		38.0	CHEMBL1293289	Homo sapiens	Selectivity ratio		38.0
	19160083	CHEMBL4382970	Binding affinity to human BRD2 BD1 (72 to 205 residues) by fluorescence polarization assay	B	Cc1nnc2n1-c1sc(C#Cc3cnn(C)c3)c(Cc3ccccc3)c1COC2		CHEMBL4555209	=	IC50	nM	3.5	CHEMBL1293289	Homo sapiens	IC50	nM	3.5
	19160084	CHEMBL4382971	Binding affinity to human BRD2 BD2 (349 to 460 residues) by fluorescence polarization assay	B	Cc1nnc2n1-c1sc(C#Cc3cnn(C)c3)c(Cc3ccccc3)c1COC2		CHEMBL4555209	=	IC50	nM	40.6	CHEMBL1293289	Homo sapiens	IC50	nM	40.6
	19160267	CHEMBL4382970	Binding affinity to human BRD2 BD1 (72 to 205 residues) by fluorescence polarization assay	B	Cc1nnc2n1-c1sc(C#Cc3cnn(C)c3)c(Cc3ccccc3)c1COC2		CHEMBL4555209	=	Ki	nM	1.7	CHEMBL1293289	Homo sapiens	Ki	nM	1.7
	19160268	CHEMBL4382971	Binding affinity to human BRD2 BD2 (349 to 460 residues) by fluorescence polarization assay	B	Cc1nnc2n1-c1sc(C#Cc3cnn(C)c3)c(Cc3ccccc3)c1COC2		CHEMBL4555209	=	Ki	nM	8.5	CHEMBL1293289	Homo sapiens	Ki	nM	8.5
	19265550	CHEMBL4405073	Binding affinity to human partial length BRD2 BD2 isoform 1 (E348 to D455 residues) expressed in bacterial expression system by bromoscan assay	B	CCS(=O)(=O)Cc1cnc(Oc2ccc(F)cc2F)c(-c2cc(C)c3c(=O)[nH]ccn23)c1		CHEMBL4440098	=	Kd	nM	1.3	CHEMBL1293289	Homo sapiens	Kd	nM	1.3
	19267664	CHEMBL4405931	Binding affinity to recombinant BRD2 BD1 (unknown origin) incubated for 1 hr by TR-FRET assay	B	COc1cc(OC)c2c(=O)[nH]c(-c3cc(C)c(OCCO)c(C)c3)nc2c1		CHEMBL2393130	=	Kd	nM	5780.0	CHEMBL1293289	Homo sapiens	Kd	nM	5780.0
	19267665	CHEMBL4405931	Binding affinity to recombinant BRD2 BD1 (unknown origin) incubated for 1 hr by TR-FRET assay	B	COc1cc(OC)c2c(=O)cc(-c3cc(C)c(OC[C@@H](O)CN4CCCCC4)c(C)c3)oc2c1		CHEMBL4549898	=	Kd	nM	1205.0	CHEMBL1293289	Homo sapiens	Kd	nM	1205.0
	19267666	CHEMBL4405931	Binding affinity to recombinant BRD2 BD1 (unknown origin) incubated for 1 hr by TR-FRET assay	B	COc1cc(OC)c2c(=O)cc(-c3cc(C)c(OC[C@@H](O)CN4CCN(C)CC4)c(C)c3)oc2c1		CHEMBL4517875	=	Kd	nM	1286.0	CHEMBL1293289	Homo sapiens	Kd	nM	1286.0
	19267667	CHEMBL4405931	Binding affinity to recombinant BRD2 BD1 (unknown origin) incubated for 1 hr by TR-FRET assay	B	COc1cc(OC)c2c(=O)cc(-c3cc(C)c(OC[C@H](O)CN4CCCCC4)c(C)c3)oc2c1		CHEMBL4455209	=	Kd	nM	791.0	CHEMBL1293289	Homo sapiens	Kd	nM	791.0
	19267668	CHEMBL4405931	Binding affinity to recombinant BRD2 BD1 (unknown origin) incubated for 1 hr by TR-FRET assay	B	COc1cc(OC)c2c(=O)cc(-c3cc(C)c(OC[C@H](O)CN4CCN(C)CC4)c(C)c3)oc2c1		CHEMBL4557050	=	Kd	nM	886.0	CHEMBL1293289	Homo sapiens	Kd	nM	886.0
	19267669	CHEMBL4405931	Binding affinity to recombinant BRD2 BD1 (unknown origin) incubated for 1 hr by TR-FRET assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	Kd	nM	78.0	CHEMBL1293289	Homo sapiens	Kd	nM	78.0
	19267670	CHEMBL4405932	Binding affinity to recombinant BRD2 BD2 (unknown origin) incubated for 1 hr by TR-FRET assay	B	COc1cc(OC)c2c(=O)[nH]c(-c3cc(C)c(OCCO)c(C)c3)nc2c1		CHEMBL2393130	=	Kd	nM	251.0	CHEMBL1293289	Homo sapiens	Kd	nM	251.0
	19267671	CHEMBL4405932	Binding affinity to recombinant BRD2 BD2 (unknown origin) incubated for 1 hr by TR-FRET assay	B	COc1cc(OC)c2c(=O)cc(-c3cc(C)c(OC[C@@H](O)CN4CCCCC4)c(C)c3)oc2c1		CHEMBL4549898	=	Kd	nM	1196.0	CHEMBL1293289	Homo sapiens	Kd	nM	1196.0
	19267672	CHEMBL4405932	Binding affinity to recombinant BRD2 BD2 (unknown origin) incubated for 1 hr by TR-FRET assay	B	COc1cc(OC)c2c(=O)cc(-c3cc(C)c(OC[C@@H](O)CN4CCN(C)CC4)c(C)c3)oc2c1		CHEMBL4517875	=	Kd	nM	1437.0	CHEMBL1293289	Homo sapiens	Kd	nM	1437.0
	19267673	CHEMBL4405932	Binding affinity to recombinant BRD2 BD2 (unknown origin) incubated for 1 hr by TR-FRET assay	B	COc1cc(OC)c2c(=O)cc(-c3cc(C)c(OC[C@H](O)CN4CCCCC4)c(C)c3)oc2c1		CHEMBL4455209	=	Kd	nM	845.0	CHEMBL1293289	Homo sapiens	Kd	nM	845.0
	19267674	CHEMBL4405932	Binding affinity to recombinant BRD2 BD2 (unknown origin) incubated for 1 hr by TR-FRET assay	B	COc1cc(OC)c2c(=O)cc(-c3cc(C)c(OC[C@H](O)CN4CCN(C)CC4)c(C)c3)oc2c1		CHEMBL4557050	=	Kd	nM	914.0	CHEMBL1293289	Homo sapiens	Kd	nM	914.0
	19267675	CHEMBL4405932	Binding affinity to recombinant BRD2 BD2 (unknown origin) incubated for 1 hr by TR-FRET assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	Kd	nM	52.0	CHEMBL1293289	Homo sapiens	Kd	nM	52.0
	19307844	CHEMBL4415494	Binding affinity to human partial length BRD2 bromodomain 1 isoform 1 (K71 to N194 residues) expressed in Escherichia coli BL21 cells assessed as residual binding level at 1 uM measured after 1 hr by quantitative PCR based BROMOscan assay relative to control	B	Cc1ccc(-n2nc(C(=O)N3C[C@H](C)N[C@H](C)C3)nc2-c2ccc3c(c2)N(C2CCCC2)[C@H](C)C(=O)N3C)cc1		CHEMBL4451357	<=	Activity	%	5.0	CHEMBL1293289	Homo sapiens	Activity	%	5.0
	19307845	CHEMBL4415495	Binding affinity to human partial length BRD2 bromodomain 2 isoform 1 (E348 to D455 residues) expressed in Escherichia coli BL21 cells assessed as residual binding level at 1 uM measured after 1 hr by quantitative PCR based BROMOscan assay relative to control	B	Cc1ccc(-n2nc(C(=O)N3C[C@H](C)N[C@H](C)C3)nc2-c2ccc3c(c2)N(C2CCCC2)[C@H](C)C(=O)N3C)cc1		CHEMBL4451357	<=	Activity	%	5.0	CHEMBL1293289	Homo sapiens	Activity	%	5.0
Active	19307871	CHEMBL4415519	Inhibition of BRD2 bromodomain 1 (unknown origin)	B	Cc1ccc(-n2c(C)nnc2-c2ccc3c(c2)N(C2CC2)C(C)C(=O)N3C)cc1		CHEMBL4578490		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Active	19307872	CHEMBL4415519	Inhibition of BRD2 bromodomain 1 (unknown origin)	B	Cc1ccc(-n2c(C)nnc2-c2ccc3c(c2)N(C2CCCC2)[C@H](C)C(=O)N3C)cc1		CHEMBL4463165		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Active	19307873	CHEMBL4415519	Inhibition of BRD2 bromodomain 1 (unknown origin)	B	Cc1ccc(-n2nc(C(=O)N3CCN(C)CC3)nc2-c2ccc3c(c2)N(C2CCCC2)[C@H](C)C(=O)N3C)cc1		CHEMBL4573400		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Active	19307874	CHEMBL4415519	Inhibition of BRD2 bromodomain 1 (unknown origin)	B	Cc1ccc(-n2nc(C(=O)N(C)CCN(C)C)nc2-c2ccc3c(c2)N(C2CCCC2)[C@H](C)C(=O)N3C)cc1		CHEMBL4577433		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Active	19307875	CHEMBL4415519	Inhibition of BRD2 bromodomain 1 (unknown origin)	B	Cc1ccc(-n2nc(C(=O)N3C[C@H](C)N[C@H](C)C3)nc2-c2ccc3c(c2)N(C2CCCC2)[C@H](C)C(=O)N3C)cc1		CHEMBL4451357		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Active	19307876	CHEMBL4415519	Inhibition of BRD2 bromodomain 1 (unknown origin)	B	Cc1ccc(-n2nc(C(=O)N3CCCN(C)CC3)nc2-c2ccc3c(c2)N(C2CCCC2)[C@H](C)C(=O)N3C)cc1		CHEMBL4449874		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Active	19307877	CHEMBL4415519	Inhibition of BRD2 bromodomain 1 (unknown origin)	B	Cc1ccc(-n2nc(C(=O)N3CC4CCC(C3)N4C)nc2-c2ccc3c(c2)N(C2CCCC2)[C@H](C)C(=O)N3C)cc1		CHEMBL4583525		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Active	19307878	CHEMBL4415519	Inhibition of BRD2 bromodomain 1 (unknown origin)	B	Cc1ccc(-n2nc(C(=O)N3C4CCC3CN(C)C4)nc2-c2ccc3c(c2)N(C2CCCC2)[C@H](C)C(=O)N3C)cc1		CHEMBL4553774		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Active	19307879	CHEMBL4415519	Inhibition of BRD2 bromodomain 1 (unknown origin)	B	Cc1ccc(-n2nc(C(=O)N3CCN4CCCC4C3)nc2-c2ccc3c(c2)N(C2CCCC2)[C@H](C)C(=O)N3C)cc1		CHEMBL4454674		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Active	19307880	CHEMBL4415519	Inhibition of BRD2 bromodomain 1 (unknown origin)	B	Cc1ccc(-n2nc(C(=O)N3CCN(C)CC3)nc2-c2ccc3c(c2)N(C2CCCC2)[C@H](C)C(=O)N3C)cc1F		CHEMBL4550548		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Active	19307881	CHEMBL4415520	Inhibition of BRD2 bromodomain 2 (unknown origin)	B	Cc1ccc(-n2c(C)nnc2-c2ccc3c(c2)N(C2CC2)C(C)C(=O)N3C)cc1		CHEMBL4578490		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Active	19307882	CHEMBL4415520	Inhibition of BRD2 bromodomain 2 (unknown origin)	B	Cc1ccc(-n2c(C)nnc2-c2ccc3c(c2)N(C2CCCC2)[C@H](C)C(=O)N3C)cc1		CHEMBL4463165		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Active	19307883	CHEMBL4415520	Inhibition of BRD2 bromodomain 2 (unknown origin)	B	Cc1ccc(-n2nc(C(=O)N3CCN(C)CC3)nc2-c2ccc3c(c2)N(C2CCCC2)[C@H](C)C(=O)N3C)cc1		CHEMBL4573400		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Active	19307884	CHEMBL4415520	Inhibition of BRD2 bromodomain 2 (unknown origin)	B	Cc1ccc(-n2nc(C(=O)N(C)CCN(C)C)nc2-c2ccc3c(c2)N(C2CCCC2)[C@H](C)C(=O)N3C)cc1		CHEMBL4577433		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Active	19307885	CHEMBL4415520	Inhibition of BRD2 bromodomain 2 (unknown origin)	B	Cc1ccc(-n2nc(C(=O)N3C[C@H](C)N[C@H](C)C3)nc2-c2ccc3c(c2)N(C2CCCC2)[C@H](C)C(=O)N3C)cc1		CHEMBL4451357		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Active	19307886	CHEMBL4415520	Inhibition of BRD2 bromodomain 2 (unknown origin)	B	Cc1ccc(-n2nc(C(=O)N3CCCN(C)CC3)nc2-c2ccc3c(c2)N(C2CCCC2)[C@H](C)C(=O)N3C)cc1		CHEMBL4449874		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Active	19307887	CHEMBL4415520	Inhibition of BRD2 bromodomain 2 (unknown origin)	B	Cc1ccc(-n2nc(C(=O)N3CC4CCC(C3)N4C)nc2-c2ccc3c(c2)N(C2CCCC2)[C@H](C)C(=O)N3C)cc1		CHEMBL4583525		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Active	19307888	CHEMBL4415520	Inhibition of BRD2 bromodomain 2 (unknown origin)	B	Cc1ccc(-n2nc(C(=O)N3C4CCC3CN(C)C4)nc2-c2ccc3c(c2)N(C2CCCC2)[C@H](C)C(=O)N3C)cc1		CHEMBL4553774		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Active	19307889	CHEMBL4415520	Inhibition of BRD2 bromodomain 2 (unknown origin)	B	Cc1ccc(-n2nc(C(=O)N3CCN4CCCC4C3)nc2-c2ccc3c(c2)N(C2CCCC2)[C@H](C)C(=O)N3C)cc1		CHEMBL4454674		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Active	19307890	CHEMBL4415520	Inhibition of BRD2 bromodomain 2 (unknown origin)	B	Cc1ccc(-n2nc(C(=O)N3CCN(C)CC3)nc2-c2ccc3c(c2)N(C2CCCC2)[C@H](C)C(=O)N3C)cc1F		CHEMBL4550548		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
	19445989	CHEMBL4432582	Inhibition of human BRD2 bromodomain 1 expressed in bacterial expression system	B	COc1nnc2ccc(N3CCC(c4ccc(OCCN5CCN(C)C(=O)[C@H]5C)cc4)CC3)nn12		CHEMBL4078100	=	Ki	nM	100.0	CHEMBL1293289	Homo sapiens	pKi		7.0
	19445994	CHEMBL4432587	Inhibition of human BRD2 bromodomain 2 expressed in bacterial expression system	B	COc1nnc2ccc(N3CCC(c4ccc(OCCN5CCN(C)C(=O)[C@H]5C)cc4)CC3)nn12		CHEMBL4078100	=	Ki	nM	251.19	CHEMBL1293289	Homo sapiens	pKi		6.6
	20638643	CHEMBL4612479	Binding affinity to human partial length BRD2 bromodomain 1 isoform 1(K71 to N194 residues) expressed in bacterial expression system by BROMOscan assay	B	CCS(=O)(=O)Nc1cc(-c2cn(C)c3c(=O)[nH]ccc23)cc2c1ccn2C(C)(c1ccccn1)c1ccccn1		CHEMBL4648912	<	Kd	nM	1.0	CHEMBL1293289	Homo sapiens	Kd	nM	1.0
	20638644	CHEMBL4612480	Binding affinity to human partial length BRD2 bromodomain 2 isoform 1 (E348 to D455 residues) expressed in bacterial expression system by BROMOscan assay	B	CCS(=O)(=O)Nc1cc(-c2cn(C)c3c(=O)[nH]ccc23)cc2c1ccn2C(C)(c1ccccn1)c1ccccn1		CHEMBL4648912	<	Kd	nM	1.0	CHEMBL1293289	Homo sapiens	Kd	nM	1.0
	20638645	CHEMBL4612481	Binding affinity to human BRD2 isoform 1 bromodomain 1 and 2 (K71 to D455 residues) expressed in bacterial expression system by BROMOscan assay	B	CCS(=O)(=O)Nc1cc(-c2cn(C)c3c(=O)[nH]ccc23)cc2c1ccn2C(C)(c1ccccn1)c1ccccn1		CHEMBL4648912	<	Kd	nM	1.0	CHEMBL1293289	Homo sapiens	Kd	nM	1.0
Not Active	20679740	CHEMBL4622539	Inhibition of human partial length BRD2 bromodomain 1 long isoform (K71 to N194 residues) expressed in bacterial expression system by BROMOscan assay	B	CNC(=O)c1cc(C(=O)N[C@H]2[C@H]3COC[C@H]32)cc2c1O[C@H](CF)[C@H]2c1ccccc1		CHEMBL4637298		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Not Active	20679741	CHEMBL4622540	Inhibition of human partial length BRD2 bromodomain 1/2 isoform 1 (K71 to D455 residues) by BROMOscan assay	B	CNC(=O)c1cc(C(=O)N[C@H]2[C@H]3COC[C@H]32)cc2c1O[C@H](CF)[C@H]2c1ccccc1		CHEMBL4637298		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Not Active	20679742	CHEMBL4622541	Inhibition of human partial length BRD2 bromodomain 2 isoform 1 (E348 to D455 residues) expressed in bacterial expression system by BROMOscan assay	B	CNC(=O)c1cc(C(=O)N[C@H]2[C@H]3COC[C@H]32)cc2c1O[C@H](CF)[C@H]2c1ccccc1		CHEMBL4637298		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
	20692792	CHEMBL4625973	Binding affinity to 6His-Thr-BRD2 (1 to 473 residues) BD1 domain (unknown origin) incubated for 30 mins by TR-FRET assay	B	CNC(=O)c1ccc(=O)n(Cc2cc(Br)ccc2F)c1		CHEMBL4637442	=	IC50	nM	31622.78	CHEMBL1293289	Homo sapiens	pIC50		4.5
	20692793	CHEMBL4625973	Binding affinity to 6His-Thr-BRD2 (1 to 473 residues) BD1 domain (unknown origin) incubated for 30 mins by TR-FRET assay	B	CNC(=O)c1ccc(=O)n(Cc2ccccc2)c1		CHEMBL4639878	=	IC50	nM	15848.93	CHEMBL1293289	Homo sapiens	pIC50		4.8
	20692794	CHEMBL4625973	Binding affinity to 6His-Thr-BRD2 (1 to 473 residues) BD1 domain (unknown origin) incubated for 30 mins by TR-FRET assay	B	CNC(=O)c1cccn(Cc2ccccc2)c1=O		CHEMBL4633353	=	IC50	nM	15848.93	CHEMBL1293289	Homo sapiens	pIC50		4.8
	20692795	CHEMBL4625973	Binding affinity to 6His-Thr-BRD2 (1 to 473 residues) BD1 domain (unknown origin) incubated for 30 mins by TR-FRET assay	B	CNC(=O)c1cc(C(=O)NC2CC2)cn(Cc2ccccc2)c1=O		CHEMBL4635134	=	IC50	nM	25118.86	CHEMBL1293289	Homo sapiens	pIC50		4.6
	20692796	CHEMBL4625973	Binding affinity to 6His-Thr-BRD2 (1 to 473 residues) BD1 domain (unknown origin) incubated for 30 mins by TR-FRET assay	B	CNC(=O)c1cc(C(=O)NC2CC2)cn(Cc2cccc3[nH]ccc23)c1=O		CHEMBL4648431	<	IC50	nM	50118.72	CHEMBL1293289	Homo sapiens	pIC50		4.3
	20696167	CHEMBL4626982	Displacement of Alexa Fluor 647 labelled I-BET762 from N-terminal His6-tagged human BRD2 BD1 (1 to 473 residues)/BD2 Y386A mutant expressed in Escherichia coli after 1 hr by TR-FRET assay	B	COCc1nc2cnc3cc(-c4c(C)noc4C)c(OC[C@H]4CCNC4)cc3c2n1[C@H](C)c1ccccc1		CHEMBL4639128	=	IC50	nM	79.43	CHEMBL1293289	Homo sapiens	pIC50		7.1
	20696224	CHEMBL4626978	Displacement of Alexa Fluor 647 labelled I-BET762 from N-terminal His6-tagged human BRD2 BD2 (1 to 473 residues)/BD1 Y113A mutant expressed in Escherichia coli after 1 hr by TR-FRET assay	B	COCc1nc2cnc3cc(-c4c(C)noc4C)c(OC[C@H]4CCNC4)cc3c2n1[C@H](C)c1ccccc1		CHEMBL4639128	=	IC50	nM	3162.28	CHEMBL1293289	Homo sapiens	pIC50		5.5
	20696248	CHEMBL4626982	Displacement of Alexa Fluor 647 labelled I-BET762 from N-terminal His6-tagged human BRD2 BD1 (1 to 473 residues)/BD2 Y386A mutant expressed in Escherichia coli after 1 hr by TR-FRET assay	B	COc1cc2c(cc1-c1c(C)noc1C)ncc1[nH]c(=O)n([C@H](C)c3ccccn3)c12		CHEMBL2017291	=	IC50	nM	50.12	CHEMBL1293289	Homo sapiens	pIC50		7.3
	20696252	CHEMBL4626978	Displacement of Alexa Fluor 647 labelled I-BET762 from N-terminal His6-tagged human BRD2 BD2 (1 to 473 residues)/BD1 Y113A mutant expressed in Escherichia coli after 1 hr by TR-FRET assay	B	COc1cc2c(cc1-c1c(C)noc1C)ncc1[nH]c(=O)n([C@H](C)c3ccccn3)c12		CHEMBL2017291	=	IC50	nM	199.53	CHEMBL1293289	Homo sapiens	pIC50		6.7
	20696265	CHEMBL4626982	Displacement of Alexa Fluor 647 labelled I-BET762 from N-terminal His6-tagged human BRD2 BD1 (1 to 473 residues)/BD2 Y386A mutant expressed in Escherichia coli after 1 hr by TR-FRET assay	B	COCc1nc2cnc3cc(-c4c(C)noc4C)c(OC)cc3c2n1[C@H](C)c1ccccc1		CHEMBL4635329	=	IC50	nM	12.59	CHEMBL1293289	Homo sapiens	pIC50		7.9
	20696269	CHEMBL4626978	Displacement of Alexa Fluor 647 labelled I-BET762 from N-terminal His6-tagged human BRD2 BD2 (1 to 473 residues)/BD1 Y113A mutant expressed in Escherichia coli after 1 hr by TR-FRET assay	B	COCc1nc2cnc3cc(-c4c(C)noc4C)c(OC)cc3c2n1[C@H](C)c1ccccc1		CHEMBL4635329	=	IC50	nM	39.81	CHEMBL1293289	Homo sapiens	pIC50		7.4
	20696277	CHEMBL4626991	Binding affinity to BRD2 BD2 (unknown origin) by isothermal titration calorimetric method	B	CC(=O)NCCCCn1c2c(c3ccccc31)C(=O)NCC2	Outside typical range	CHEMBL3770724	>	Kd	nM	300000.0	CHEMBL1293289	Homo sapiens	Kd	uM	300.0
	20696280	CHEMBL4626989	Binding affinity to BRD2 BD1 (unknown origin) by isothermal titration calorimetric method	B	CC(=O)NCCCCn1c2c(c3ccccc31)C(=O)NCC2		CHEMBL3770724	=	Kd	nM	3300.0	CHEMBL1293289	Homo sapiens	Kd	uM	3.3
	20696288	CHEMBL4626984	Binding affinity to BRD2 BD1 (unknown origin) by fluorescence anisotropy competition binding assay	B	CC(=O)NCCCCn1c2c(c3ccccc31)C(=O)NCC2		CHEMBL3770724	=	Ki	nM	17200.0	CHEMBL1293289	Homo sapiens	Ki	uM	17.2
	22069280	CHEMBL4650066	Thermal Shift Assay. Domain start/stop: K71-N194	B	CCOC(=O)Nc1cc(-c2ccc(C)c(NS(C)(=O)=O)c2)nn2c(C)nnc12		CHEMBL3133807	=	Delta TM	C	5.24	CHEMBL1293289	Homo sapiens	Delta TM	C	5.24
	22069281	CHEMBL4650066	Thermal Shift Assay. Domain start/stop: K71-N194	B	CCC(=O)N1CCOc2c(cc(-c3ccc(OC)c(OC)c3)cc2OCC2CCCN(C)C2)C1		CHEMBL3906203	=	Delta TM	C	2.1	CHEMBL1293289	Homo sapiens	Delta TM	C	2.1
	22069282	CHEMBL4650066	Thermal Shift Assay. Domain start/stop: K71-N194	B	COc1ccc(CCc2nc3cc(-c4c(C)noc4C)ccc3n2C[C@H](C)N2CCOCC2)cc1Cl		CHEMBL3622373	=	Delta TM	C	0.99	CHEMBL1293289	Homo sapiens	Delta TM	C	0.99
	22069283	CHEMBL4650066	Thermal Shift Assay. Domain start/stop: K71-N194	B	O=C(C=CN1C[C@H]2C[C@@H]1CN2c1ccccn1)c1ccccc1O		CHEMBL4650213	=	Delta TM	C	0.4	CHEMBL1293289	Homo sapiens	Delta TM	C	0.4
	22069284	CHEMBL4650066	Thermal Shift Assay. Domain start/stop: K71-N194	B	COc1ccccc1S(=O)(=O)Nc1ccc2c(c1)CN(C)C(=O)N2		CHEMBL2179387	=	Delta TM	C	4.61	CHEMBL1293289	Homo sapiens	Delta TM	C	4.61
	22069285	CHEMBL4650067	Thermal Shift Assay. Domain start/stop: K71-N194	B	CCOC(=O)Nc1cc(-c2ccc(C)c(NS(C)(=O)=O)c2)nn2c(C)nnc12		CHEMBL3133807	=	Delta TM	C	4.68	CHEMBL1293289	Homo sapiens	Delta TM	C	4.68
	22069286	CHEMBL4650067	Thermal Shift Assay. Domain start/stop: K71-N194	B	CCC(=O)N1CCOc2c(cc(-c3ccc(OC)c(OC)c3)cc2OCC2CCCN(C)C2)C1		CHEMBL3906203	=	Delta TM	C	1.08	CHEMBL1293289	Homo sapiens	Delta TM	C	1.08
	22069287	CHEMBL4650067	Thermal Shift Assay. Domain start/stop: K71-N194	B	COc1ccccc1S(=O)(=O)Nc1ccc2c(c1)CN(C)C(=O)N2		CHEMBL2179387	=	Delta TM	C	3.1	CHEMBL1293289	Homo sapiens	Delta TM	C	3.1
	22069288	CHEMBL4650067	Thermal Shift Assay. Domain start/stop: K71-N194	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	Delta TM	C	5.58	CHEMBL1293289	Homo sapiens	Delta TM	C	5.58
	22069289	CHEMBL4650069	Thermal Shift Assay. Domain start/stop: E348-D455	B	CCOC(=O)Nc1cc(-c2ccc(C)c(NS(C)(=O)=O)c2)nn2c(C)nnc12		CHEMBL3133807	=	Delta TM	C	6.23	CHEMBL1293289	Homo sapiens	Delta TM	C	6.23
	22069290	CHEMBL4650069	Thermal Shift Assay. Domain start/stop: E348-D455	B	CCC(=O)N1CCOc2c(cc(-c3ccc(OC)c(OC)c3)cc2OCC2CCCN(C)C2)C1		CHEMBL3906203	=	Delta TM	C	1.23	CHEMBL1293289	Homo sapiens	Delta TM	C	1.23
	22069291	CHEMBL4650069	Thermal Shift Assay. Domain start/stop: E348-D455	B	COc1ccc(CCc2nc3cc(-c4c(C)noc4C)ccc3n2C[C@H](C)N2CCOCC2)cc1Cl		CHEMBL3622373	=	Delta TM	C	1.41	CHEMBL1293289	Homo sapiens	Delta TM	C	1.41
	22069292	CHEMBL4650069	Thermal Shift Assay. Domain start/stop: E348-D455	B	O=C(C=CN1C[C@H]2C[C@@H]1CN2c1ccccn1)c1ccccc1O		CHEMBL4650213	=	Delta TM	C	0.0	CHEMBL1293289	Homo sapiens	Delta TM	C	0.0
	22069293	CHEMBL4650069	Thermal Shift Assay. Domain start/stop: E348-D455	B	COc1ccccc1S(=O)(=O)Nc1ccc2c(c1)CN(C)C(=O)N2		CHEMBL2179387	=	Delta TM	C	5.32	CHEMBL1293289	Homo sapiens	Delta TM	C	5.32
	22069294	CHEMBL4650069	Thermal Shift Assay. Domain start/stop: E348-D455	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	Delta TM	C	8.16	CHEMBL1293289	Homo sapiens	Delta TM	C	8.16
	22069295	CHEMBL4650068	Thermal Shift Assay. Domain start/stop: K71-N194	B	COc1cc(C#N)ccc1S(=O)(=O)Nc1ccc2c(c1)cc(C)c(=O)n2C		CHEMBL3752151	=	Delta TM	C	0.62	CHEMBL1293289	Homo sapiens	Delta TM	C	0.62
	22069296	CHEMBL4650068	Thermal Shift Assay. Domain start/stop: K71-N194	B	COc1cc2c(cc1NS(=O)(=O)c1ccc(Br)cc1C)n(C)c(=O)n2C		CHEMBL3770173	=	Delta TM	C	1.41	CHEMBL1293289	Homo sapiens	Delta TM	C	1.41
	22069297	CHEMBL4650068	Thermal Shift Assay. Domain start/stop: K71-N194	B	Cc1cc(=O)n(C)c2cc(N3C(=O)CC[C@@H](NS(=O)(=O)CC(C)C)[C@@H]3c3ccc(Cl)cc3)ccc12		CHEMBL4650212	=	Delta TM	C	0.38	CHEMBL1293289	Homo sapiens	Delta TM	C	0.38
	22069298	CHEMBL4650068	Thermal Shift Assay. Domain start/stop: K71-N194	B	CCCS(=O)(=O)c1nc(NC2CC2)cc(-c2ccc3c(ccn3C3CC(C)(C)NC(C)(C)C3)c2)n1		CHEMBL3785432	=	Delta TM	C	0.54	CHEMBL1293289	Homo sapiens	Delta TM	C	0.54
	22069299	CHEMBL4650068	Thermal Shift Assay. Domain start/stop: K71-N194	B	CCn1cc(-c2cccc(C(F)(F)F)c2)c2sc(C(=N)NC3CCS(=O)(=O)CC3)cc2c1=O		CHEMBL3769507	=	Delta TM	C	2.54	CHEMBL1293289	Homo sapiens	Delta TM	C	2.54
	22069300	CHEMBL4650068	Thermal Shift Assay. Domain start/stop: K71-N194	B	COc1ccccc1C(=O)Nc1cc2c(cc1N1CCCC1)n(C)c(=O)n2C		CHEMBL3356143	=	Delta TM	C	0.75	CHEMBL1293289	Homo sapiens	Delta TM	C	0.75
	22069301	CHEMBL4650068	Thermal Shift Assay. Domain start/stop: K71-N194	B	Cc1nnc2c3ccccc3c(N[C@@H](C)[C@H](c3ccccc3)N(C)C)nn12		CHEMBL4570969	=	Delta TM	C	-0.06	CHEMBL1293289	Homo sapiens	Delta TM	C	-0.06
	22069302	CHEMBL4650068	Thermal Shift Assay. Domain start/stop: K71-N194	B	CC(=O)c1cc(-c2cc(C(=O)NC3CC3)ccc2C)c2ncccn12		CHEMBL4065619	=	Delta TM	C	1.14	CHEMBL1293289	Homo sapiens	Delta TM	C	1.14
	22069303	CHEMBL4650068	Thermal Shift Assay. Domain start/stop: K71-N194	B	Cn1cc(CCn2cnc(-c3cnn(C)c3)c2-c2ccc(C#N)cc2)cn1		CHEMBL4296718	=	Delta TM	C	0.06	CHEMBL1293289	Homo sapiens	Delta TM	C	0.06
	22069304	CHEMBL4650070	Thermal Shift Assay. Domain start/stop: E348-D455	B	COc1cc(C#N)ccc1S(=O)(=O)Nc1ccc2c(c1)cc(C)c(=O)n2C		CHEMBL3752151	=	Delta TM	C	0.11	CHEMBL1293289	Homo sapiens	Delta TM	C	0.11
	22069305	CHEMBL4650070	Thermal Shift Assay. Domain start/stop: E348-D455	B	COc1cc2c(cc1NS(=O)(=O)c1ccc(Br)cc1C)n(C)c(=O)n2C		CHEMBL3770173	=	Delta TM	C	1.02	CHEMBL1293289	Homo sapiens	Delta TM	C	1.02
	22069306	CHEMBL4650070	Thermal Shift Assay. Domain start/stop: E348-D455	B	Cc1cc(=O)n(C)c2cc(N3C(=O)CC[C@@H](NS(=O)(=O)CC(C)C)[C@@H]3c3ccc(Cl)cc3)ccc12		CHEMBL4650212	=	Delta TM	C	-0.14	CHEMBL1293289	Homo sapiens	Delta TM	C	-0.14
	22069307	CHEMBL4650070	Thermal Shift Assay. Domain start/stop: E348-D455	B	CCCS(=O)(=O)c1nc(NC2CC2)cc(-c2ccc3c(ccn3C3CC(C)(C)NC(C)(C)C3)c2)n1		CHEMBL3785432	=	Delta TM	C	0.39	CHEMBL1293289	Homo sapiens	Delta TM	C	0.39
	22069308	CHEMBL4650070	Thermal Shift Assay. Domain start/stop: E348-D455	B	CCn1cc(-c2cccc(C(F)(F)F)c2)c2sc(C(=N)NC3CCS(=O)(=O)CC3)cc2c1=O		CHEMBL3769507	=	Delta TM	C	1.39	CHEMBL1293289	Homo sapiens	Delta TM	C	1.39
	22069309	CHEMBL4650070	Thermal Shift Assay. Domain start/stop: E348-D455	B	COc1ccccc1C(=O)Nc1cc2c(cc1N1CCCC1)n(C)c(=O)n2C		CHEMBL3356143	=	Delta TM	C	0.74	CHEMBL1293289	Homo sapiens	Delta TM	C	0.74
	22069310	CHEMBL4650070	Thermal Shift Assay. Domain start/stop: E348-D455	B	Cc1nnc2c3ccccc3c(N[C@@H](C)[C@H](c3ccccc3)N(C)C)nn12		CHEMBL4570969	=	Delta TM	C	0.23	CHEMBL1293289	Homo sapiens	Delta TM	C	0.23
	22069311	CHEMBL4650070	Thermal Shift Assay. Domain start/stop: E348-D455	B	CC(=O)c1cc(-c2cc(C(=O)NC3CC3)ccc2C)c2ncccn12		CHEMBL4065619	=	Delta TM	C	0.84	CHEMBL1293289	Homo sapiens	Delta TM	C	0.84
	22069312	CHEMBL4650070	Thermal Shift Assay. Domain start/stop: E348-D455	B	Cn1cc(CCn2cnc(-c3cnn(C)c3)c2-c2ccc(C#N)cc2)cn1		CHEMBL4296718	=	Delta TM	C	0.28	CHEMBL1293289	Homo sapiens	Delta TM	C	0.28
	22069313	CHEMBL4650071	Thermal Shift Assay. Domain start/stop: E348-D455	B	CCOC(=O)Nc1cc(-c2ccc(C)c(NS(C)(=O)=O)c2)nn2c(C)nnc12		CHEMBL3133807	=	Delta TM	C	6.68	CHEMBL1293289	Homo sapiens	Delta TM	C	6.68
	22070005	CHEMBL4650198	Reverse ITC (compound as receptor). Domain start/stop: E348-D455	B	CCOC(=O)Nc1cc(-c2ccc(C)c(NS(C)(=O)=O)c2)nn2c(C)nnc12		CHEMBL3133807	=	Kd	nM	50.3	CHEMBL1293289	Homo sapiens	Kd	uM	0.0503
	22389835	CHEMBL4666847	Binding affinity to human partial length BRD2 (BD1) (K71 to N194 residues) expressed in bacterial expression system by BROMOscan assay	B	Cc1noc(C)c1-c1ccc2nc(-c3cnn(CC(C)(C)O)c3)nc(N3CCOC[C@@H]3c3ccccc3)c2c1		CHEMBL4749664	=	Kd	nM	45.0	CHEMBL1293289	Homo sapiens	Kd	nM	45.0
	22389836	CHEMBL4666848	Binding affinity to human partial length BRD2 (BD1,2) (K71 to D455 residues) expressed in bacterial expression system by BROMOscan assay	B	Cc1noc(C)c1-c1ccc2nc(-c3cnn(CC(C)(C)O)c3)nc(N3CCOC[C@@H]3c3ccccc3)c2c1		CHEMBL4749664	=	Kd	nM	87.0	CHEMBL1293289	Homo sapiens	Kd	nM	87.0
	22389837	CHEMBL4666849	Binding affinity to human partial length BRD2 (BD2) (E348 to D455 residues) expressed in bacterial expression system by BROMOscan assay	B	Cc1noc(C)c1-c1ccc2nc(-c3cnn(CC(C)(C)O)c3)nc(N3CCOC[C@@H]3c3ccccc3)c2c1		CHEMBL4749664	=	Kd	nM	200.0	CHEMBL1293289	Homo sapiens	Kd	nM	200.0
	22397746	CHEMBL4668944	Displacement of Alexa Fluor 647 labelled ligand from 6His-Thr tagged BRD2 BD2/BD1 Y113A mutant (1 to 473 residues) (unknown origin) measured after 30 mins by TR-FRET assay	A	CC(=O)Nc1c(F)cc(C(=O)N[C@H]2CC[C@H](O)CC2)cc1O[C@@H](C)c1ccccc1		CHEMBL4636881	=	IC50	nM	251.19	CHEMBL1293289	Homo sapiens	pIC50		6.6
	22397747	CHEMBL4668945	Displacement of Alexa Fluor 647 labelled ligand from 6His-Thr tagged BRD2 BD1/BD2 Y386A mutant (1 to 473 residues) (unknown origin) measured after 30 mins by TR-FRET assay	A	CC(=O)Nc1c(F)cc(C(=O)N[C@H]2CC[C@H](O)CC2)cc1O[C@@H](C)c1ccccc1		CHEMBL4636881	=	IC50	nM	10000.0	CHEMBL1293289	Homo sapiens	pIC50		5.0
	22794029	CHEMBL4710396	Inhibition of BRD2 BD1 (unknown origin) preincubated for 15 mins followed by peptide addition and measured after 60 mins by TR-FRET assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	IC50	nM	29.0	CHEMBL1293289	Homo sapiens	IC50	nM	29.0
	22794030	CHEMBL4710396	Inhibition of BRD2 BD1 (unknown origin) preincubated for 15 mins followed by peptide addition and measured after 60 mins by TR-FRET assay	B	COc1ccccc1S(=O)(=O)Nc1ccc2c(c1)C(=C(C)C)C(=O)N2		CHEMBL4752543	=	IC50	nM	24.0	CHEMBL1293289	Homo sapiens	IC50	nM	24.0
	22794031	CHEMBL4710396	Inhibition of BRD2 BD1 (unknown origin) preincubated for 15 mins followed by peptide addition and measured after 60 mins by TR-FRET assay	B	CC(C)=C1C(=O)Nc2ccc(NS(=O)(=O)c3ccccc3Br)cc21		CHEMBL4798353	=	IC50	nM	40.0	CHEMBL1293289	Homo sapiens	IC50	nM	40.0
	22794032	CHEMBL4710396	Inhibition of BRD2 BD1 (unknown origin) preincubated for 15 mins followed by peptide addition and measured after 60 mins by TR-FRET assay	B	COc1ccc(Br)cc1S(=O)(=O)Nc1ccc2c(c1)C(=C(C)C)C(=O)N2		CHEMBL4743540	=	IC50	nM	39.0	CHEMBL1293289	Homo sapiens	IC50	nM	39.0
	22794033	CHEMBL4710397	Inhibition of BRD2 BD2 (unknown origin) preincubated for 15 mins followed by peptide addition and measured after 60 mins by TR-FRET assay	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266	=	IC50	nM	6.7	CHEMBL1293289	Homo sapiens	IC50	nM	6.7
	22794034	CHEMBL4710397	Inhibition of BRD2 BD2 (unknown origin) preincubated for 15 mins followed by peptide addition and measured after 60 mins by TR-FRET assay	B	COc1ccccc1S(=O)(=O)Nc1ccc2c(c1)C(=C(C)C)C(=O)N2		CHEMBL4752543	=	IC50	nM	18.0	CHEMBL1293289	Homo sapiens	IC50	nM	18.0
	22794035	CHEMBL4710397	Inhibition of BRD2 BD2 (unknown origin) preincubated for 15 mins followed by peptide addition and measured after 60 mins by TR-FRET assay	B	CC(C)=C1C(=O)Nc2ccc(NS(=O)(=O)c3ccccc3Br)cc21		CHEMBL4798353	=	IC50	nM	25.0	CHEMBL1293289	Homo sapiens	IC50	nM	25.0
	22794036	CHEMBL4710397	Inhibition of BRD2 BD2 (unknown origin) preincubated for 15 mins followed by peptide addition and measured after 60 mins by TR-FRET assay	B	COc1ccc(Br)cc1S(=O)(=O)Nc1ccc2c(c1)C(=C(C)C)C(=O)N2		CHEMBL4743540	=	IC50	nM	22.0	CHEMBL1293289	Homo sapiens	IC50	nM	22.0
	22823580	CHEMBL4716995	Inhibition of BRD2 BD1 (unknown origin) using biotinylated JQ1 analog as substrate measured after 20 mins by AlphaLISA assay	B	Cc1nnc2n1-c1ccc(-c3ccc(N)nc3)cc1N(c1ccc(Cl)cc1)C[C@H]2C		CHEMBL4780530	=	IC50	nM	3.0	CHEMBL1293289	Homo sapiens	IC50	uM	0.003
	22823581	CHEMBL4716996	Inhibition of BRD2 BD2 (unknown origin) using biotinylated JQ1 analog as substrate measured after 20 mins by AlphaLISA assay	B	Cc1nnc2n1-c1ccc(-c3ccc(N)nc3)cc1N(c1ccc(Cl)cc1)C[C@H]2C		CHEMBL4780530	=	IC50	nM	3.0	CHEMBL1293289	Homo sapiens	IC50	uM	0.003
	22856021	CHEMBL4724819	Binding affinity to human partial length BRD2-BD1 (K71 to N194 residues) expressed in bacterial expression system by BROMOscan method	B	CN1C(=O)c2c(F)cccc2Oc2cc(N[C@H]3CC[C@H](O)CC3)ncc21		CHEMBL4763016	=	Kd	nM	71.0	CHEMBL1293289	Homo sapiens	Kd	nM	71.0
	22856022	CHEMBL4724819	Binding affinity to human partial length BRD2-BD1 (K71 to N194 residues) expressed in bacterial expression system by BROMOscan method	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461	=	Kd	nM	110.0	CHEMBL1293289	Homo sapiens	Kd	nM	110.0
	22856087	CHEMBL4724831	Binding affinity to human partial length BRD2-BD2 (E348 to D455 residues) expressed in bacterial expression system by BROMOscan method	B	CN1C(=O)c2c(F)cccc2Oc2cc(N[C@H]3CC[C@H](O)CC3)ncc21		CHEMBL4763016	=	Kd	nM	160.0	CHEMBL1293289	Homo sapiens	Kd	nM	160.0
	22856088	CHEMBL4724831	Binding affinity to human partial length BRD2-BD2 (E348 to D455 residues) expressed in bacterial expression system by BROMOscan method	B	CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21		CHEMBL1232461	=	Kd	nM	25.0	CHEMBL1293289	Homo sapiens	Kd	nM	25.0
	22880737	CHEMBL4727028	Binding affinity to full length BRD2 BD2 in human HuT78 cell lysates incubated for 45 mins by liquid chromatography-mass spectrometry based chemoproteomic binding assay	B	Cc1cc2c(-c3ccco3)cnc(N[C@@H]3CCN(C)C[C@H]3C(=O)NC3CCCCC3)c2[nH]c1=O		CHEMBL4648362	<	Kd	nM	25118.86	CHEMBL1293289	Homo sapiens	pKd		4.6
	22880919	CHEMBL4727051	Binding affinity to human partial length BRD2 bromodomain 1 long isoform (K71 to N194 residues) expressed in bacterial expression system by BROMOscan assay	B	Cc1cc2c(-c3ccco3)cnc(N[C@@H]3CCN(C)C[C@H]3C(=O)NC3CCCCC3)c2[nH]c1=O		CHEMBL4648362	=	Kd	nM	19.95	CHEMBL1293289	Homo sapiens	pKd		7.7
	22880923	CHEMBL4727055	Binding affinity to human partial length BRD2 bromodomain 2 isoform 1 (E348 to D455 residues) expressed in bacterial expression system by BROMOscan assay	B	Cc1cc2c(-c3ccco3)cnc(N[C@@H]3CCN(C)C[C@H]3C(=O)NC3CCCCC3)c2[nH]c1=O		CHEMBL4648362	=	Kd	nM	25118.86	CHEMBL1293289	Homo sapiens	pKd		4.6
	22880932	CHEMBL4727064	Binding affinity to full length BRD2 BD1 in human HuT78 cell lysates incubated for 45 mins by liquid chromatography-mass spectrometry based chemoproteomic binding assay	B	Cc1cc2c(-c3ccco3)cnc(N[C@@H]3CCN(C)C[C@H]3C(=O)NC3CCCCC3)c2[nH]c1=O		CHEMBL4648362	=	Kd	nM	3.981	CHEMBL1293289	Homo sapiens	pKd		8.4
	22887509	CHEMBL4728489	Inhibition of His6-tagged BRD2 bromodomain 1 (unknown origin) expressed in Escherichia coli Bl21(DE3) cells at 1 uM incubated for 4 hrs by FP assay relative to control	B	CC(C)N1c2cc(Nc3nccc(-c4cncc5ccccc45)n3)ccc2N(C)C(=O)[C@H]1C		CHEMBL4742169	<	Inhibition	%	12.0	CHEMBL1293289	Homo sapiens	INH	%	12.0
	22887510	CHEMBL4728490	Inhibition of His6-tagged BRD2 bromodomain 2 (unknown origin) expressed in Escherichia coli Bl21(DE3) cells at 1 uM incubated for 4 hrs by FP assay relative to control	B	CC(C)N1c2cc(Nc3nccc(-c4cncc5ccccc45)n3)ccc2N(C)C(=O)[C@H]1C		CHEMBL4742169	<	Inhibition	%	12.0	CHEMBL1293289	Homo sapiens	INH	%	12.0
	22897948	CHEMBL4730991	Binding affinity to N-terminal His-tagged human recombinant BRD2 bromodomain 1 (71 to 194 residues) expressed in Escherichia coli assessed as change in melting temperature at 10 uM by BromoMELT assay	B	COc1ccccc1S(=O)(=O)Nc1ccc2c(c1)CN(C)C(=O)N2		CHEMBL2179387	=	Delta Tm	degrees C	3.5	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	3.5
	22897949	CHEMBL4730991	Binding affinity to N-terminal His-tagged human recombinant BRD2 bromodomain 1 (71 to 194 residues) expressed in Escherichia coli assessed as change in melting temperature at 10 uM by BromoMELT assay	B	CN1Cc2cc(N=[S@@](C)(=O)c3ccccc3)ccc2NC1=O		CHEMBL4790505	=	Delta Tm	degrees C	2.5	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	2.5
	22953222	CHEMBL4767050	Binding affinity to human recombinant His6-tagged BRD2 bromodomain 1 (K77 to N194 residues) expressed in Escherichia coli BL21 (DE3) cells assessed as change in melting temperature at 200 uM incubated for 30 mins by SYPRO orange dye based thermal shift assay	B	COc1cc2onc(C)c2cc1NS(=O)(=O)c1cc(Br)ccc1OC		CHEMBL4798044	=	Delta Tm	degrees C	5.3	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	5.3
	22953223	CHEMBL4767050	Binding affinity to human recombinant His6-tagged BRD2 bromodomain 1 (K77 to N194 residues) expressed in Escherichia coli BL21 (DE3) cells assessed as change in melting temperature at 200 uM incubated for 30 mins by SYPRO orange dye based thermal shift assay	B	CNc1cc2onc(C)c2cc1NS(=O)(=O)c1cc(Br)ccc1OC		CHEMBL4781472	=	Delta Tm	degrees C	5.3	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	5.3
	22953224	CHEMBL4767050	Binding affinity to human recombinant His6-tagged BRD2 bromodomain 1 (K77 to N194 residues) expressed in Escherichia coli BL21 (DE3) cells assessed as change in melting temperature at 200 uM incubated for 30 mins by SYPRO orange dye based thermal shift assay	B	Cc1noc2c(Br)cc(-c3nc4ccc(N5CCOCC5)cc4n3CC3CCCCC3)cc12		CHEMBL4782221	=	Delta Tm	degrees C	6.0	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	6.0
	22953225	CHEMBL4767050	Binding affinity to human recombinant His6-tagged BRD2 bromodomain 1 (K77 to N194 residues) expressed in Escherichia coli BL21 (DE3) cells assessed as change in melting temperature at 200 uM incubated for 30 mins by SYPRO orange dye based thermal shift assay	B	Cc1noc2ccc(-c3nc4ccc(N5CCOC[C@@H]5C)cc4n3CC3CCCCC3)cc12		CHEMBL4791634	=	Delta Tm	degrees C	6.3	CHEMBL1293289	Homo sapiens	deltaTm	degrees C	6.3
	23148625	CHEMBL4809925	Displacement of Alexa Fluor 647 labelled ligand from 6His-Thr tagged BRD2 BD1/BD2 Y386A mutant (1 to 473 residues) (unknown origin) measured after 30 mins by TR-FRET assay	A	CNC(=O)c1cc(C(=O)N[C@H]2C[C@@H]2C)cc(C(O)c2ccccc2)n1		CHEMBL4862372	=	IC50	nM	39810.72	CHEMBL1293289	Homo sapiens	pIC50		4.4
	23148626	CHEMBL4809926	Displacement of Alexa Fluor 647 labelled ligand from 6His-Thr tagged BRD2 BD2/BD1 Y113A mutant (1 to 473 residues) (unknown origin) measured after 30 mins by TR-FRET assay	B	CNC(=O)c1cc(C(=O)N[C@H]2C[C@@H]2C)cc(C(O)c2ccccc2)n1		CHEMBL4862372	=	IC50	nM	39.81	CHEMBL1293289	Homo sapiens	pIC50		7.4
	23148634	CHEMBL4809934	Binding affinity to human partial length BRD2 BD 1 expressed in bacterial expression system by BROMOscan assay	A	CNC(=O)c1cc(C(=O)N[C@H]2C[C@@H]2C)cc(C(O)c2ccccc2)n1		CHEMBL4862372	=	Kd	nM	25118.86	CHEMBL1293289	Homo sapiens	pKd		4.6
	23148635	CHEMBL4809935	Binding affinity to human partial length BRD2 BD 2 (E348 to D455 residues) expressed in bacterial expression system by BROMOscan assay	B	CNC(=O)c1cc(C(=O)N[C@H]2C[C@@H]2C)cc(C(O)c2ccccc2)n1		CHEMBL4862372	=	Kd	nM	10.0	CHEMBL1293289	Homo sapiens	pKd		8.0
	23233280	CHEMBL4827447	Displacement of Alexa Fluor 647 labelled ligand from 6His-Thr tagged BRD2 BD1/BD2 Y386A mutant (1 to 473 residues) (unknown origin) measured after 30 mins by TR-FRET assay	B	CNC(=O)CN(CC(c1ccccc1)c1ccccc1)C(=O)c1cc(C)c(OC)c(C)c1		CHEMBL4878540	=	IC50	nM	25118.86	CHEMBL1293289	Homo sapiens	pIC50		4.6
	23233281	CHEMBL4827448	Displacement of Alexa Fluor 647 labelled ligand from 6His-Thr tagged BRD2 BD2/BD1 Y113A mutant (1 to 473 residues) (unknown origin) measured after 30 mins by TR-FRET assay	B	CNC(=O)CN(CC(c1ccccc1)c1ccccc1)C(=O)c1cc(C)c(OC)c(C)c1		CHEMBL4878540	=	IC50	nM	398.11	CHEMBL1293289	Homo sapiens	pIC50		6.4
	23233445	CHEMBL4827465	Inhibition of human BRD2 BD1 (K71 to N194 residues) expressed in bacterial expression system at 10 uM by DiscoverX assay relative to control	B	CNC(=O)[C@H](C1CCOCC1)N(CC(c1ccccc1)c1ccccn1)C(=O)c1cc(C)c(=O)n(C)c1		CHEMBL4852928	=	Inhibition	%	75.0	CHEMBL1293289	Homo sapiens	INH	%	75.0
	23233449	CHEMBL4827469	Inhibition of human BRD2 BD2 (E348 to D455 residues) expressed in bacterial expression system at 10 uM by DiscoverX assay relative to control	B	CNC(=O)[C@H](C1CCOCC1)N(CC(c1ccccc1)c1ccccn1)C(=O)c1cc(C)c(=O)n(C)c1		CHEMBL4852928	>=	Inhibition	%	99.8	CHEMBL1293289	Homo sapiens	INH	%	99.8
Not Active	23246175	CHEMBL4829972	Inhibition of BRD2-BD1 (unknown origin) at 1 uM using acetylated H4 as substrate incubated for 1 hr by AlphaScreen assay	B	CN(C)CCCn1ccc2cc(-c3nc(S(C)(=O)=O)nc4[nH]ccc34)ccc21		CHEMBL4873042		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Not Active	23246176	CHEMBL4829973	Inhibition of BRD2-BD2 (unknown origin) at 1 uM using acetylated H4 as substrate incubated for 1 hr by AlphaScreen assay	B	CN(C)CCCn1ccc2cc(-c3nc(S(C)(=O)=O)nc4[nH]ccc34)ccc21		CHEMBL4873042		Inhibition	%		CHEMBL1293289	Homo sapiens	INH		
Not Active	23246194	CHEMBL4829985	Binding affinity to BRD2-BD1 (unknown origin) assessed as change in melting temperature at 50 uM by thermal shift assay	B	CN(C)CCCn1ccc2cc(-c3nc(S(C)(=O)=O)nc4[nH]ccc34)ccc21		CHEMBL4873042		Activity			CHEMBL1293289	Homo sapiens	Activity		
Not Active	23246195	CHEMBL4829986	Binding affinity to BRD2-BD2 (unknown origin) assessed as change in melting temperature at 50 uM by thermal shift assay	B	CN(C)CCCn1ccc2cc(-c3nc(S(C)(=O)=O)nc4[nH]ccc34)ccc21		CHEMBL4873042		Activity			CHEMBL1293289	Homo sapiens	Activity		
	23269670	CHEMBL4835103	Inhibition of 6His-Thr-BRD2 (1 to 473 residues) BD2 domain Y386A or Y113A mutant (unknown origin) incubated for 30 mins by TR-FRET assay	B	CCNC(=O)c1ccc(OCc2cccc(C)n2)c(-c2cn(C)nn2)c1		CHEMBL4856289	=	IC50	nM	1584.89	CHEMBL1293289	Homo sapiens	pIC50		5.8
	23269671	CHEMBL4835103	Inhibition of 6His-Thr-BRD2 (1 to 473 residues) BD2 domain Y386A or Y113A mutant (unknown origin) incubated for 30 mins by TR-FRET assay	B	CCNC(=O)c1cc(Cc2cccc3[nH]ccc23)nc(-c2cn(C)nn2)c1		CHEMBL4856853	=	IC50	nM	50.12	CHEMBL1293289	Homo sapiens	pIC50		7.3
	23269672	CHEMBL4835103	Inhibition of 6His-Thr-BRD2 (1 to 473 residues) BD2 domain Y386A or Y113A mutant (unknown origin) incubated for 30 mins by TR-FRET assay	B	C[C@H](Oc1ccc(C(=O)NC2CC2)cc1-c1cn(C)nn1)c1ccccn1		CHEMBL4867703	=	IC50	nM	251.19	CHEMBL1293289	Homo sapiens	pIC50		6.6
	23269673	CHEMBL4835104	Inhibition of 6His-Thr-BRD2 (1 to 473 residues) BD1 domain (unknown origin) incubated for 30 mins by TR-FRET assay	B	CCNC(=O)c1ccc(OCc2cccc(C)n2)c(-c2cn(C)nn2)c1		CHEMBL4856289	<	IC50	nM	50118.72	CHEMBL1293289	Homo sapiens	pIC50		4.3
	23269674	CHEMBL4835104	Inhibition of 6His-Thr-BRD2 (1 to 473 residues) BD1 domain (unknown origin) incubated for 30 mins by TR-FRET assay	B	CCNC(=O)c1cc(Cc2cccc3[nH]ccc23)nc(-c2cn(C)nn2)c1		CHEMBL4856853	=	IC50	nM	25118.86	CHEMBL1293289	Homo sapiens	pIC50		4.6
	23269675	CHEMBL4835104	Inhibition of 6His-Thr-BRD2 (1 to 473 residues) BD1 domain (unknown origin) incubated for 30 mins by TR-FRET assay	B	C[C@H](Oc1ccc(C(=O)NC2CC2)cc1-c1cn(C)nn1)c1ccccn1		CHEMBL4867703	=	IC50	nM	39810.72	CHEMBL1293289	Homo sapiens	pIC50		4.4
	23278077	CHEMBL4836561	Binding affinity to 6His-Thr-BRD2 (1 to 473 residues) BD2 domain Y386A or Y113A mutant (unknown origin) incubated for 30 mins by TR-FRET assay	B	CNC(=O)c1cc(C(=O)N[C@H]2CC[C@H](O)CC2)n([C@@H](C)c2ccccc2)n1		CHEMBL4854042	=	IC50	nM	251.19	CHEMBL1293289	Homo sapiens	pIC50		6.6
	23278078	CHEMBL4836561	Binding affinity to 6His-Thr-BRD2 (1 to 473 residues) BD2 domain Y386A or Y113A mutant (unknown origin) incubated for 30 mins by TR-FRET assay	B	CNC(=O)c1cc(C(=O)N[C@H]2CC[C@H](O)CC2)c([C@@H](C)c2ccccc2)o1		CHEMBL4865767	=	IC50	nM	50.12	CHEMBL1293289	Homo sapiens	pIC50		7.3
	23278079	CHEMBL4836562	Binding affinity to 6His-Thr-BRD2 (1 to 473 residues) BD1 domain (unknown origin) incubated for 30 mins by TR-FRET assay	B	CNC(=O)c1cc(C(=O)N[C@H]2CC[C@H](O)CC2)n([C@@H](C)c2ccccc2)n1		CHEMBL4854042	=	IC50	nM	25118.86	CHEMBL1293289	Homo sapiens	pIC50		4.6
	23278080	CHEMBL4836562	Binding affinity to 6His-Thr-BRD2 (1 to 473 residues) BD1 domain (unknown origin) incubated for 30 mins by TR-FRET assay	B	CNC(=O)c1cc(C(=O)N[C@H]2CC[C@H](O)CC2)c([C@@H](C)c2ccccc2)o1		CHEMBL4865767	=	IC50	nM	19952.62	CHEMBL1293289	Homo sapiens	pIC50		4.7
	23278281	CHEMBL4836608	Inhibition of 6His-Thr-BRD2 (1 to 473 residues) BD1 domain (unknown origin) incubated for 30 mins by TR-FRET assay	B	CNC(=O)c1cc(C(=O)N[C@@H]2[C@H]3C[C@H](O)C[C@H]32)cc2c1OC[C@@]2(C)c1ccccc1		CHEMBL4869149	=	IC50	nM	25118.86	CHEMBL1293289	Homo sapiens	pIC50		4.6
	23278291	CHEMBL4836618	Inhibition of recombinant human BRD2 BD2 (348 to 455 residues) expressed in bacterial expression system by bromoscan assay	B	CNC(=O)c1cc(C(=O)N[C@@H]2[C@H]3C[C@H](O)C[C@H]32)cc2c1OC[C@@]2(C)c1ccccc1		CHEMBL4869149	=	IC50	nM	2.512	CHEMBL1293289	Homo sapiens	pIC50		8.6
	23278293	CHEMBL4836620	Inhibition of recombinant human BRD2 BD1 (71 to 194 residues) expressed in bacterial expression system by bromoscan assay	B	CNC(=O)c1cc(C(=O)N[C@@H]2[C@H]3C[C@H](O)C[C@H]32)cc2c1OC[C@@]2(C)c1ccccc1		CHEMBL4869149	=	IC50	nM	10000.0	CHEMBL1293289	Homo sapiens	pIC50		5.0
	23278301	CHEMBL4836628	Inhibition of 6His-Thr-BRD2 (1 to 473 residues) BD2 domain Y386A or Y113A mutant (unknown origin) incubated for 30 mins by TR-FRET assay	B	CNC(=O)c1cc(C(=O)N[C@@H]2[C@H]3C[C@H](O)C[C@H]32)cc2c1OC[C@@]2(C)c1ccccc1		CHEMBL4869149	=	IC50	nM	10.0	CHEMBL1293289	Homo sapiens	pIC50		8.0
	23373756	CHEMBL4885533	BRD2(BRD2LHRC) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL1293289	Homo sapiens	pIC50		6.0
Active	23374362	CHEMBL4885665	BET mutant TR-FRET assay (BRD2 BD1)	B	Cc1cc2c(-c3ccco3)cnc(N[C@@H]3CCN(C)C[C@H]3C(=O)NC3CCCCC3)c2[nH]c1=O		CHEMBL4648362		IC50	nM	100.0	CHEMBL1293289	Homo sapiens	pIC50		7.0
Not Active	23374363	CHEMBL4885666	BET mutant TR-FRET assay (BRD2 BD2)	B	Cc1cc2c(-c3ccco3)cnc(N[C@@H]3CCN(C)C[C@H]3C(=O)NC3CCCCC3)c2[nH]c1=O		CHEMBL4648362		IC50	nM	19952.62	CHEMBL1293289	Homo sapiens	pIC50		4.7
Active	23374370	CHEMBL4885673	BRD2 BD1 Bromoscan (DiscoverX)	B	Cc1cc2c(-c3ccco3)cnc(N[C@@H]3CCN(C)C[C@H]3C(=O)NC3CCCCC3)c2[nH]c1=O		CHEMBL4648362		Kd	nM	19.95	CHEMBL1293289	Homo sapiens	pKd		7.7
Not Active	23374371	CHEMBL4885674	BRD2 BD2 Bromoscan (DiscoverX)	B	Cc1cc2c(-c3ccco3)cnc(N[C@@H]3CCN(C)C[C@H]3C(=O)NC3CCCCC3)c2[nH]c1=O		CHEMBL4648362		Kd	nM	25118.86	CHEMBL1293289	Homo sapiens	pKd		4.6
Active	23374378	CHEMBL4885681	BRD2 BD1 Chemoproteomics	B	Cc1cc2c(-c3ccco3)cnc(N[C@@H]3CCN(C)C[C@H]3C(=O)NC3CCCCC3)c2[nH]c1=O		CHEMBL4648362		Kd	nM	3.981	CHEMBL1293289	Homo sapiens	pKd		8.4
Not Active	23374379	CHEMBL4885682	BRD2 BD2 Chemoproteomics	B	Cc1cc2c(-c3ccco3)cnc(N[C@@H]3CCN(C)C[C@H]3C(=O)NC3CCCCC3)c2[nH]c1=O		CHEMBL4648362	<	Kd	nM	25118.86	CHEMBL1293289	Homo sapiens	pKd		4.6
	23374398	CHEMBL4885701	BRD2 (BD1) DiscoverX BROMOscan	B	Cc1cc2c(-c3ccco3)cnc(N[C@@H]3CCN(C)C[C@H]3C(=O)NC3CCCCC3)c2[nH]c1=O		CHEMBL4648362		Kd	nM	19.95	CHEMBL1293289	Homo sapiens	pKd		7.7
	23374399	CHEMBL4885702	BRD2 (BD2) DiscoverX BROMOscan	B	Cc1cc2c(-c3ccco3)cnc(N[C@@H]3CCN(C)C[C@H]3C(=O)NC3CCCCC3)c2[nH]c1=O		CHEMBL4648362		Kd	nM	25118.86	CHEMBL1293289	Homo sapiens	pKd		4.6
Not Active	23374429	CHEMBL4885665	BET mutant TR-FRET assay (BRD2 BD1)	B	Cc1cc2c(-c3ccco3)cnc(N[C@H]3CCN(C)C[C@@H]3C(=O)NC3CCCCC3)c2[nH]c1=O		CHEMBL4635540		IC50	nM	2511.89	CHEMBL1293289	Homo sapiens	pIC50		5.6
Not Active	23374430	CHEMBL4885666	BET mutant TR-FRET assay (BRD2 BD2)	B	Cc1cc2c(-c3ccco3)cnc(N[C@H]3CCN(C)C[C@@H]3C(=O)NC3CCCCC3)c2[nH]c1=O		CHEMBL4635540		IC50	nM	15848.93	CHEMBL1293289	Homo sapiens	pIC50		4.8
Not Active	23374531	CHEMBL4885732	TR-FRET assay (BRD2 BD1)	B	CC(=O)Nc1c(F)cc(C(=O)N[C@H]2CC[C@H](O)CC2)cc1O[C@@H](C)c1ccccc1		CHEMBL4636881		IC50	nM	10965.0	CHEMBL1293289	Homo sapiens	IC50	nM	10965.0
Active	23374532	CHEMBL4885733	TR-FRET assay (BRD2 BD2)	B	CC(=O)Nc1c(F)cc(C(=O)N[C@H]2CC[C@H](O)CC2)cc1O[C@@H](C)c1ccccc1		CHEMBL4636881		IC50	nM	264.0	CHEMBL1293289	Homo sapiens	IC50	nM	264.0
Not Active	23374539	CHEMBL4885740	BET mutant TR-FRET assay (BRD2 BD1)	B	CC(=O)Nc1c(F)cc(C(=O)N[C@H]2CC[C@H](O)CC2)cc1O[C@@H](C)c1ccccc1		CHEMBL4636881		IC50	nM	10000.0	CHEMBL1293289	Homo sapiens	pIC50		5.0
Active	23374540	CHEMBL4885741	BET mutant TR-FRET assay (BRD2 BD2)	B	CC(=O)Nc1c(F)cc(C(=O)N[C@H]2CC[C@H](O)CC2)cc1O[C@@H](C)c1ccccc1		CHEMBL4636881		IC50	nM	251.19	CHEMBL1293289	Homo sapiens	pIC50		6.6
Not Active	23374547	CHEMBL4885748	BRD2 BD1 Bromoscan (DiscoverX)	B	CC(=O)Nc1c(F)cc(C(=O)N[C@H]2CC[C@H](O)CC2)cc1O[C@@H](C)c1ccccc1		CHEMBL4636881		Kd	nM	1621.0	CHEMBL1293289	Homo sapiens	Kd	nM	1621.0
Active	23374548	CHEMBL4885749	BRD2 BD2 Bromoscan (DiscoverX)	B	CC(=O)Nc1c(F)cc(C(=O)N[C@H]2CC[C@H](O)CC2)cc1O[C@@H](C)c1ccccc1		CHEMBL4636881		Kd	nM	35.0	CHEMBL1293289	Homo sapiens	Kd	nM	35.0
	23374564	CHEMBL4885765	BRD2(1) DiscoverX BROMOscan	B	CC(=O)Nc1c(F)cc(C(=O)N[C@H]2CC[C@H](O)CC2)cc1O[C@@H](C)c1ccccc1		CHEMBL4636881		Kd	nM	1621.0	CHEMBL1293289	Homo sapiens	Kd	nM	1621.0
	23374565	CHEMBL4885766	BRD2(1,2) DiscoverX BROMOscan	B	CC(=O)Nc1c(F)cc(C(=O)N[C@H]2CC[C@H](O)CC2)cc1O[C@@H](C)c1ccccc1		CHEMBL4636881		Kd	nM	100.0	CHEMBL1293289	Homo sapiens	Kd	nM	100.0
	23374566	CHEMBL4885767	BRD2(2) DiscoverX BROMOscan	B	CC(=O)Nc1c(F)cc(C(=O)N[C@H]2CC[C@H](O)CC2)cc1O[C@@H](C)c1ccccc1		CHEMBL4636881		Kd	nM	35.0	CHEMBL1293289	Homo sapiens	Kd	nM	35.0
Not Active	23374646	CHEMBL4885732	TR-FRET assay (BRD2 BD1)	B	CNC(=O)c1cc(C(=O)NC2CC2)cn(Cc2ccccc2)c1=O		CHEMBL4635134		IC50	nM	25420.0	CHEMBL1293289	Homo sapiens	IC50	nM	25420.0
Active	23374647	CHEMBL4885733	TR-FRET assay (BRD2 BD2)	B	CNC(=O)c1cc(C(=O)NC2CC2)cn(Cc2ccccc2)c1=O		CHEMBL4635134		IC50	nM	285.0	CHEMBL1293289	Homo sapiens	IC50	nM	285.0
Not Active	23374654	CHEMBL4885800	BET mutant TR-FRET assay (BRD2 BD1)	B	CNC(=O)c1cc(C(=O)NC2CC2)cn(Cc2ccccc2)c1=O		CHEMBL4635134		IC50	nM	25118.86	CHEMBL1293289	Homo sapiens	pIC50		4.6
Active	23374655	CHEMBL4885801	BET mutant TR-FRET assay (BRD2 BD2)	B	CNC(=O)c1cc(C(=O)NC2CC2)cn(Cc2ccccc2)c1=O		CHEMBL4635134		IC50	nM	316.23	CHEMBL1293289	Homo sapiens	pIC50		6.5
Not Active	23374662	CHEMBL4885808	BRD2 BD1 Bromoscan (DiscoverX)	B	CNC(=O)c1cc(C(=O)NC2CC2)cn(Cc2ccccc2)c1=O		CHEMBL4635134		Kd	nM	12589.25	CHEMBL1293289	Homo sapiens	pKd		4.9
Active	23374663	CHEMBL4885809	BRD2 BD2 Bromoscan (DiscoverX)	B	CNC(=O)c1cc(C(=O)NC2CC2)cn(Cc2ccccc2)c1=O		CHEMBL4635134		Kd	nM	15.85	CHEMBL1293289	Homo sapiens	pKd		7.8
	23374679	CHEMBL4885825	BRD2(1) DiscoverX BROMOscan	B	CNC(=O)c1cc(C(=O)NC2CC2)cn(Cc2ccccc2)c1=O		CHEMBL4635134		Kd	nM	12589.25	CHEMBL1293289	Homo sapiens	pKd		4.9
	23374680	CHEMBL4885826	BRD2(2) DiscoverX BROMOscan	B	CNC(=O)c1cc(C(=O)NC2CC2)cn(Cc2ccccc2)c1=O		CHEMBL4635134		Kd	nM	15.85	CHEMBL1293289	Homo sapiens	pKd		7.8
Active	23379088	CHEMBL4885732	TR-FRET assay (BRD2 BD1)	B	COCc1nc2cnc3cc(-c4c(C)noc4C)c(OC[C@H]4CCNC4)cc3c2n1[C@H](C)c1ccccc1		CHEMBL4639128		IC50	nM	75.0	CHEMBL1293289	Homo sapiens	IC50	nM	75.0
Not Active	23379089	CHEMBL4885733	TR-FRET assay (BRD2 BD2)	B	COCc1nc2cnc3cc(-c4c(C)noc4C)c(OC[C@H]4CCNC4)cc3c2n1[C@H](C)c1ccccc1		CHEMBL4639128		IC50	nM	3950.0	CHEMBL1293289	Homo sapiens	IC50	nM	3950.0
Active	23379096	CHEMBL4886807	BET mutant TR-FRET assay (BRD2 BD1)	B	COCc1nc2cnc3cc(-c4c(C)noc4C)c(OC[C@H]4CCNC4)cc3c2n1[C@H](C)c1ccccc1		CHEMBL4639128		IC50	nM	79.43	CHEMBL1293289	Homo sapiens	pIC50		7.1
Not Active	23379097	CHEMBL4886808	BET mutant TR-FRET assay (BRD2 BD2)	B	COCc1nc2cnc3cc(-c4c(C)noc4C)c(OC[C@H]4CCNC4)cc3c2n1[C@H](C)c1ccccc1		CHEMBL4639128		IC50	nM	3162.28	CHEMBL1293289	Homo sapiens	pIC50		5.5
Active	23379104	CHEMBL4886815	BRD2 Bromoscan (DiscoverX)	B	COCc1nc2cnc3cc(-c4c(C)noc4C)c(OC[C@H]4CCNC4)cc3c2n1[C@H](C)c1ccccc1		CHEMBL4639128		Kd	nM	13.0	CHEMBL1293289	Homo sapiens	Kd	nM	13.0
	23379117	CHEMBL4886828	BRD2(1) DiscoverX BROMOscan	B	COCc1nc2cnc3cc(-c4c(C)noc4C)c(OC[C@H]4CCNC4)cc3c2n1[C@H](C)c1ccccc1		CHEMBL4639128		Kd	nM	13.0	CHEMBL1293289	Homo sapiens	Kd	nM	13.0
	23379118	CHEMBL4886829	BRD2(2) DiscoverX BROMOscan	B	COCc1nc2cnc3cc(-c4c(C)noc4C)c(OC[C@H]4CCNC4)cc3c2n1[C@H](C)c1ccccc1		CHEMBL4639128		Kd	nM	840.0	CHEMBL1293289	Homo sapiens	Kd	nM	840.0
Not Active	23379201	CHEMBL4886857	BET mutant TR-FRET assay (BRD2 BD1)	B	CNC(=O)c1cc(C(=O)N[C@@H]2[C@H]3COC[C@H]32)cc2c1O[C@H](CF)[C@H]2c1ccccc1		CHEMBL4637208		IC50	nM	39810.72	CHEMBL1293289	Homo sapiens	pIC50		4.4
Active	23379202	CHEMBL4886858	BET mutant TR-FRET assay (BRD2 BD2)	B	CNC(=O)c1cc(C(=O)N[C@@H]2[C@H]3COC[C@H]32)cc2c1O[C@H](CF)[C@H]2c1ccccc1		CHEMBL4637208		IC50	nM	31.62	CHEMBL1293289	Homo sapiens	pIC50		7.5
Not Active	23379209	CHEMBL4886865	BRD2 BD1 Bromoscan (DiscoverX)	B	CNC(=O)c1cc(C(=O)N[C@@H]2[C@H]3COC[C@H]32)cc2c1O[C@H](CF)[C@H]2c1ccccc1		CHEMBL4637208		Kd	nM	5011.87	CHEMBL1293289	Homo sapiens	pKd		5.3
Active	23379210	CHEMBL4886866	BRD2 BD2 Bromoscan (DiscoverX)	B	CNC(=O)c1cc(C(=O)N[C@@H]2[C@H]3COC[C@H]32)cc2c1O[C@H](CF)[C@H]2c1ccccc1		CHEMBL4637208		Kd	nM	5.012	CHEMBL1293289	Homo sapiens	pKd		8.3
	23379246	CHEMBL4886904	BRD2 (BD1) DiscoverX BROMOscan	B	CNC(=O)c1cc(C(=O)N[C@@H]2[C@H]3COC[C@H]32)cc2c1O[C@H](CF)[C@H]2c1ccccc1		CHEMBL4637208		Kd	nM	5011.87	CHEMBL1293289	Homo sapiens	pKd		5.3
	23379247	CHEMBL4886905	BRD2 (BD2) DiscoverX BROMOscan	B	CNC(=O)c1cc(C(=O)N[C@@H]2[C@H]3COC[C@H]32)cc2c1O[C@H](CF)[C@H]2c1ccccc1		CHEMBL4637208		Kd	nM	5.012	CHEMBL1293289	Homo sapiens	pKd		8.3
